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ABSTRACT 
 
 
 
Skeletal muscle exhibits remarkable plasticity, altering its size in response to a variety 
of stimuli, including exercise, nutrient availability, neural activity, hormonal factors, 
growth factors, injury, disease, and ageing. Total muscle mass reflects protein 
turnover, which is controlled by the dynamic balance between net muscle protein 
synthesis (MPS) and net muscle protein degradation/breakdown (MPB). Although 
research to date has made significant advances in understanding the molecular 
signalling pathways responsible for exercise and nutrient-induced increases in MPS, 
the effect of diverse anabolic stimulation on MPB signalling has not been investigated. 
Understanding the intracellular signalling pathways regulating protein turnover in 
response to anabolic stimulation is essential for the development of therapeutic 
interventions to attenuate muscle loss during disease states and ageing. Sarcopenia, or 
an age-related loss of skeletal muscle mass and function, occurs during ageing. 
Sarcopenia is characterized by physical frailty, an increased risk of falls and fractures 
and a loss in functional independence. A disruption in the normal regulation of skeletal 
muscle protein turnover most likely plays a significant role in the development and 
severity of sarcopenia. Older individuals have a reduced rate of MPS and anabolic 
signalling in response to exercise when compared to younger individuals. However, 
the contribution of changes in MPB signalling in older versus younger individuals, 
particularly in response to RE, are far less defined.  
 
This thesis examined mRNA and/or protein levels of muscle-specific E3-ubiquitin 
ligases, FBXO32 (also known as atrogin-1; muscle atrophy F-box, MAFbx) and 
muscle ring finger-1 (MURF-1). These E3-ubiquitin ligases are principal mediators of 
ubiquitin proteasome pathway (UPP) degradation, the primary mechanism for skeletal 
muscle protein degradation. Additionally, mRNA and/or protein expression of the 
transcriptional regulators of atrogin-1 and MURF-1, Forkhead box O1/03 (FOXO1 
and FOXO3) as well as a recently discovered E3-ligase, FBXO40 were measured. 
Substrates of atrogin-1− including eukaryotic translation initiation factor 3, subunit F 
(EIF3F), MYOGENIN (MYOG) and myogenic differentiation 1  (MYOD1)−and of 
MURF-1− including pyruvate kinase (PKM) and myosin heavy chain (MHC) were 
  ii 
also measured in response to 1) single-bout and chronic endurance exercise (EE) and 
resistance exercise (RE), 2) contraction mode-specific single-bout and chronic 
exercise with/without whey protein hydrolysate (WPH) supplementation, and 3) in 
older versus younger individuals at basal and following single-bout RE.  
 
Following endurance training (ET) and resistance training (RT), atrogin-1, FBXO40, 
FOXO1, and FOXO3 mRNA increased independently of exercise mode, whereas 
MURF-1 mRNA and FOXO3 protein increased following ET only. In the trained state, 
atrogin-1, MURF-1, FBXO40 and FOXO1, FOXO3 mRNA, and FOXO3 protein 
increased following single-bout EE, but not RE. In contrast to EE, FBXO40 mRNA 
and protein decreased following single-bout RE. While single-bout EE performed in 
the trained state increases molecular markers of UPP, prior RT attenuates single-bout 
RE-induced UPP signalling. These results suggest that skeletal muscle adaptations 
following ET are more reliant on UPP protein degradation processes than adaptation 
following RT.  
 
Investigating contraction-mode specific exercise revealed that single-bout eccentric 
(ECC) exercise decreased atrogin-1 and FOXO3 mRNA, as well as FOXO1 and 
phospho-FOXO1 protein, while increasing MURF-1 mRNA. Concentric (CONC) 
single-bout exercise mediated a greater increase in MURF-1 mRNA, increased 
FOXO1 mRNA and downregulated FOXO1, FOXO3, and EIF3F protein. Following 
ECC-training, an increase in basal phospho-FOXO1 was observed. While WPH 
supplementation with ECC and CONC training augmented skeletal muscle 
hypertrophy, it did not have an additional effect on mRNA and/or protein levels of any 
of the targets measured following single-bout exercise performed following 
habituation, and during hypertrophy-inducing exercise training. This study showed 
that UPP molecular markers are differentially regulated by exercise contraction mode, 
but not WHP supplementation when combined with hypertrophy-inducing training. 
This highlights the complexity in understanding the differing roles these factors play 
in healthy adaptations to exercise.   
 
In younger versus older individuals, a comparable upregulation of atrogin-1, MURF-
1 and FBXO40 mRNA was observed 2 h following single-bout RE. In contrast, at 
basal, older subjects had an attenuated FBXO40 mRNA and protein level, which may 
  iii 
reflect a compensatory mechanism to limit age-related skeletal muscle loss. 
Additionally, an increase in PKM protein was observed in older versus younger 
subjects, potentially accounting for the reduced oxidative metabolism associated with 
muscle wasting in older people. 
 
Previous research identified that atrogin-1 and MURF-1 mediate MPB during skeletal 
muscle atrophy. The data presented here suggest that atrogin-1 and MURF-1 may also 
play an important role in muscle protein turnover that is required for skeletal muscle 
adaptation following divergent acute and chronic exercise. When combined with 
exercise stimulation, age and WPH supplementation had minimal effect on the 
expression of mRNA and/or protein levels measured. Taken together, these studies 
provide insight into the influence of specific and divergent anabolic stimuli on the 
mRNA and/or protein expression of E3-ubiquitin ligases, as well as their 
transcriptional regulators and substrate targets. Identifying mediators of UPP protein 
degradation is important to elucidate the cellular signalling responsible for maintaining 
skeletal muscle mass. This thesis has contributed toward understanding the 
relationships between divergent exercise modes, nutrition, skeletal muscle adaptations 
and ageing, which is a prerequisite to develop effective interventions to prevent and 
attenuate skeletal muscle wasting. 
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CHAPTER 1 
 
LITERATURE REVIEW 
 
 
 
1.1 Introduction 
Human skeletal muscle accounts for approximately 3040% of total body weight 
[197], and with a protein content of about 20%, it serves as the principal reservoir for 
protein/amino acids (AAs) [79]. As an essential tissue in the body, skeletal muscle is 
mainly responsible for the control of movement, the maintenance of posture, 
thermoregulation, breathing, and also plays a fundamental role in whole body 
metabolism [24, 50, 79]. Skeletal muscle tissue exhibits remarkable plasticity that can 
alter its size in response to a variety of stimuli, including, mechanical load, neural 
activity, nutrient availability, hormonal factors, growth factors, injury, and disease 
[134, 433]. In adult muscle, total muscle mass and fibre size reflect protein turnover, 
the dynamic balance between net protein synthesis and protein degradation. For an 
increase in skeletal muscle growth, or hypertrophy to occur, the rate of muscle protein 
synthesis (MPS) must be greater than the rate of muscle protein 
degradation/breakdown (MPB); this is seen during development and in response to 
anabolic stimulation. In contrast, a decrease in skeletal muscle mass, or atrophy, is 
observed when MPB exceeds MPS, as occurs during ageing, disuse and disease states. 
 
Exercise and nutritional availability are two stimuli profoundly affecting skeletal 
muscle protein turnover. Although research to date has made significant advances in 
understanding the signalling pathways responsible for exercise and nutrient-induced 
increases in protein synthesis, very few studies have investigated protein degradation 
signalling, a necessary component of protein turnover.  
 
The preservation of skeletal muscle mass plays an important role in maintaining health, 
disease prevention, and profoundly affects quality of life. Muscle atrophy secondary 
to many diseases is increasingly encountered in clinical practice [231] and is seen as 
one of the most potent stimuli limiting treatment options and attenuating patients 
response to treatment. Consequently, muscle atrophy is a strong predictor of morbidity 
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and mortality in cardiovascular, musculoskeletal, nervous, renal and respiratory 
diseases and cancers. These diseases are some of the top 10 causes of Australian deaths 
[15] at a cost to our health care system of over $20 billion per year, or 45% of the 
allocated health care budget [16]. 
 
The regulation of skeletal muscle mass is largely mediated by intracellular signalling 
pathways controlling both MPS and MPB [169]. Understanding the molecular and 
physiological mechanisms regulating muscle mass is a prerequisite for the 
development of therapeutic interventions aimed at improving clinical outcomes and 
reducing the economic burden on our health-care system. 
 
It is well established that the v-akt murine thymoma viral oncogene homolog 1 
(AKT)/mechanistic target of rapamycin (serine/threonine kinase) (MTOR) molecular 
signalling pathway plays a critical role in stimulating MPS and therefore, the induction 
of skeletal muscle hypertrophy in response to anabolic stimuli. However, regulatory 
mechanisms involved in MPB in response to exercise, nutrition, or a combination 
thereof, remain elusive. Similarly, protein degradation signalling in young versus 
elderly skeletal muscle is not well understood. Therefore, of the two contributing 
processes to net muscle protein balance (NMPB), muscle protein degradation 
signalling is the primary focus of this PhD. 
 
1.2 Skeletal muscle structure, composition and function  
Skeletal muscle is made up of bundles of muscle fibres, nerves and blood vessels. 
Muscle fibres are long multinucleated cylindrical cells, which form the functional units 
of skeletal muscle. Both the number of muscle fibres (genetically determined) and size 
of muscle fibres (continuously remodelled by changes in MPS and MPB) determine 
an individual’s total skeletal muscle volume [405]. Each muscle fibre contains 
thousands of myofibrils. Myofibrils consist of bundles of contractile proteins, called 
myofilaments, which are composed primarily of actin and myosin- the thin and thick 
myofilaments, respectively. Actin and myosin myofilaments are organised in a parallel 
arrangement in the smallest contractile unit of skeletal muscle, called the sarcomere. 
Myofibrils are surrounded by the sarcoplasm, which houses important organelles 
including the mitochondria and the sarcoplasmic reticulum; involved in oxidative 
metabolism and calcium (Ca2+) storage, respectively.   
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Skeletal muscle structure is closely linked to its function. The primary function of 
skeletal muscle is to produce force for movement via muscle contraction. The initial 
step in skeletal muscle contraction is the arrival of a nerve impulse at the 
neuromuscular junction, causing release of acetylcholine (ACh). ACh diffuses across 
the synapse and binds to the nicotinic acetylcholine receptors on the plasma membrane 
of the muscle fibre, known as the sarcolemma. This leads to a change in the 
transmembrane potential and the production of an action potential (AP) that spreads 
across the surface of the muscle fibre and along the transverse tubules. When the AP 
reaches the sarcoplasmic reticulum, intracellular Ca2+ is released and diffuses in the 
muscle to bind to troponin. A change in the position of the troponin-tropomyosin 
complex occurs, exposing the active sites of actin for the myosin head to bind. Muscle 
contraction is achieved by the repeated cycles of cross-bridge binding, pivoting, and 
detachment, with the expenditure of adenosine triphosphate (ATP) by the myosin 
ATPase enzyme [322].  
 
1.2.1 Skeletal muscle fibre types 
Skeletal muscle is composed of a heterogeneous mix of different myofibres. In human 
skeletal muscle, there are three main fibre types: type I (slow twitch), type IIa (fast 
twitch- intermediate) and type IIx (fast twitch), which differ in their contractile and 
metabolic characteristics. These differences are determined by the predominant 
myosin heavy chain (MHC) isoform of the muscle fibre and the gene expression 
profile of other cellular components such as the mitochondria and glycolytic and 
oxidative enzymes [50, 368].  
 
For instance, type I fibres contain myosin with a low ATPase activity and possess a 
slow maximal shortening velocity (Vmax) i.e. a slow contraction speed. These fibres 
contain a greater capillary density, mitochondria, oxidative enzymes, myoglobin, and 
metabolize ATP more slowly compared to type II fibres. Their large oxygen supply 
provides type I fibres with a greater capacity for aerobic metabolism, therefore they 
are specialized to contract for extended periods [301, 302]. In contrast, type IIx fibres 
contain myosin with a high ATPase activity and possess a high Vmax. As tension 
produced is directly proportional to the number of myofibrils, these fibres can produce 
greater force. As they contain fewer mitochondria and have a lower capillary density, 
type II fibres have a limited aerobic metabolism capacity, and are less resistant to 
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fatigue compared to type I fibres. However, type II fibres metabolize ATP quickly, 
and contain large glycogen reserves as well as glycolytic enzymes, providing them 
with a large anaerobic capacity suitable for power events  [301, 302]. Type IIa contain 
contractile, metabolic, and fatigue characteristics that are between type I and type IIx 
fibres [301, 302]. 
 
An individual’s muscle fibre type composition is determined by the genotype and is 
influenced by environmental factors such as exercise training [356]. Early research 
studies in rodents reported a higher basal rate of both protein synthesis and protein 
degradation in type I muscle fibres [232, 245]. However, studies in human skeletal 
muscle have found no biologically significant difference in sarcoplasmic and 
myofibrillar protein synthesis rates between different myofibres [100, 276]. 
Conversely, a loss of skeletal muscle mass with ageing is specific to atrophy of the 
type II muscle fibres.  
 
1.3 Embryonic skeletal muscle growth and development  
Myofibres are developed early during embryonic/neonatal development; the process 
of forming skeletal muscle is called myogenesis. In the embryo, precursor cells in the 
somites become determined for myogenic lineage, proliferate to give rise to myoblasts, 
terminally differentiate, exit the cell cycle and fuse to one another to form 
multinucleated myofibres. The process of myogenesis from a mononucleated 
precursor cell to a functional myofibre requires synchronized changes in gene 
expression. This coordination is mediated in part by myogenic factors (MYFs), basic 
helix-loop-helix muscle-specific transcriptional factors consisting of myogenic 
differentiation 1 (MYOD), myogenic factor 5 (MYF5), myogenin (MYOG) and 
myogenic factor 6 (MYF6) [336, 409]. The primary MRFs, MYOD and MYF5 are 
necessary for the determination of skeletal myoblasts while MYOG and MYF6 
(secondary MYFs) [53] are involved in differentiation, fusion and growth during the 
later stages of myogenesis. The completion of myogenesis is marked by the formation 
of mature muscle fibres containing numerous myofibrils with the ability to contract 
skeletal muscle.   
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1.4 Postnatal muscle regeneration and growth   
After embryonic development, muscle fibres are terminally differentiated and can no 
longer divide. Postnatal skeletal muscle processes include 1) the proliferation, 
differentiation and fusion of myogenic stem cell, known as satellite cells (SCs), and 2) 
a dynamic balance between synthesis and breakdown of skeletal muscle proteins.   
 
1.4.1 Skeletal muscle regeneration 
In postnatal muscle regeneration and growth, myoblasts are derived from the activation 
of resident muscle precursor SCs. SCs are quiescent skeletal muscle specific cells 
which are located between the basal lamina of adult skeletal muscle and the 
sarcolemma. In response to a stress or injury stimulus, SCs enter the cell cycle and 
undergo cellular division. Of the two identical daughter cells produced, one remains 
quiescent while the other undergoes myogenic activation, proliferation, differentiation 
and fusion. SCs are able to fuse with existing damaged myofibres, or fuse to each other 
to form new myofibres [68].  
 
MYFs are similarly involved during myogenesis in postnatal regeneration. MYOD and 
MYF5 are rapidly upregulated early and are required for the proliferation of SCs, while 
MYOG and MYF6 are expressed later during fusion and terminal differentiation. The 
distinct roles of MYOD and MYOG in adult myogenesis are highlighted by knockout 
(KO) studies in mice. MyoD deficient mice have a decrease in body mass and impaired 
muscle regeneration due to a failure of SCs to differentiate into mature myoblasts 
[270]. A deficiency in Myog results in a reduction in skeletal muscle albeit a 
presentation of myoblasts, suggesting that it is required for terminal differentiation 
[178, 282].  
 
While SCs show very little activity, they express paired homeobox transcription factor 
7 (PAX7) when quiescent, a marker specific to SCs. While muscle development in the 
embryo is not affected by the absence of PAX7, adult regenerative myogenesis and 
growth are compromised. PAX7 functions upstream of MYF5 and MYOD and is 
therefore important in controlling the activation, proliferation and fate of SCs [326]. 
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1.4.2 Skeletal muscle protein turnover 
Human skeletal muscle protein turnover is measured via stable isotope labelled AA 
tracers [267, 305]. MPS and MPB/degradation are usually measured as the fractional 
synthesis rate (FSR) and fractional breakdown rate (FBR) on mixed muscle, 
respectively, representing an average of all proteins in the muscle. However, muscle 
proteins can be divided into distinct protein fractions, including: myofibrillar 
[comprise the majority (>70%) of muscle proteins], such as actin and myosin, 
tropomyosin, troponin, titin, elastin; sarcoplasmic proteins (2030%), consisting of 
glycolytic enzymes and proteins of the sarcoplasmic reticulum; and mitochondrial 
protein fractions (5%), comprising enzymes of the tricarboxylic acid cycle, β-
oxidation, and mitochondrial respiratory chain. The different protein fractions differ 
in response to different exercise modalities [419]. In contrast to MPS, the analyses of 
MPB cannot differentiate between protein fractions [32, 434].  
 
The regulation of skeletal muscle mass and fibre size is determined by a dynamic 
equilibrium between MPS and MPB. Protein turnover, or the continuous and 
simultaneous synthesis and degradation of proteins, is critical to maintain protein 
quality and quantity. The turnover rate of skeletal muscle proteins is ~12% every day 
in healthy, recreationally active individuals [172, 329, 413]. This is a slow protein 
turnover rate compared to other tissues in the body; i.e. intestinal proteins are 3040% 
per day. However, when taking its mass into account, skeletal muscle contributes to 
3050% of whole-body protein turnover, which can be altered by exercise, nutritional 
state, age, injury, disease, and hormones [25, 407]. In a steady state, muscle proteins 
are continuously synthesized and degraded for repair and growth and generally, no net 
growth or loss of muscle occurs (depending on nutritional status).  
 
However, in a state where the rate of MPS exceeds the rate of MPB, there is an increase 
in muscle mass and fibre size, or hypertrophy; referred to as a positive NMPB or 
protein gain [157]. This is characterized by an increase in the size of pre-existing 
muscle fibres via the addition of new contractile proteins, mainly actin and myosin 
[129, 136, 375]. Anabolic stimuli that are capable of increasing skeletal muscle mass 
include RT [237, 375] nutrients, anabolic hormones such as growth hormone, insulin-
like growth factor 1 (IGF1), and testosterone [351].  
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In contrast, in a catabolic state, the balance between MPS and MPB within muscle 
fibres favours the latter, and a decrease in skeletal muscle mass and fibre size, or 
atrophy occurs (muscle is in a negative NMPB or protein loss) [152, 153]. A loss of 
muscle mass commonly occurs during starvation, ageing, disease states, injury, 
inactivity, denervation, and catabolic hormone treatment (corticosteroids). Skeletal 
muscle atrophy (and associated muscle weakness) is an integral aspect of 
neuromuscular disorders, Duchenne muscular dystrophy (DMD) and amyotrophic 
lateral sclerosis (ALS) [240, 255] as well as a major consequence of multiple chronic 
diseases, including cancer cachexia, heart disease, chronic obstructive pulmonary 
disease (COPD), sepsis, HIV/AIDS, and diabetes [256, 437].  
 
Maintaining muscle mass is a critical component of a healthy and sustaining life. 
Society is facing a rise in global ageing, consequently increasing the economic weight 
on health care resources. A better understanding of the molecular mechanisms 
involved in muscle regeneration and protein turnover is therefore required to aid the 
development of effective countermeasures to prevent, attenuate and/or reverse aged-
related skeletal muscle loss.   
 
1.4.3 Protein turnover during ageing 
Aged-related muscle atrophy (sarcopenia) is characterised by a selective atrophy of 
type II muscle fibres (~35%; Fig. 1.1) as well as a decrease in the content of SCs [202, 
242, 243, 392], resulting in a progressive decline in muscle mass, strength, and 
function [99, 120]. On average, 0.51.0% of muscle mass is lost per year from 40 years 
of age, with the loss of muscle mass rapidly increasing after 65 years of age [164]. 
Sarcopenia can result in overall weakness, frailty, reduced muscle function and aerobic 
capacity, thereby increasing functional dependence [81], the risk of falls, fractures and 
chronic metabolic illnesses (obesity, type 2 diabetes) [294], and finally, mortality [261, 
289].  
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Figure 1.1 Muscle fibre cross-sectional area (CSA) in young versus older individuals. Data are 
presented as means ± SEM. Type II muscle fibre CSA is significantly reduced in older subjects 
compared to younger individuals, *P < 0.05. Adapted from [391].  
 
While the aetiology of aged-related muscle atrophy is multifactorial, a disruption in 
the regulation of skeletal muscle protein turnover is the most metabolically explainable 
[42]. Early investigations reported a 2030% reduction in 
basal/fasting/postabsorptive) MPS [22, 177, 411, 412] and a 50% increase in MPB 
[388] in older, compared to younger individuals. However, if such contrasting rates 
were truly apparent, then the 0.51.0% rate of muscle loss typically seen per year 
would be much greater [257]. It is currently agreed that basal MPS and/or MPB rates 
do not significantly differ between healthy young and older individuals [90, 177, 204, 
205, 225, 292, 318, 402-404], therefore, studies are now focusing on the effect of 
anabolic stimuli on protein metabolism in older compared to younger subjects. Skeletal 
muscle of healthy young individuals is highly responsive to anabolic stimulation such 
as exercise and AAs. Although resistance exercise (RE)/endurance exercise (EE) and 
nutrition are able to stimulate MPS in older individuals [177, 352, 403, 413, 430], 
numerous evidence reveals an ‘anabolic resistance’, which is a reduced MPS in 
response to RE [225] and ingestion of essential amino acids (EAAs) [with or without 
carbohydrates (CHOs)] [57, 90, 167, 204, 402] in older compared to younger 
individuals [225]. The latter is thought to be a key contributor to aged-related loss of 
muscle mass [205].  
 
Some studies report only modest differences in anabolic signalling [173] and no 
significant difference in MPS [177, 430] between older and younger individuals in 
response to RE. Conversely, others show an attenuation of AKT/MTOR signalling, 
and a decrease in MPS, in RE in older compared to younger individuals [106, 112, 
137, 225, 295]. The contribution of changes in MPB signalling in older versus younger 
individuals, particularly in response to RE, are far less defined. One study showed a 
slight increase in basal MPB in older men [404]. However, another study observed no 
difference, instead showing that the normal insulin-induced inhibition of MPB is 
blunted in older individuals [418]. As the measurement of MPB is not performed as 
routinely as MPS due to its methodological difficulties and few studies using direct 
(stable isotope tracers) to measure MPB, studies primarily rely on mRNA and protein 
measurements of targets involved in MPB processes. A study by Raue et al. (2007) 
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demonstrated that genes involved in skeletal muscle proteolysis are differentially 
regulated in older versus younger women at rest and in response to RE [320]. However, 
most studies have not measured changes in protein expression, therefore it is not yet 
known if the changes in mRNA translate to changes in protein expression, and/or 
changes in MPB. There is a clear gap in the literature regarding the effect of exercise 
on muscle protein turnover, specifically MPB, and associated protein degradation 
signalling in older compared to younger individuals.     
 
The following discussion will focus on exercise and nutrition, two of the most readily 
available countermeasures for skeletal muscle atrophy.  
 
1.5 Exercise and skeletal muscle adaptation 
Skeletal muscle responds to physiological stimuli, and remodels itself according to the 
demands imposed on it, as well as by an individual’s genetic make-up. Exercise 
training elicits the necessary stimuli to promote positive skeletal muscle adaptations 
and is seen as one of the most potent interventions to maintain whole body health and 
reduce the risk of chronic disease [67, 338]. The intensity, frequency, volume, duration 
and mode of exercise performed, as well as the subject’s training status and nutritional 
availability, largely modulate metabolic and physiological exercise-induced skeletal 
muscle adaptations [74, 77, 225, 395]. The extracellular stress signals elicited by 
muscle contraction during RE and EE drive acute transient changes in intracellular 
signalling, gene transcription and protein translation, resulting in skeletal muscle 
remodelling during the recovery periods between exercise sessions [237, 311, 337, 
395, 396].  
 
Exercise-induced adaptations of muscle fibres are the net effect of the dynamics of 
protein synthesis and degradation of muscle proteins. However, given that the rate of 
protein turnover in skeletal muscle is relatively slow [172, 329, 363, 413], the 
development of exercise-induced adaptations require the accumulation of repeated 
bouts of acute exercise over a prolonged period (68-weeks) [162, 268, 311]. 
 
During exercise, it is difficult to measure protein turnover, as the muscle is not in a 
steady state and the duration of the exercise is usually too short for such measurements. 
Available data indicate that MPS is decreased/unchanged during RE/EE [64, 105, 106, 
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113, 140], likely explained by energy conservation whereby intramuscular AAs are 
used for energy production rather than muscle adaptation [105, 182, 327]. In contrast, 
MPB is unchanged or increases during exercise, which is actually measured during the 
rest periods between exercise sets [113, 378].  
 
Both RE [307] and EE [64] increase muscle protein turnover by increasing MPS and 
MPB (by a lesser extent) in the post-exercise recovery period. Both acute RE and EE 
increase the activation of the AKT/MTOR signalling pathway, with little difference 
between the exercise modalities [419]. However, with respect to chronic training, 
AKT/MTOR signalling increases following 10-weeks of RT but does not change with 
equivalent duration ET [419].     
 
1.5.1 Endurance exercise 
Regularly performed EE [moderate-intensity and long duration (3060 min)], 
typically enhances whole-body and muscle oxidative capacity/oxidative enzymes via 
an increase in capillary density and mitochondrial content, particularly the synthesis 
of mitochondrial proteins. [162, 181, 419]. Notably, ET results in a switch in substrate 
utilization i.e. enhanced lipid oxidation over CHOs at the same relative intensity, 
effectively sparing muscle glycogen stores [304].  
 
1.5.1.1 Protein turnover following endurance exercise   
There has been less research focused on muscle protein turnover after acute EE when 
compared with RE. However, several studies have reported an increase in mixed MPS 
after EE. Low-intensity EE (45 min, as well as 4 h at 40% VO2 max) [64, 112, 352] 
and moderate-intensity EE (1 h at ~70% 1 RM) [175] similarly increase mixed MPS 
(~45%) in the postabsorptive state [264]. With respect to specific protein fractions, an 
increase in myofibrillar and sarcoplasmic FSR have been reported following 1 h of 
single leg kicking, with the increase in myofibrillar FSR persisting for up to 72 h [272]. 
Conversely, Wilkinson et al. (2008) showed that single leg EE cycling increased FSR 
of mitochondrial proteins in both untrained and ET subjects, but had no effect on acute 
myofibrillar protein synthesis regardless of training status [419]. This disparity may 
be explained by a greater amount of muscular work required during single leg kicking 
compared to single leg cycling [419]. With respect to high-intensity EE, Mascher et 
al. (2011) reported an increase in FSR at 90 min post-single leg cycling, followed by 
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a progressive increase in FSR during the subsequent 90 min of recovery [264]. 
However, high intensity swimming does not increase FSR [382]. This inconsistency 
may reflect differences in subject training backgrounds, as the swimmers were well 
trained compared with recreationally active subjects in the former cycling study. Both 
RT and ET has been found to increase basal MPS (and, paradoxically, also increase 
the FBR) [177, 308, 310, 355]).  
 
While the knowledge regarding MPB following EE is scarce, MPB was increased 10 
min following a single bout of low-intensity EE (45 min at 40% VO2 max) in fasting, 
untrained young and older men. However, this increase returned to basal levels by 60 
min post-exercise in the young but not the older men [352].  
 
1.5.2 Resistance exercise 
RE, also known as strength exercise whereby muscle exerts force against a resistance 
whilst contracting i.e. high-intensity, short duration, weight-bearing exercise repeated 
at a sufficient frequency, increases muscle mass and strength [187, 268, 333, 363, 414]. 
This is largely due to an increase in the size of pre-existing muscle fibres via a net 
accretion of muscle sarcoplasmic and myofibrillar proteins over time [155, 268, 333, 
363].  
 
1.5.2.1 Protein turnover following resistance exercise   
The principal acute response after a bout of RE is a rapid (within 24 h) transient 
increase in MPS [307]. In trained individuals, the rate of MPS is elevated for up to 
1624 h [69, 258, 371] while in untrained individuals, mixed muscle FSR persists for 
2448 h post-exercise (112% increase at 3 h, 65% at 24 h, 34% at 48 h) [33, 69, 258, 
307, 371, 430]. RT stimulates mixed MPS [258, 308]; specifically, myofibrillar FSR 
is increased (36%) following an acute bout of RE in trained individuals [419]. 
Interestingly, Wilkinson et al. (2008) reported that in untrained individuals, acute RE 
stimulates an increase in both myofibrillar and mitochondrial protein synthesis (67% 
and 69%, respectively). [419].  
 
Following a bout of RE in the fasting state, despite the large increase in MPS, NMPB 
remains negative (although less negative compared to rest), because the rate of MPB, 
which exceeds the rate of MPS prior to exercise, also increases [33, 35, 102, 307, 308]. 
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However, the rise in MPB following RE is of less magnitude and more short-lived than 
that of MPS (31% at 3 h, 18% at 24 h, before returning to resting levels by 48 h post-
exercise) [33, 307]. NMPB will remain negative without the supplementation of 
nutrients, particularly protein, in the post-exercise recovery period [33, 34, 307, 381].  
 
1.5.2.2 Contraction specific resistance exercise  
RE encompasses the combination of static and dynamic muscle actions. During static 
muscle actions, muscle is actively held at a fixed position under the tension of an 
external load. Dynamic muscle actions involve both concentric (CONC) and eccentric 
(ECC) phases of muscle contractions, involving the muscle fibres shortening and 
lengthening whilst developing tension, respectively. Traditional RE requires a 
combination of both CONC and ECC phases of contraction. However, it is postulated 
that ECC and CONC RE performed in isolation distinctively stimulate skeletal muscle, 
thereby resulting in divergent cellular and metabolic muscle adaptations [187]. For 
instance, ECC muscle contractions generate greater force at a higher metabolic 
efficiency and a lower cardiopulmonary response when compared to CONC muscle 
contractions [332]. However, unaccustomed ECC RE is associated with transient 
muscle damage characterized by soreness, swelling, decreased maximal force 
production, Z-band streaming, and a leaking of sarcoplasmic proteins (creatine kinase, 
myoglobin, troponin, etc.) into the blood [132, 364]; which is attenuated or even 
abolished with training [121, 133, 149]. While unaccustomed CONC RE similarly 
induces significant myofibrillar disruption, it is of far less magnitude than 
unaccustomed ECC RE [150]. Whether ECC RE induced-muscle 'damage' causes an 
accelerated adaptation and muscle remodelling, when compared with traditional RE is 
debatable [432] and has been reviewed previously [347].  
 
Studies comparing ECC and CONC training have generally shown that ECC training 
(particularly when performed at high intensities) results in a greater muscle CSA and 
fibre size, as well as muscle strength, when compared to CONC training alone [124, 
179, 186, 187, 229, 332, 393]. The superiority of ECC training on muscle hypertrophy 
and strength is thought to be attributable to higher forces attained during ECC muscle 
contractions [332]. Additionally, a meta-analysis conducted by Roig et al. (2008) 
showed that the strength gains of ECC training are velocity specific [332].  Conversely, 
other studies have found similar increases in muscle hypertrophy and strength induced 
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by ECC and CONC training [37, 200, 350, 358]. Moreover, when exercise intensity 
and total volume of work is equivalent between contraction modes, no difference in 
training-induced gains in muscle mass occur [280]; suggesting that the greater ECC 
training induced-hypertrophy response may be due to an increased external load with 
this mode of exercise rather than contraction type, per se [280].  
 
1.5.2.3 Protein turnover with ECC and CONC resistance exercise 
Studies have investigated whether there are any differences in protein turnover 
response between ECC and CONC contraction modes. With the exception of one study 
showing a greater increase in myofibrillar MPS after maximal ECC RE compared to 
maximal CONC RE [277], there seem to be only small temporal differences in mixed 
MPS [91, 307], or myofibrillar MPS [149], between ECC and CONC RE. Moreover, 
the one study which has measured MPB found no differences between ECC and 
CONC contraction modes [307]. However, the ECC RE in this study may not have 
been severe enough (in assuming a relationship exists between ECC RE-induced 
damage and protein degradation), as the study also observed no differences in the 
myofibrillar damage between the contraction modes [307]. 
 
1.5.2.4 Molecular signalling with ECC and CONC resistance exercise  
Maximal ECC RE results in a greater activation of members of the AKT/MTOR 
pathway (p70-S6K, and the ribosomal protein S6K) when compared to CONC RE 
[115]. However, whether protein degradation signalling is differentially altered by 
muscle exercise contraction mode in response to acute exercise and/or long-term 
exercise training is yet to be fully elucidated. Moreover, few studies linking molecular 
signalling mechanisms with ECC versus CONC long-term training outcomes have 
been performed and this is an area that requires investigation.   
 
Although EE and RE significantly increase MPS, the NMPB following exercise will 
remain negative without the ingestion of food [33, 307], specifically protein [34, 319, 
381]. Therefore, adequate nutrition is a critical component in combination with 
exercise; summation of consecutive periods of positive NMPB result in protein 
accumulation and ultimately skeletal muscle hypertrophy over time [303, 330]. 
 
  14 
1.6 Protein metabolism and feeding 
Protein metabolism is modified throughout the day by the ingestion of dietary protein. 
During fasting (postabsorptive period) MPB exceeds MPS (Fig. 1.2A), therefore 
NMPB is negative (Fig. 1.2B) and there is a continuous flow of AAs into the body’s 
free AA pool [225, 307]. AAs released through MPB are mainly reincorporated into 
newly synthesized proteins, while a considerable quantity are consumed for energy or 
lost due to AA oxidation and/or carbon donation for liver gluconeogenesis [405]. 
Because 100% of AAs from proteolysis are not reused, we have a daily requirement 
to ingest protein to replace the AAs that are lost. Following feeding (postprandial 
period), or more specifically protein ingestion, the digestion and absorption of protein 
results in an increase in plasma AAs. This rapidly increases MPS, while moderately 
decreasing MPB; mediated via an associated increase in plasma insulin [44, 314, 328, 
401]. Therefore, feeding/dietary AAs, shifts NMPB to positive (Fig. 1.2B), and as 
such, muscle protein that is lost between meals (i.e. in the postabsorptive period) is 
replaced to ensure muscle mass is maintained.  
 
1.6.1 Nutrition and protein turnover at rest 
Ingestion of a mixed meal or mixed AA infusions increase acute MPS [30, 328] of 
myofibrillar, sarcoplasmic, and mitochondrial proteins [41]. A ~3 fold increase in MPS 
occurs 3060 min after AA ingestion, reaching peak stimulation around 1.5 h, before 
returning to basal rates by around 23 h despite sustained circulating AAs 
(hyperaminoacidaemia) [13, 41, 279]; termed as the ‘muscle full’ phenomenon [156]. 
This anabolic effect is exclusively attributable to EAAs direct activation on regulatory 
proteins in mRNA translation while non-EAAs do not stimulate MPS [357, 383, 400]. 
Increasing levels of each EAA are required to maximally stimulate MPS [424, 425]. 
However, leucine appears to be the most important branched-chain amino acid 
(BCAA) for increasing postprandial MPS, as it is able to independently stimulate MPS 
through activation of MTOR signalling [8, 9, 87, 145, 290, 357].  
 
In contrast to MPS, EAAs or protein intake has a small, inhibitory effect on MPB (Fig. 
1.2A) [2, 163]. Infusion of mixed AAs or BCAAs decrease MPB in the forearm [250, 
251]. Likewise, leucine alone and EAAs + CHO ingestion suppresses MPB [154, 250, 
281, 283, 285, 286]. The inhibition of MPB is regulated by the release of insulin [163]. 
However, other studies have reported that increasing availability of EAAs post-
  15 
exercise does not significantly effect MPB [34, 49, 224, 381]. 
 
1.6.1.1 Protein Amount 
Dose-response studies have established that ~810 g of EAAs (~2025 g of high 
quality protein, ~1.52 g leucine) maximally stimulates mixed MPS at rest and 
during/immediately post-RE in young healthy men [90, 278]. No extra stimulatory 
effect on mixed MPS occurs with ingestion of additional protein or free leucine alone 
[90, 278]. However, it appears that muscle from elderly subjects has a reduction in AA 
sensitivity [107, 108] as a greater amount of protein (35 or 40 g of whey protein) is 
required to maximally stimulate myofibrillar MPS post-exercise in older adults [299, 
428].  
 
1.7 Nutrition and protein turnover following exercise 
The usual RE-induced increase in MPB in the postabsorptive state is prevented when 
EAAs, with or without CHOs, are ingested post-exercise. This inhibition/decrease in 
MPB together with a synergistic increase in MPS [33, 34, 48, 49, 307, 319, 381], 
results in a positive NMPB and subsequent muscle protein accretion (Fig. 1A and B) 
[307]. Specifically, when EAAs, with or without CHOs are ingested following an acute 
bout of RE [34, 49, 91, 216, 273, 277, 319, 371, 381, 384] or EE [148, 188, 241, 272], 
the increase in MPS is enhanced and remains elevated for a longer duration compared 
to the response of feeding or exercise alone [34, 49, 272, 279, 305]. Both myofibrillar 
and sarcoplasmic proteins may remain stimulated for up to 35 h post-RE [279, 324, 
416]. Furthermore, performing exhaustive RE followed by ingestion of 15 g of whey 
protein stimulates myofibrillar proteins synthesis for at least 24 h [58]. The ability of 
nutrition to increase MPS following RE is achieved by hyperaminoacidaemia rather 
than glucose [48, 273]. Moreover, there is an increase in the number of AAs 
incorporated into muscle protein, suggesting that exercise pre-conditions skeletal 
muscle and thereby delays/extends the muscle-full ‘set point’ response [279].  
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Figure 1.2 Muscle protein synthesis and breakdown at rest, following amino acid ingestion (AA), 
following resistance exercise (RE) and RE combined with AA ingestion (A). Net muscle protein balance 
(NMPB) under the same conditions (B). Data are presented as means ± SD. Images from [154], original 
data from [126, 129].  
 
1.7.1 The role of CHO and insulin in protein turnover 
Although an increase in circulating insulin (hyperinsulinaemia) has been reported to 
increase MPS rates and therefore muscle protein accretion [104, 141, 147, 188], this 
only exists when increased AAs are available [33, 141]. CHO ingestion alone and/or 
hyperinsulinaemia do not significantly affect MPS at rest [9, 210] and post-exercise 
[35, 40, 48, 90, 147, 163, 252, 376]. In fact, co-ingestion with a small or large amount 
of CHO with an adequate amount of protein does not augment MPS following exercise 
[212, 362]. Furthermore, a dose-response study by Greenhaff et al. (2008) 
demonstrated that a low concentration of insulin (5 μU/ml) produces a maximal AA-
induced increase in MPS, where after greater concentrations of insulin (up to 150 
μU/ml) resulted in no further stimulation of MPS [163].  
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In contrast, CHO ingestion post-exercise inhibits exercise-induced MPB due to the 
simultaneous hyperinsulinaemia [35, 147, 163], and therefore improves NMPB [48, 
154, 273, 335, 362]. However, the NMPB still remains negative without protein 
ingestion [48, 273]. Interestingly, protein alone causes a rise in insulin similar to that 
produced following ingestion of a mixed meal [13]. MPB appears to be highly 
responsive to relatively small changes in insulin concentration; increasing circulating 
insulin to 30 μU/ml decreases MPB by 50%, while higher concentrations do not 
provide any further inhibitory effect of MPB [163]. Protein ingestion (25 g of whey 
protein) compared to co-ingestion of protein with CHO (additional 50 g CHO) results 
in no differences in MPS and MPB at rest or following acute RE [362]. Collectively, 
this data suggests that adequate protein ingestion post-RE [278] and succeeding 
hyperaminoacidaemia and hyperinsulinaemia, is sufficient to maximize MPS in 
addition to maximally inhibiting MPB. Therefore, there is no additional anabolic/anti-
proteolytic benefit of CHO ingestion with sufficient protein after exercise; EAAs are 
the primary regulator to optimize MPS in protein turnover post-exercise [362].    
 
1.7.2 Protein ingestion to maximise MPS following RE  
1.7.2.1 The role of protein quality   
Differences in AA composition and/or digestibility and absorption kinetics influence 
plasma AA concentration. For example, whey protein [221] is rapidly digested and 
absorbed, producing a quick, large, albeit transient increase in plasma AA levels [43, 
94, 95, 213]. In contrast, casein protein is slowly digested and absorbed, resulting in a 
moderate, but prolonged release of AAs into the blood [43, 94, 95]. Subsequently, 
“fast-acting” whey protein produces a large, but short-lived increase in MPS [43, 94, 
95, 213] while “slow-acting” casein protein induces a slower, albeit prolonged increase 
in MPS [43, 94, 95]. Additionally, although casein and whey protein both contain all 
of the required AAs to stimulate MPS, whey protein contains a greater leucine content 
[43, 94, 370].  
 
Ingestion of whey protein following RE increases mixed MPS during the early hours 
of recovery to a greater extent than casein [59, 298, 370, 416] and soy protein [176, 
370, 428], likely attributable to its rapid digestion/absorption properties and its higher 
BCAA content, particularly leucine [43, 94, 95, 213, 298, 372, 416]. However, other 
studies report that whey and casein or caseinate, a slightly more soluble form of casein, 
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result in an equal MPS and MPB response when measured up to 6 h post-exercise [101, 
324, 325, 380]. These discrepancies between studies in relation to the hypertrophic 
effects of different protein sources may be explained by the measuring period 
following protein ingestion as different proteins differentially stimulate MPS. 
Moreover, ingestion of a soy-dairy protein blend (25% soy, 25% whey, and 50% 
casein) compared to whey protein, 1 h following acute high-intensity RE, similarly 
increased mixed muscle FSR 02 h post-exercise [323]. However, during the later 
post-exercise period (24 h), the increase in FSR persisted in the soy-dairy blend group 
only. [323]. A difference between this study and the previous was that that the absolute 
leucine content between the protein interventions was matched. However, it has been 
previously reported that co-ingestion with leucine does not augment MPS following 
RE provided that sufficient protein is ingested [214-216].  
 
1.7.2.2 The role of protein timing  
The timing of protein ingestion with acute/chronic exercise regimes required to 
maximise MPS has been an area of considerable interest. Studies have reported a 
greater NMPB, muscle fibre hypertrophy, lean mass accretion, and muscle strength 
when protein is ingested immediately post-exercise as opposed to hours later [84, 117, 
191, 422]. Moreover, recent data found that EAA ingestion (with CHOs) before and 
during RE results in a greater increase in MPS post-exercise compared to ingestion 
immediately post-exercise [28, 384]; thought due to a greater delivery of AAs to the 
muscle during the early stages of recovery [28, 29, 140]. However, other studies have 
found no benefit of pre-exercise protein and CHO ingestion on post-exercise MPS 
compared to RE without nutritional supplementation [140, 379]. In light of these 
mixed results, a recent meta-analysis was conducted to investigate the effects of 
protein timing on hypertrophy and strength in response to RT [348]. Protein timing 
had a small to moderate effect on muscle hypertrophy and no effect on muscle strength. 
However, when covariates were controlled for, no effect on hypertrophy or strength 
was observed. Notably, the strongest predictor of hypertrophy was total protein intake 
[348].  
 
The interaction between protein quantity and the timing of protein ingestion following 
RE is not clearly understood. One study found that the rapid aminoacidemia attained 
by ingesting a large bolus of whey protein (25 g) produced a greater increase in 
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myofibrillar MPS when measured 15 h following single-bout RE compared with a 
slower, moderate, and prolonged aminoacidemia achieved with a series of small 
“pulsed” protein ingestions (10 x 2.5 g) [416]. In a recent investigation by Areta et al. 
(2013), subjects undertook a bout or RE followed by ingestion of 80 g whey protein 
ingestion throughout 12 h of recovery as: 1) 8 x 10 g every 1.5 h (pulse); 4 x 20 g every 
3 h (intermediate); or 2 x 40 g every 6 h (bolus). Although all feeding patterns 
increased MPS (112 h) above rest, regular moderate protein ingestion (20 g of whey 
protein every 3 h) was superior for maximizing the rate of MPS post-RE [11]. This 
study highlighted the importance of the distribution of protein ingestion as a major 
influence on MPS during 12 h post-RE [11]. Future research is required to investigate 
the application of these results to different exercise modalities, as well as the associated 
MPB processes and molecular signalling.   
 
1.7.3 Long term effects of nutrients and resistance exercise 
Several studies have demonstrated an increase in basal muscle protein turnover 
following RT and ET [177, 308, 310, 355], with differences in the myofibrillar and 
mitochondrial fractions in response to acute exercise depending on the mode of 
exercise training [419]. However, this may simply reflect the acute effects of the 
exercise rather than training per se, particularly where measurements were performed 
within 24 h following the final exercise bout [177, 430]. Nonetheless, the data suggests 
that chronic training results in a more rapid but more short-lived increase in MPS in 
response to an acute bout of RE when compared to untrained individuals, suggestive 
of an enhanced adaptive efficiency [371].  
 
Research has shown that training adaptations are largely due to an accumulation of the 
individual effects of repeated bouts of exercise [3, 412]. Training studies have shown 
that protein supplementation combined with RE results in an increase in muscle 
myofibre CSA or lean body mass [7, 36, 60, 86, 176, 208, 422], although, this is not a 
universal finding [10, 63, 72, 116, 223, 391, 408]. In light of these conflicting results, 
Cermak et al. (2012) performed a meta-analysis including data from 22 random control 
trials. It was concluded that protein supplementation combined with RT augments 
skeletal muscle adaptation (increased hypertrophy and strength) in both younger and 
older adults [66]. Clearly, differences between subject group characteristics i.e. muscle 
training and nutritional status impact on the outcome of these studies. The literature in 
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the field highlights a need to link acute data with longitudinal adaptations, specifically 
in the same subject group with the same intervention. This will lead to clear 
conclusions, and consequently aid interventions to promote muscle mass/prevent 
muscle loss.  
 
Regarding chronic muscle adaptations and the comparison of protein sources 
following RT, whey protein has been considered advantageous for muscle hypertrophy 
[63, 85, 86, 192, 372]. Whey protein results in a greater type I and type II myofibre 
hypertrophy when compared to soy or carbohydrate ingestion, following RT in young 
healthy males [7, 176, 306]. Clearly, there is minimal data available regarding skeletal 
muscle protein degradation signalling regarding acute and long-term accumulative 
responses of protein ingestion in combination with RE. Therefore, research into 
proteolytic signalling in response to different modes of RE, protein supplementation, 
and a combination thereof, in conjunction with important functional outcomes (muscle 
hypertrophy and strength measures) is warranted.  
 
1.7.4 Molecular signalling with exercise and nutrition 
It is well established that intracellular mRNA translation in response to exercise and 
nutrient-induced increases in MPS is mediated largely via MTOR signalling [39, 45, 
105, 139]. Acute activation of members of the MTOR pathway [MTOR, p70-S6K and 
4E-BP1 (Fig.  1.4)] are closely associated with RT-induced gains in muscle mass [17, 
374]. Moreover, EAA ingestion combined with RE results in a greater activation of 
MTOR signalling proteins than either EAAs or RE alone/pre-training [104, 384, 416, 
419]. Despite an appreciable increase in our understanding of the molecular regulators 
of muscle mass in recent years, a lack of research on MPB signalling still remains. 
Because NMPB following exercise is dictated by changes in both MPS and MPB, it is 
imperative to further characterize the effects of specific exercise modalities as well as 
the combination of exercise and AAs on genes and proteins involved in MPB 
signalling. The following section will address the fundamental role and the regulation 
skeletal MPB. In line with the topic of the PhD, an understanding of specific 
proteolytic signalling in response to divergent exercise in combination with nutritional 
modulation will evolve as the primary research investigation.  
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1.8 Muscle protein breakdown/degradation 
The degradation of proteins is fundamental for the maintenance of cellular 
homeostasis. MPB is necessary for sustaining intracellular AA levels, mediating the 
quality of muscle proteins by the renewal of structural and damaged proteins, and to 
prevent the build-up of misfolded proteins [156, 166, 266]. However, when the rate of 
MPB exceeds the rate of MPS, as occurs in a variety of catabolic situations, skeletal 
muscle atrophy occurs. The relative contribution of these two opposing processes 
during particular human anabolic and catabolic conditions is uncertain.  
 
Unique transcriptional pathways and mechanisms are activated during MPB, 
demonstrating that skeletal muscle atrophy is not simply the converse of hypertrophy 
[195]. Increased cellular protease activity accompanied by increased protein 
degradation is evident during atrophy. Several studies have assessed the involvement 
of the three main cell proteolytic systems in MPB: the Ca2+-dependent calpains [110, 
190], the lysosomal pathway [399], and the ATP-dependent UPP [82, 142, 190, 194]. 
The activation of these pathways is dependent on the physiological and pathological 
cause of muscular atrophy and the extent to which these systems regulate atrophy 
during various wasting conditions is not well understood. Additionally, the proteolytic 
signalling pathways involved in human muscle remodelling following specific 
exercise, as well as the effect of concomitant nutritional supplementation remain 
poorly defined.  
 
1.8.1 The calpain pathway 
Calpains (Ca2+-activated cysteine proteases) are involved in the breakdown of specific 
substrates in a large number of processes during a cells life [23, 385]. While several 
tissue-specific isoforms have been reported, two ubiquitous isoforms, μ- and m-calpain 
(calpains 1 and 2, respectively), are well characterized [385]. These isoforms are 
inactive when cytoplasmic Ca2+ concentrations are at resting levels and their activities 
differ noticeably due to their sensitivity to Ca2+ [385]. The calpain system is involved 
in many physiological functions, including; proteolysis of proteins involved in the cell 
cycle, apoptosis, cytoskeleton organization, and signal transduction [159]. In muscle 
tissue, three main calpains are expressed: the ubiquitous calpains 1 and 2 and calpain 
3 [23]. Numerous studies have observed that calpain levels are elevated in atrophic 
conditions such as disuse, denervation, glucocorticoid treatment and sepsis [171, 183, 
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369, 399, 420]. Additionally, an increase in calpain activity has also been observed as 
a result of disuse, sepsis, fasting, and muscular dystrophy [4, 21, 190, 315, 361, 399, 
420]. Finally, studies have shown that calpains are required for the release of muscle 
proteins such as actin and myosin to allow for their subsequent degradation by the 
proteasome [211, 359, 420].  
 
1.8.2 The autophagic-lysosomal pathway 
Lysosomes are membrane-bound vesicles containing high concentrations of various 
acid hydrolases [27]. These proteases, known as cathepsins, are responsible for 
degradation of most membrane and extracellular proteins by the process of endocytosis 
as well as cytoplasmic proteins and organelles through autophagy [349, 435]. 
Autophagy is the primary process in the lysosomal system; cytoplasmic contents are 
sequestered into vacuoles called autophagosomes, which then fuse with lysosomes 
where the proteins are digested [254]. In skeletal muscle cells, previous in vitro studies 
have shown that lysosomal enzymes degrade myofibrillar proteins, such as troponin, 
myosin heavy chain and tropomyosin [111]. Autophagy is constitutively active in 
skeletal muscle, as it is essential for cell survival in the degradation of unwanted 
proteins. When lysosomal function is inhibited, or with a genetic deficiency of 
lysosomal proteins (as occurs with Pompe’s and Danon’s diseases), autophagosomes 
accumulate in the cell, storing an abnormal amount of excess proteins inside the 
lysosome [166, 262, 266]. An increase in autophagy/lysosomal activity is observed 
during various atrophic conditions [339] but does not seem to contribute significantly 
to cytosolic protein degradation [23, 399]. Additionally, inhibitors of lysosomal and 
Ca2+-dependent degradation pathways during muscle atrophy only slightly reduce total 
muscle degradation. The bulk of muscle proteins lost during muscle atrophy are 
degraded by the ubiquitin proteasome pathway (UPP) [235, 274].  
 
1.8.3 The ubiquitin proteasome pathway  
Under normal physiological conditions, the ATP-dependent UPP constantly degrades 
damaged and misformed/dysfunctional proteins to mediate normal protein turnover 
and cellular function [118]. It is estimated that 8090% of all proteins in MPB are 
ultimately degraded via the UPP [158]. Therefore, the UPP plays a major role in 
skeletal MPB through the degradation of cytosolic and nuclear proteins, as well as 
myofibrillar proteins [196, 233, 297]. For instance, the levels of ubiquitin-protein 
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conjugates increases during atrophy [236], as does the mRNA levels of genes that 
encode diverse components of the UPP during atrophy [14, 161]. Moreover, inhibitors 
of the proteasome supress the increase in proteolysis usually observed in atrophying 
skeletal muscles [20, 313, 373]. However, the UPP cannot degrade proteins in 
actomyosin or intact myofibrils. The initial step of myofibrillar proteolysis is mediated 
by the caspase and/or calpain pathways through disassembly of myofibrils; cleaving 
actomyosin, products of which are subsequently removed by the UPP [110, 420]. 
 
The UPP involves the degradation of specific target proteins; substrate targets are 
identified for degradation following the conjugation of ubiquitin (Ub) proteins (Fig. 
1.3). A cascade then follows, whereby a second Ub peptide is ligated to the first, and 
a third to the second, and so on until a polyubiquitin chain of five or more Ub is built 
onto the protein substrate. This ATP-dependent process, known as ubiquitination, 
occurs via three enzymatic steps; polypeptide Ub is bound to an ubiquitin-activating 
enzyme (E1) and then transferred to an ubiquitin-conjugating/carrier enzyme (E2) and 
finally, Ub is attached to a protein target by a substrate specific ubiquitin-ligating 
enzyme (E3) [235]. The polyubiquitin chain renders the substrate a target for the 26 S 
proteasome, which subsequently degrades the target protein into smaller peptides 
[195]. While only one E1 protein and a few dozen E2 proteins exist, hundreds of E3’s 
have been identified as the key enzymes involved in UPP-mediated protein 
degradation. E3-ligases mediate ubiquitination, where they attach activated Ub to 
specific myofibrillar protein substrates. Therefore, because E3-ligases confer tissue 
and substrate specificity, i.e. muscle specific E3s for muscle protein degradation, they 
have received attention as a potential target to attenuate skeletal muscle atrophy.  
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Figure 1.3 Ubiquitin proteasome pathway (UPP)-mediated protein degradation. Ubiquitin (Ub) is 
activated by E1 in an ATP dependent process. E1 transfers Ub to the E2 carrier protein. Finally, E2 
binds to an E3-ligase that recognizes the substrate, inducing the transfer of Ub from E2 to the substrate. 
This process is repeated until a chain of Ub molecules is formed, rendering the protein substrate for 
degradation by the ATP dependent-26S proteasome. Peptides get released to form amino acids while 
ubiquitin (Ub) is released and reused. 
 
1.9 Atrogin-1 and MuRF1 
Atrogin-1 (also known as Muscle atrophy F-Box, MAFbx or F-box protein 32, 
Fbxo32) and MuRF1 (muscle-specific RING finger protein 1) were identified as 
having E3-ubiquitin ligase activity based on their sequence structure and results from 
in vitro experiments [38]. They are specifically expressed in striated as well as smooth 
muscle [26, 38, 161, 237]. Atrogin-1 is a member of the SKP1, CUL1 and F-box (SCF) 
containing proteins complex, which needs to be assembled to establish its E3-ligase 
activity [161]. Atrogin-1 is comprised of an F-box motif (approximately 40 AAs) 
which it mediates its interaction with SKP1 [161], a leucine charged residue-rich 
domain which binds several proteins, in addition to a predicted PDZ domain, 
cytochrome c binding site and two nuclear localisation signals. MuRF1 contains an N-
terminal RING domain [198], a MuRF family conserved region, a zinc-finger domain 
(B-box), leucine-rich coiled-coil domains [360], and an acidic C-terminal tail [65]. 
Atrogin-1 and MuRF1 were first discovered in 2001 following cDNA microarray 
analysis in fasting and immobilization models of rodent muscle atrophy [38]. Increased 
atrogin-1 and MuRF1 expression have subsequently been observed in a multitude of 
rodent atrophy models in vitro and in vivo. These include ageing [76], uraemia [234], 
denervation [38, 339], diabetes [97, 234], burn injury [228], underweighting [170, 201, 
234], sepsis [135, 426] hindlimb suspension [339], cancer [83], renal failure [109], 
treatment with dexamethasone (DEX- a synthetic glucocorticoid) [346, 367] as well 
as the catabolic cytokine, tumour necrosis factor-alpha (TNF-alpha) [61, 246], 
suggesting that atrogin-1 and MuRF1 are induced in rodent muscular atrophy 
regardless of aetiology [152]. Additional support for the role of atrogin-1 and MuRF1 
in muscle atrophy comes from observations that mice null of atrogin-1 and MuRF1 
have a 56% and 36% respective sparing of muscle loss induced by denervation [38]. 
Additionally, MuRF1 KO mice are also resistant to DEX-induced muscle loss [18] 
while atrogin-1 KO mice have reduced starvation-induced-muscle atrophy [80]. 
Finally, atrogin-1 over-expression induces atrophy of C2C12 myotubes in vitro [38].  
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These collective observations led to suggestions that therapeutically targeting atrogin-
1 and MURF-1 induction could attenuate human muscle atrophy [38, 152]. However, 
recent studies have revealed that atrogin-1 and MURF-1 may have other unidentified 
roles in human muscle physiology than previously first thought.  
 
1.10 Modulation of atrogin-1 and MuRF1 does not always lead to concomitant 
changes in proteasome activity or muscle mass   
Atrogin-1 and MuRF1 are collectively termed ‘atrogenes’ for atrophy-genes; their 
mRNA expression rapidly increases early during numerous models of muscle atrophy, 
even before muscle atrophy is detectable [38, 151]. However, under chronic conditions 
of muscle atrophy atrogin-1 and MuRF1 expression seems to be reduced to baseline 
or below baseline, or remain unchanged [239, 341]. These observations suggest that 
‘atrogenes’ may contribute to the initiation of an atrophy program and as such are 
considered early 'markers' of muscle atrophy. However, there is accumulating 
evidence that levels of atrogin-1 and MuRF1 are not always associated with muscle 
protein breakdown. For example, alcohol intoxication increases atrogin-1 and MuRF1 
mRNA in rodent skeletal muscle without a concomitant rise in proteolysis [390]. 
Proteasome activity is actually increased rather than decreased in MuRF1 KO mice 
compared to wild type mice following denervation [160]. Several other studies in 
atrophic rodent skeletal muscle have reported an increase in protein degradation 
independent of changes in atrogin-1 and MuRF1 mRNA levels [123], or atrogin-1 only 
[61, 96]. In human muscle atrophy conditions, sarcopenia [238] and lower limb 
unloading [341] do not result in an increase in atrogin-1 expression. Increasing human 
skeletal muscle mass under anabolic stimulation is independent of reduced atrogin-1 
and MURF-1 mRNA and protein levels. For instance, hypertrophy-inducing RT is 
associated with an increase in atrogin-1 and MURF-1 mRNA (and an increase in 
atrogin-1 protein), whereas de-training induced-muscle atrophy resulted in a reduction 
of these ‘atrogenes’ back to basal levels [237]. Collectively, these findings question 
the role of atrogin-1 and MURF-1 in skeletal muscle atrophy and highlight the 
necessity for investigations into their potential role in human muscle following 
anabolic stimulation. To ascertain the significance of such findings there is a need to 
measure ‘atrogenes’ protein as well as mRNA levels; changes in mRNA levels do not 
always subsequently change protein levels. For example, an increase in human atrogin-
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1 mRNA in COPD muscle atrophy does not result in an increase in the atrogin-1 
protein [103].  
 
Although identifying the atrophy conditions that are associated with changes in the 
expression of ‘atrogenes’ is important, it does not provide information concerning their 
actions or functions. Very few studies have measured changes in atrogin-1 and MURF-
1 protein levels under anabolic stimulation and their post-transcriptional or post-
translational regulators are not known. It is clear that ‘atrogenes’ are involved in 
degradation. However, from the limited evidence available, it is unknown whether 
atrogin-1 and MURF-1 are necessary for skeletal muscle atrophy, or whether they have 
other roles in muscle physiology. Presently, the physiological roles and regulation of 
‘atrogenes’ in human skeletal muscle are yet to be thoroughly investigated.  
 
1.11 Transcriptional regulation of atrogin-1 and MuRF1 by Foxo transcription 
factors 
The Forkhead box O (Foxo) proteins, a subgroup of the Forkhead family of 
transcription factors, regulate the expression of atrogin-1 and MuRF1 as well as genes 
involved in autophagy such as microtubule-associated protein 1 light chain 3 alpha 
(Map1lc3a) and gamma-aminobutyric acid receptor associated protein (Gabarap) in 
catabolic rodent muscle in vitro as well as atrophic muscle in vivo [262, 346, 367]. The 
Foxo transcription factor isoforms include: Foxo1 (FKHR), Foxo3 (FKHRL1) and 
Foxo4 (afx) [387]. Foxo proteins are predominantly sequestered to the nucleus (in a 
dephosphorylated state) where they transcribe the expression of atrogin-1 and MuRF1 
[317]. However, in addition to stimulating protein synthesis, Akt (when 
phosphorylated by IGF1 or insulin) can also phosphorylate and thereby inhibit the 
translocation of Foxo to the nucleus, where they induce the transcription of atrogin-1 
and MuRF1 (Fig. 1.4) [55, 230, 340, 346, 367]. Foxo1 and Foxo3 mRNA are 
upregulated during multiple in vitro and in vivo rodent models of muscle atrophy [39, 
70, 143, 234, 346, 367]. Moreover, the transgenic expression of Foxo1 and Foxo3 in 
mouse muscle results in reduced muscle mass and muscle fibre atrophy [203, 346]. 
Conversely, blocking Foxo3 activation with a dominant-negative (d.n) Foxo3 in 
mouse myotubes or by RNA interference (RNAi) in mouse muscle in vivo attenuates 
atrogin-1 upregulation during muscle atrophy induced by DEX treatment and 
starvation [247, 346]. Foxo3 activation directly binds to the atrogin-1 promoter in 
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mouse muscle, causing an increase in atrogin-1 transcription and a decrease in 
myotube size [346]. IGF1 and insulin antagonize the mRNA induction of atrogin-1 
and MuRF1 in vivo atrophic rodent muscle [97, 135, 228, 367] and in C2C12 myotubes 
in vitro following DEX treatment and starvation [340, 346, 367]; mediated through 
activation of phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha 
(PI3K)/Akt/Foxo signalling [346, 367]. However, IGF1/insulin is no longer able to 
block the upregulation of ‘atrogenes’ when myotubes express a constitutively active 
(c.a) Foxo1 or Foxo3, a modification preventing their phosphorylation and inactivation 
by Akt. Therefore, while Foxo1 is not sufficient to directly induce atrogin-1 
expression, inactivation of Foxo1 is required for IGF1/insulin to block the 
upregulation of atrogin-1 and MuRF1 mRNA expression [367].  
 
 
 
Figure 1.4 Pathways downstream of IGF1/insulin. Proteins known to stimulate protein synthesis are 
shown in green while inhibitory proteins are highlighted red. In response to anabolic stimulation, Akt 
regulates muscle protein synthesis and protein breakdown. Akt inhibits the transcriptional upregulation 
of atrogin-1 and MuRF1 via the inhibition of the Foxo family of transcriptional factors. The dotted line 
indicates inhibition while an arrow indicates activation. Abbreviations: IGF1, insulin-like growth 
factor-1; IGFR, insulin-like growth factor 1 receptor; IR, insulin receptor; IRS1, insulin receptor 
substrate 1; PI3K, phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha, p, 
phosphorylation; Akt, v-akt murine thymoma viral oncogene homolog 1; GSK3β, glycogen synthase 
kinase 3 beta; EIF-2B, eukaryotic translation initiation factor 2B, subunit 1 alpha, 26kDa; MTOR, 
mechanistic target of rapamycin (serine/threonine kinase); P70-S6K, ribosomal protein S6 kinase, 
70kDa, polypeptide 1; 4E-BP1, eukaryotic translation initiation factor 4E binding protein 1; Foxo1/o3, 
Forkhead box O1/O3.  
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1.11.1 FOXO regulation of atrogin-1 and MURF-1 in human skeletal muscle 
In contrast to observations in rodents, human studies using clinical models of atrophy 
thus far have not supported an AKT/FOXO regulatory pathway in the transcriptional 
regulation of atrogin-1 and MURF-1 [103, 238-240]. For example, COPD patients 
with muscle atrophy have an increase in atrogin-1 and MURF-1 expression and an 
expected increase in FOXO1 mRNA and protein in the nucleus [103]. However, this 
occurred despite an increase in phosphorylated AKT, which is generally believed to 
block atrogin-1/MuRF1 via the inhibition of Foxo. In addition, patients with ALS 
skeletal muscle atrophy have an increase in atrogin-1 mRNA and protein in 
conjunction with a decrease in phosphorylated AKT [240]. Reduced activation of AKT 
suggests an increase in nuclear nonphosphorylated FOXO proteins. However, there 
was no change in the nuclear FOXO1 or FOXO3 [240]. Finally, human skeletal 
proteolysis induced by short-term unloading does not alter phosphorylated AKT or 
FOXO1/FOXO3 mRNA and protein levels albeit an increase in the expression of 
atrogin-1 and MURF-1 mRNA [168]. Collectively, these observations suggest that the 
AKT/FOXO regulation of atrogin-1 and MURF-1 does not occur, at least in these 
models of human atrophy. Discordance in AKT/FOXO regulation is not without 
precedent; in human primary breast tumours, FOXO3 is retained in the cytoplasm 
without an expected increase in phosphorylated AKT [189]. Others have also 
demonstrated a similar discordance in the regulation of FOXO/atrogin-1/MURF-1 
following exercise in healthy models of human skeletal muscle [174, 237]. For 
example, RT induced-hypertrophy increases human atrogin-1 and MURF-1 albeit an 
increase in phosphorylated AKT and concomitant decrease in FOXO1 nuclear protein 
content; suggested to inhibit atrogin-1 and MURF-1 [237]. This further indicates that 
atrogin-1 and MURF-1 may be regulated via pathways other than AKT/FOXO in 
human skeletal muscle [237]. Conversely, time point data from human muscle 
following acute running and RE [253] demonstrates that changes in FOXO3 mRNA 
expression closely resemble changes in atrogin-1 mRNA. However, these studies only 
show a correlation between FOXO mRNA and atrogin-1 mRNA without measuring 
protein levels or demonstrating a causal relationship. A more complete understanding 
of the transcriptional regulators of human atrogin-1 and MURF-1 is required and will 
provide important information that will assist the development of therapeutic agents 
to reduce muscle atrophy. As such, models aimed at establishing the transcriptional 
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regulators of atrogin-1 and MURF-1 during various catabolic conditions, as well as 
during anabolic human skeletal muscle are needed.  
 
1.12 Atrogin-1- Substrate targets  
1.12.1 MyoD & Myogenin - Potential role of atrogin-1 in skeletal muscle 
differentiation 
Atrogin-1 degrades MyoD-1, thereby inhibiting C2C12 myotube differentiation [377]. 
Additionally, atrogin-1 ubiquitinates myogenin during DEX-induced myotube atrophy 
[199]. MyoD-1 and myogenin are key myogenic transcription factors, critical for 
muscle development, differentiation and regeneration. The atrogin-1-MyoD-1 
interaction occurs in the nucleus [377]. Over-expression of atrogin-1 in proliferating 
C2C12 myoblasts inhibits MyoD-1-induced myotube differentiation and formation by 
inducing Ub degradation of MyoD-1 and preventing the activation of muscle specific-
genes required for myogenesis [377]. Atrogin-1 is upregulated by 2-3-fold during the 
course of C2C12 differentiation [377] while MyoD-1 and myogenin function in the 
early and middle stages of myogenesis, respectively. Together, these findings suggest 
that atrogin-1 may play a role in the course of muscle differentiation and regeneration 
through determining the abundance of key myogenic transcription factors [244]. The 
observation that MyoD levels increase upon denervation-induced atrophy questions 
the physiological significance of MyoD as an atrogin-1 substrate during skeletal 
muscle atrophy [193].  
 
1.12.2 Eif3f- Potential role of Atrogin-1 in the regulation of proteins involved in 
hypertrophy signalling/protein synthesis 
The translation initiation factor, eukaryotic translation initiation factor 3, subunit F 
(Eif3f) is ubiquitinated and degraded by atrogin-1 during myotube atrophy induced by 
starvation, DEX treatment, and oxidative stress [88, 226]. Eif3f increases protein 
synthesis of skeletal muscle structural proteins thereby increasing hypertrophy in vitro 
and in vivo rodent muscle [226]. The increase in MPS via Eif3f is following upstream 
activation of IGF1/PI3K/AKT signalling [38, 39, 161, 230, 293, 334, 346, 367]. These 
observations indicate that in addition to targeting myofibrillar proteins for degradation, 
atrogin-1 may also target key anabolic proteins for ubiquitination, leading to a decrease 
in MPS observed during multiple catabolic conditions [226].  
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1.12.3 Atrogin-1 interacts with proteins that are involved in a wide variety of cellular 
activities in muscle 
Atrogin-1 ubiquitinates myofibrillar proteins, including all isoforms of the myosin 
heavy and light chains during myostatin-induced skeletal muscle atrophy [248]. 
Interestingly, immunoprecipitation studies in cultured C2C12 myoblasts and myotubes 
recently demonstrated that atrogin-1 interacts with transcriptional factors, components 
of translation apparatus, mitochondrial proteins, and enzymes involved in glycolysis 
and gluconeogenesis. In addition, atrogin-1 interacts with sarcomeric proteins, and 
degrades desmin and vimentin following myostatin treatment [249].  
 
1.13 MuRF1- Substrate targets   
1.13.1 Contractile (structural) proteins 
MuRF1 ubiquitinates and degrades MHC protein upon DEX treatment in C2C12 
myotubes [75, 128]. Additionally, MuRF1 degrades myosin-binding protein C and 
myosin light chains 1 and 2 (MYL1 and MYL2) during denervation and fasting in 
mice muscle in vivo [78]. It has also been discovered that MuRF1 potentially drives 
ubiquitination of actin; one of the most abundant proteins in skeletal muscle, in 
catabolic conditions in vitro and in vivo mouse muscle [312]. 
 
1.13.2 Sarcomeric proteins 
MuRF1 binds to the giant myofibrillar protein, titin in vitro [65] and disrupts the 
integrity of titin’s M-line. The MuRF1-titin interaction suggests that MuRF1 regulates 
the stability of the sarcomeric-M-line [269], although it is not clear it MuRF1 induces 
titin degradation. MuRF1 also targets troponin 1 for ubiquitination and degradation in 
vitro and in vivo cultured cardiomyocytes [206]. 
 
1.13.3 Enzymes involved in energy metabolism 
MuRF-1 interacts with several enzymes required for energy production [423]. Muscle 
creatine kinase (oxidised form) is ubiquitinated by MuRF-1 [219, 436]. Moreover, 
MuRF-1 may regulate CHO metabolism via interactions with several glycolytic and 
glycogen energy metabolic enzymes [180]. MuRF-1 also prevents pathological cardiac 
hypertrophy by inhibiting protein kinase C epsilon (PRKCE) activity and translocation 
[12].  
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Taken together, this accumulating evidence suggests that atrogin-1 and MuRF1 may 
have functional roles beyond the degradation of proteins during muscle atrophy. 
Substrate targets of atrogin-1 suggest a potential role of this E3-ubiquin ligase in 
processes involved in growth and regeneration. MuRF1 substrate proteins indicate that 
MuRF1 is involved in muscle structure and contraction, in addition to muscle 
metabolism. Presently, atrogin-1 and MuRF1 substrate targets have only been 
identified in rodent skeletal muscle. While ATROGIN-1 and MURF-1 are known E3-
ubiquitin ligases, the specific proteins they target for ubiquitination and subsequent 
proteasomal degradation in conditions of human skeletal muscle atrophy and 
hypertrophy are not known. Hypothetically, ATROGIN-1/MURF-1 could increase 
protein degradation in two ways 1) target key hypertrophy proteins for ubiquitination, 
leading to a decrease in protein synthesis, or 2) directly targeting myofibrillar proteins 
for degradation. Establishing the proteins that ATROGIN-1 and MURF-1 interact with 
and degrade is vital to fully understand the roles that these proteins play in human 
skeletal muscle function and development. A greater understanding of ATROGIN-1 
and MURF-1 regulation in healthy conditions and during ageing will assist in 
identifying mechanisms to combat skeletal muscle atrophy.  
 
1.14 Atrogin-1 and MURF-1 regulation with exercise    
Research has established that atrogin-1 and MURF-1 are pivotal regulators of muscle 
protein degradation; an important post-exercise muscle adaptation process. However, 
the role of ATROGIN-1 and MURF-1 in response to exercise is not fully known. 
Following hypertrophy induced-functional overload in mice over 14 days, atrogin-1 
and MuRF1 expression increased at day 1, returned to basal at day 3 and were 
thereafter supressed below basal [19]. Interestingly, an increase in proteasome activity 
persisted despite atrogin-1 and MuRF1 expression levels returning to baseline. 
Moreover, atrogin-1 but not MuRF1 female KO mice showed a significant reduction 
in functional-overload-induced growth compared to wild type mice [19]. This data 
indicates that atrogin-1 may be necessary for normal growth and remodelling in 
response to increased loading.   
 
Although atrogin-1 and MURF-1 are both regulated by exercise in human skeletal 
muscle, the direction of their transient regulation is dependent on the mode and 
intensity [217, 253, 265]. Previous studies have observed that atrogin-1 mRNA is 
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downregulated at 312 h following a single bout of RE, while MURF-1 mRNA is 
upregulated within 14 h post-exercise in untrained subjects [154, 253, 265, 429]. In 
contrast, treadmill running at 75% of VO2 max for 30 min increases both atrogin-1 and 
MURF-1 mRNA 14 h post-exercise in untrained subjects [253]. Training status (i.e. 
the state of skeletal muscle adaptation) appears to influence the atrogin-1 and MURF-
1 response to exercise. Accordingly, a single-bout of RE reduces atrogin-1 mRNA 3 h 
post-exercise in ET subjects, but does not affect its regulation in RT subjects [77]. 
Likewise, cycling for 60 min at 70% VO2 max exercise increases atrogin-1 mRNA by 
~2-fold in ET subjects, but only by ~0.4-fold in RT subjects [77]. ET-induced 
increases in UPP may reflect an adaptation that plays a role in controlling the reduced 
growth of type 1 muscle fibres in order to optimise oxygen supply to the mitochondria 
[389]. 
 
Hypertrophy-inducing RT (8-weeks, at 8595% 1 RM) results in an increase in 
atrogin-1 mRNA and protein and MURF-1 mRNA [237]. Finally, ‘atrogene’ mRNA 
regulation is muscle contraction dependent; atrogin-1 is decreased at 324 h post-ECC 
RE, while MURF-1 is increased 3 h post-CONC exercise [217, 288].  
 
Acute studies performed thus far have made an important contribution to understand 
the time course of ‘atrogene’ regulation. However, very few chronic training studies 
have measured protein degradation signalling in conjunction with important outcome 
measures of adaptations to RT and/or protein supplementation. Furthermore, the 
response of atrogin-1 and MURF-1 to specific exercise training modalities is yet to be 
directly compared, especially when removing the influence of unaccustomed stress 
responses. In addition, measurements of the protein levels of ‘atrogenes’, in response 
to divergent exercise contraction modes are currently lacking and represent a necessary 
prerequisite to ascertain the implications of changes in mRNA levels.  
 
1.15 Atrogin-1 and MURF-1 regulation with protein supplementation and 
exercise    
Few studies have investigated the combination of RE and AA supplementation on 
markers of proteolysis, atrogin-1 and MURF-1, with conflicting reports. Hulmi et al. 
(2009) reported that whey protein ingestion before and after leg press RE had no effect 
on atrogin-1 mRNA expression (MURF-1 mRNA was not measured) [191]. In 
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addition, a recent study comparing whey or calcium caseinate protein (0.30 g/kg lean 
body mass) to a non-caloric control ingested immediately after single leg, leg 
extension RE, found that changes in atrogin-1, MURF-1, and FOXO1/3 mRNA were 
protein supplementation independent; no group differences were observed in MPB 
[325]. In contrast, following unilateral leg-press exercise, BCAA supplementation 
reduced atrogin-1 mRNA and attenuated an exercise-induced increase in MURF-1 
protein at 3 h post-exercise [47]. Similarly, Areta et al. (2013) found that a large bolus 
of whey protein suppressed MURF-1 mRNA compared to intermediate and pulse 
protein ingestion i.e. moderate and small quantities of protein, respectively, during 6 
h following single-bout-RE [11]. Another study demonstrated that whey protein (25 
g) ingested immediately and 26 h after single-bout RE increased atrogin-1 and MURF-
1 mRNA expression ~24 h after exercise; MURF-1 mRNA increased in men, but not 
women, at 28 h [415].  
 
The physiological significance of these results are not known. Furthermore, whether 
or not the acute responses of atrogin-1 and MURF-1 mRNA following contraction 
specific-RE accumulate into muscle adaptations following long-term contraction-
specific RT has not been investigated. 
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1.16 Summary and Significance of Research 
Understanding the molecular mechanisms in response to divergent-exercise stimuli 
and/or nutritional supplementation is important for identifying therapeutic 
interventions to attenuate skeletal muscle loss during ageing and disease states. While 
the activation of protein synthesis pathways by exercise and nutrition has been 
extensively investigated, the specific and combined effects of exercise and nutrition 
on protein degradation signalling are poorly characterised.  
 
Skeletal muscle protein turnover is fundamental for the maintenance of skeletal muscle 
and cellular homeostasis; and is altered in response to both exercise and nutrition. The 
UPS is the main mechanism for muscle protein degradation, however little is known 
about how the regulation of protein degradation signalling contributes to skeletal 
muscle remodelling following exercise training. Moreover, the role and physiological 
significance of E3-ubiquitin-ligases, atrogin-1 and MURF-1, in response to divergent 
exercise modalities, exercise contractions, and protein supplementation are currently 
unclear. This PhD will explore the effects of contrasting anabolic stimuli on 
‘atrogenes’ (and their associated signalling) in healthy people, and finally compare 
degradation signalling in younger and elderly individuals, with and without anabolic 
stimulation (acute RE).  
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1.17 Aims 
 
The specific aims of the thesis are: 
 
1. To investigate the mRNA and/or protein expression of molecular markers of UPP 
signalling following 1) long-term endurance and resistance training and 2) a single-
bout of EE and RE following training. The markers of UPP signalling measured 
included atrogin-1, MURF-1, FBXO40, FOXO1, FOXO3, as well as protein substrates 
of atrogin-1 including, EIF3F, MYOGENIN (MYOG) and MYOD1, and MURF-1 
including, pyruvate kinase, muscle (PKM) and MHC. 
 
2. To investigate the mRNA and/or protein expression of molecular markers of UPP 
signalling in response to unilateral CONC versus ECC RE before and after 1) short-
term exercise-habituation, 2) single-bout RE and 3) 12-weeks of hypertrophy-inducing 
training. In addition, the effects of whey protein supplementation will be investigated. 
A second aim was to also examine the effect of leucine-enriched whey protein 
hydrolysate (WPH) supplementation combined with RE on the potential single-bout 
exercise and training-induced changes in mRNA and protein, when compared with a 
control isocaloric carbohydrate supplement (iCHO). The markers of UPP signalling 
measured included atrogin-1, MURF-1, FOXO1, FOXO3, as well the atrogin-1 protein 
substrate, EIF3F. 
 
3. To investigate the mRNA and/or protein expression of molecular markers of UPP 
signalling in older versus younger individuals at basal and in response to a single-bout 
of bilateral leg extension RE following overnight fasting. The markers of UPP 
signalling measured included atrogin-1, MURF-1, FBXO40, FOXO1, FOXO3, as well 
as protein substrates of atrogin-1 including, EIF3F, MYOGENIN (MYOG) and 
MYOD1, and MURF-1 including, pyruvate kinase, muscle (PKM) and MHC. 
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1.18 Hypotheses 
 
It is hypothesised that: 
 
1. The mRNA and/or protein expression of molecular markers of UPP signalling 
would be 1) increased following ET and RT, possibly with a greater response 
following ET; 2) upregulated in the ET-trained state, following single-bout EE, 
whereas in the RT-trained state, RE will not produce a similar level of regulation. 
 
2. The mRNA and/or protein expression of molecular markers of UPP signalling 
would 1) be regulated to a greater extent in the exercise-habituated fed state 
following acute unilateral ECC RE, when compared with CONC RE; 2) be 
attenuated with WPH supplementation following both single-bout unilateral ECC 
and CONC RE; and 3) be regulated to a greater extent following unilateral ECC 
hypertrophy-inducing RT, when compared with other combinations of contraction 
mode and supplementation.   
 
3. The mRNA and/or protein expression of molecular markers of UPP signalling 
would be similarly expressed in healthy younger versus older individuals at basal. 
However, in response to a single-bout of RE in the fasted state, there may be age-
related differences consistent with anabolic resistance in UPP marker/s.  
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CHAPTER 2 
 
GENERAL METHODOLOGY   
 
 
 
2.1 Western blotting 
Proteins from whole tissue lysates were separated by sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) in a buffer containing 12 mM Tris-
HCl (pH 8.8), 200 mM glycine and 0.1% SDS. Proteins were transferred onto an 
Immobilon-FL polyvinylidene fluoride (PVDF) membrane (Millipore, Billerica, MA) 
in a Bjerrum buffer containing 50 mM Tris, 17 mM glycine and 10% methanol. 
Membranes were blocked with 5% BSA in PBS for 1 h at room temperature and were 
thereafter incubated at 4°C overnight with the following primary antibodies diluted in 
5% BSA in PBS: MURF-1 (MP3401, ECM Biosciences, Versailles, KY) at 1:1000; 
FBXO40 (H00051725-B01P, Abnova, Taipei City, Taiwan) at 1:200–1:250; FOXO1 
(C29H4, Cell Signaling Technology, Danvers, MA) at 1:500; FOXO3 (ab17026, 
Abcam, Cambridge, MA, USA) at 1:500; EIF3F (Jomar Bioscience, Adelaide, 
Australia) at 1:500; MYOD1 (M-318: sc-760, Santa Cruz Biotechnology) at 1:200; 
MYOGENIN (MYOG) (MAB3876, Merck Millipore, Billerica, MA) at 1:300–1:500; 
PKM (3198, Cell Signaling Technology, Danvers, MA) at 1:1000; and 
MHC/sarcomeric myosin (MF 20, Developmental Studies Hybridoma Bank, Iowa 
City, IA) at 1:1000. Alternatively, membranes were blocked with 5% BSA in TBST 
for 1 h at room temperature and were thereafter incubated at 4°C overnight with the 
following primary antibodies diluted in 5% BSA in TBST: phospho-FOXO1 (Ser256, 
9461, Cell Signaling Technology, Danvers, MA) at 1:500; and phospho-FOXO3 
(Ser253, 9466, Cell Signaling Technology, Danvers, MA) at 1:400. FOXO1 and 
FOXO3 can be activated through phosphorylation by Akt at Ser256 and Ser253, 
respectively, resulting in their nuclear export and inhibition of transcription factor 
activity. Following overnight primary antibody incubation, membranes were washed 
with either PBS or TBST (4 x 5 min) and were subsequently incubated for 1 h with the 
following infrared-fluorescent conjugated secondary antibodies, diluted at 1:5000 in 
PBS or TBST containing 50% Odyssey® Blocking Buffer (LI-COR Biosciences, 
Lincoln, USA) and 0.01% SDS: IRDye 800CW goat anti-rabbit IgG (LI-COR 
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Biosciences, Lincoln, USA) for MURF-1, FOXO1, phospho-FOXO1, phospho-
FOXO3, EIF3F, MYOD1 and PKM; IRDye 800CW donkey anti-goat IgG (LI-COR 
Biosciences, Lincoln, USA) for FOXO3; and Alexa Fluor® 680 rabbit anti-mouse IgG 
(Life Technologies, Carlsbad, CA, USA) for FBXO40, MYOG, MHC, and GAPDH. 
Following another series of washing, proteins were exposed using the Odyssey® 
Infrared Imaging System (LI-COR Biosciences, Lincoln, USA), and individual protein 
band optical densities were quantified using Odyssey® Infrared Imaging System 
software. To control for protein loading, all blots were normalized against GAPDH 
protein (G8795, Sigma-Aldrich, Sydney, Australia). GAPDH protein was suitable as 
an appropriate housekeeping protein, as its levels did not change between divergent 
exercise training and single-bout exercise, as well as between young and old 
individuals [365, 366]. MURF-1, FOXO1, phospho-FOXO1, FOXO3, and phospho-
FOXO3 protein levels were measured in all experimental chapters. However, chapter 
3 and 5 include additional protein measures of FBXO40, EIF3F, MYOD1, MYOG, 
PKM, and MHC. 
 
2.2 RNA extraction and reverse transcription  
In experimental chapter 3 and 4, RNA was extracted from ~20 mg of muscle using the 
guanidinium thiocyanate-phenol-chloroform extraction method, as previously 
described [71]. In experimental chapter 5, RNA was extracted from ~15 mg of muscle 
using Tri-Reagent Solution (Life Technologies, Carlsbad, CA, USA) according to 
the manufacturer’s protocol. RNA concentration was determined 
spectrophotometrically using the Nanodrop 1000 (Thermo Fischer Scientific, MA, 
USA). One μg of RNA was reverse transcribed to cDNA using the High Capacity 
RNA-to-cDNA kit (Life Technologies, Carlsbad, CA, USA) according to the 
manufacturer’s protocol. Prior to PCR, 1 μL ribonuclease H (RNase H) (Life 
Technologies, Carlsbad, CA, USA) was added to each sample and incubated at 37°C 
for 30 min. The cDNA was stored at −20°C until further analysis.  
 
2.3 Real-time quantitative PCR 
Real-time PCR was performed using the Stratagene MX3000 PCR system (Agilent 
Technologies, Santa Clara, CA). The mRNA levels atrogin-1, MURF-1, FOXO1, and 
FOXO3 were measured in all experimental chapters; FBX040 mRNA was measured 
in experimental chapter 3 and 5 only. mRNA levels were measured using 1 x SYBR 
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Green PCR Master Mix (Life Technologies, Carlsbad, CA, USA) and 5 ng of cDNA. 
To compensate for variations in input RNA amounts and efficiency of the reverse 
transcription, data was normalized to ribosomal protein, large PO (RPLPO, also known 
as 36B4) in experimental chapter 3 and 4, and peptidylprolyl isomerase A (PPIA, also 
known as cyclophilin) mRNA in chapter 5. RPLPO was stable with divergent exercise 
training and single-bout exercise, while PPIA RNA was stable between young and 
aged individuals pre- and post-RE [365, 366]. All primers were used at a final 
concentration of 300 nM and probes at 100 nM. Primer and probe details are provided 
in Table 2.1. The PCR conditions were 1 cycle of 10 min at 95 °C; 40 cycles of 30 s at 
95 °C, 60 s at 60 °C. For RPLPO and PPIA, a melting curve was included at the end 
of the PCR cycles. RT-PCR analyses were conducted in triplicate. Ct values were 
obtained from the MxPro QPCR software (Agilent Technologies, Santa Clara, CA, 
USA). Mean Ct values and their SEM were calculated for each of the samples. Ct 
values were logarithmically transformed and mean log transformed Ct values (referred 
to as arbitrary unit values) were then considered for further analysis.  
 
Gene 
GenBank 
Accession 
Number 
Sequences 
Atrogin-1 NM_058229.3 
Forward GCAGCTGAACAACATTCAGATCAC 
Reverse CAGCCTCTGCATGATGTTCAGT 
Probe (FAM)-CTTCAAAGGCACCTTCACTGACCTG(BHQ-1) 
MURF-1 NM_032588.3 
Forward CCTGAGAGCCATTGACTTTGG 
Reverse CTTCCCTTCTGTGGACTCTTCCT 
Probe (Texas Red)- 
AGGAAGAATTCATTGAAGAAGAAGATCAGG(BHQ-2) 
FBXO40 NM_016298.3 
Forward AGTCCACAGAGAGATCTG 
Reverse TGTGCTCTACAATGTTGAA 
Probe (HEX)-AGTTCAGCAGCCTCTTCTCCA(BHQ) 
FOXO1 NM_002015 
Forward AAGAGCGTGCCCTACTTCAA 
Reverse CTGTTGTTGTCCATGGATGC 
FOXO3 NM_001455 
Forward CTTCAAGGATAAGGGCGACA 
Reverse TCTTGCCAGTTCCCTCATT 
RPLPO NM_053275.3 
Forward TCTACAACCCTGAAGTGCTTGATATC 
Reverse GCAGACAGACACTGGCAACATT 
PPIA NM_021130 
Forward CATCTGCACTGCCAAGACTGA 
Reverse TTCATGCCTTCTTTCACTTTGC 
 
Table 2.1 Human primer and probe sequences used for real-time PCR analysis. Atrogin-1, muscle 
atrophy F-box; MURF-1, muscle ring finger-1; FBXO40, F-box protein 40; FOXO1, forkhead box O1; 
FOXO3, forkhead box O3; RPLPO, acidic ribosomal phosphoprotein PO; PPIA, peptidylprolyl 
isomerase A. 
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2.4 Validation of atrogin-1 and MURF-1 antibodies 
Western blotting is widely used in skeletal muscle biomedical research to analyse 
protein expression. This method is limited by the specificity of commercially available 
antibodies against the protein target of interest. Atrogin-1 and MURF-1 antibodies are 
used in the current literature. However, it was determined whether particular 
commercial antibodies that are being used are specific, and hence validate their use in 
this thesis.  
 
2.4.1 Preparation of constructs  
The full-length coding region of human atrogin-1 (1067 nucleotides) was amplified 
using the primers; 5’ agcaatgtgcggccgcgatgccattcctcgggcagg and 5’ atcctctagatcagaa 
cttgaacaagttgataaag, and directionally cloned into the NotI and XbaI sites of the 
pFLAG-CMV-4 vector (Sigma-Aldrich, Sydney, Australia). The full-length coding 
region of human MURF-1 (1058 nucleotides) was amplified using the primers; 5’ 
cgacaagcttatggattataagtcgagcctgatc and 5’ atcctctagattactggtgtccttcttccttcc, and 
directionally cloned into the HindIII and XbaI sites of the pFLAG-CMV-4 vector 
(Sigma-Aldrich, Sydney, Australia).  
 
2.4.2 Cell culture 
The pGFP (Clontech Laboratories, Inc., CA, USA), pFLAG-hatrogin-1 or pFLAG-
hMURF-1 plasmid was transfected into C2C12 myoblasts using Lipofectamine 2000 
(Life Technologies, Carlsbad, CA, USA) at a 1:4 DNA: transfection reagent ratio as 
recommended by the manufacturer and harvested 24 h post-transfection. 
 
2.4.3 Protein extraction and western blotting  
Total protein from whole cell lysates was extracted using RIPA buffer (Millipore, 
North Ryde, Australia) with 1 μL/mL protease inhibitor cocktail (Sigma-Aldrich, 
Sydney, Australia) and 10 μL/mL Halt Phosphatase Inhibitor Single-Use Cocktail 
(Thermo Scientific, Rockford, USA). Total protein content was determined using the 
BCA Protein Assay Kit (Pierce Biotechnology, Rockford, USA) according to the 
manufacturer’s instructions. Proteins were separated by SDS-PAGE in a buffer 
containing 12 mM Tris-HCl (pH 8.8), 200 mM glycine and 0.1% SDS. Proteins were 
transferred onto an Immobilon-FL PVDF membrane (Millipore, Billerica, MA) in a 
Bjerrum buffer containing 50 mM Tris, 17 mM glycine and 10% methanol. 
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Membranes were blocked with 5% BSA in PBS for 1 h at room temperature and were 
thereafter incubated with mouse monoclonal ANTI-FLAG® Clone M2 (F3165, Sigma-
Aldrich, Sydney, Australia) at 1:1000 at room temperature for 1 h. Following 
exposure, the same membrane was also incubated in following primary antibodies 
(diluted in 5% BSA in PBS) at 4°C overnight: MuRF1 polyclonal (C-terminal region) 
(MP3401, ECM Biosciences, Versailles, KY) at 1:1000; FBXO32 goat polyclonal 
(GTX47565, GeneTex, Inc., Irvine, CA) at 0.2 ug/ml; atrogin-1 rabbit polyclonal 
(AP2041 Lot #1, ECM Biosciences, Versailles, KY) at 1:1000; atrogin-1 rabbit 
polyclonal (AP2041 Lot #2, ECM Biosciences, Versailles, KY) at 1:1000; MAFbx 
rabbit polyclonal (H-300): sc-33785 (Santa Cruz Biotechnology, Inc., Dallas, Texas) 
at 1:500‒1:1000; FBXO32 purified MaxPab mouse polyclonal antibody (B01P) 
H00114907-B01P (Abnova, Taipei City, Taiwan) at 1:1000. Following primary 
antibody incubation, membranes were washed with PBS (4 x 5 min) and were 
subsequently incubated for 1 h with the following infrared-fluorescent conjugated 
secondary antibodies, diluted at 1:5000 in PBS, containing 50% Odyssey® Blocking 
Buffer (LI-COR Biosciences, Lincoln, USA) and 0.01% SDS: IRDye 800CW goat 
anti-rabbit IgG (LI-COR Biosciences, Lincoln, USA) for MuRF1, atrogin-1 (ECM 
Biosciences Lot#1 and Lot#2) and MAFbx (Santa Cruz Biotechnology, Inc); 800CW 
donkey anti-goat IgG (LI-COR Biosciences, Lincoln, USA) for FBXO32 (GeneTex, 
Inc.); and Alexa Fluor® 680 rabbit anti-mouse IgG (Life Technologies, Carlsbad, CA, 
USA) for FBXO32 (Abnova) and FLAG. Following another series of washing, 
proteins were exposed using the Odyssey® Infrared Imaging System (LI-COR 
Biosciences, Lincoln, USA). 
 
2.4.4 Atrogin-1 antibody validation  
Five commercially available antibodies were tested for atrogin-1 protein specificity 
via western blot analysis. C2C12 myoblasts overexpressing a FLAG-tagged human 
atrogin-1, C2C12 myoblasts overexpressing a GFP (control) and human skeletal 
muscle tissue were loaded on a gel for comparison. For each antibody tested, the 
membrane was probed with a mouse monoclonal ANTI-FLAG® Clone M2 (F3165, 
Sigma-Aldrich, Sydney, Australia). The results in Fig.2.1A‒Fig.2.5A (lane 2) show 
that the C2C12 myoblast cell lysates overexpressing FLAG-hAtrogin-1 detect the 
FLAG protein. No band was detected in C2C12 lysates overexpressing GFP only 
[Fig.2.1A‒Fig.2.5A (lane 1)], confirming the successful transfection of the constructs. 
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Thereafter, membranes were probed with each of the commercially available atrogin-
1 antibodies [Fig.2.1B‒Fig.2.5B (lane 2)]. As seen in Fig.2.3B and Fig.2.4B (lane 2), 
atrogin-1 protein is detected in the C2C12 myoblast cell lysates overexpressing FLAG-
hAtrogin-1. This result confirms that the exogenous expression of atrogin-1 protein is 
detected by the atrogin-1 rabbit polyclonal (AP2041 Lot #2, ECM Biosciences, 
Versailles, KY) and the MAFbx rabbit polyclonal (H-300): sc-33785 (Santa Cruz 
Biotechnology, Inc., Dallas, Texas), respectively. 
 
To determine if the endogenous level of atrogin-1 protein was detected by each 
commercial atrogin-1 antibody, membranes were probed with each atrogin-1 antibody 
(Fig.2.1B‒Fig.2.5B). All western blots performed contained a human muscle tissue 
lysate (~30ug) prepared from a random mix of human skeletal muscle protein. As seen 
in Fig.2.1B‒Fig.2.5B (lane 3), none of the commercially available antibodies detected 
endogenous atrogin-1 protein at the corresponding molecular weight for atrogin-1 
protein in human muscle tissue. Note that the corresponding molecular weight was 
determined by the C2C12 myoblast cell lysates overexpressing FLAG-hAtrogin-1 
when probed with atrogin-1 (~37 kD). 
 
 
  
 
 
 
 
 
 
 
 
 
Figure 2.1 Western blot analysis of C2C12 myoblasts overexpressing GFP (lane 1), C2C12 myoblasts 
overexpressing FLAG-hAtrogin-1 (lane 2), and human muscle tissue (lane 3) probed with mouse 
monoclonal ANTI-FLAG ® Clone M2 (F3165, Sigma-Aldrich, Sydney, Australia) (A), and thereafter 
probed with FBXO32 goat polyclonal (GTX47565, GeneTex, Inc., Irvine, CA) (B). 
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Figure 2.2 Western blot analysis of C2C12 myoblasts overexpressing GFP (lane 1), C2C12 myoblasts 
overexpressing FLAG-hAtrogin-1 (lane 2), and human muscle tissue (lane 3) probed with mouse 
monoclonal ANTI-FLAG ® Clone M2 (F3165, Sigma-Aldrich, Sydney, Australia) (A), and thereafter 
probed with atrogin-1 rabbit polyclonal (AP2041 Lot #1, ECM Biosciences, Versailles, KY) (B). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.3 Western blot analysis of C2C12 myoblasts overexpressing GFP (lane 1), C2C12 myoblasts 
overexpressing FLAG-hAtrogin-1 (lane 2), and human muscle tissue (lane 3) probed with mouse 
monoclonal ANTI-FLAG ® Clone M2 (F3165, Sigma-Aldrich, Sydney, Australia) (A), and thereafter 
probed with atrogin-1 rabbit polyclonal (AP2041 Lot #2, ECM Biosciences, Versailles, KY) (B). 
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Figure 2.4 Western blot analysis of C2C12 myoblasts overexpressing GFP (lane 1), C2C12 myoblasts 
overexpressing FLAG-hAtrogin-1 (lane 2), and human muscle tissue (lane 3) probed with mouse 
monoclonal ANTI-FLAG ® Clone M2 (F3165, Sigma-Aldrich, Sydney, Australia) (A), and thereafter 
probed with MAFbx rabbit polyclonal (H-300): sc-33785 (Santa Cruz Biotechnology, Inc., Dallas, 
Texas) (B). 
 
 
 
 
Figure 2.5 Western blot analysis of C2C12 myoblasts overexpressing GFP (lane 1), C2C12 myoblasts 
overexpressing FLAG-hAtrogin-1 (lane 2), and human muscle tissue (lane 3) probed with mouse 
monoclonal ANTI-FLAG ® Clone M2 (F3165, Sigma-Aldrich, Sydney, Australia) (A), and thereafter 
probed with FBXO32 purified MaxPab mouse polyclonal antibody (B01P) H00114907-B01P (Abnova, 
Taipei City, Taiwan) (B). 
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Therefore, the validation methods performed for each of the commercially available 
antogin-1 antibodies tested cannot confirm specificity for detecting the endogenous 
atrogin-1 protein. Consequently, atrogin-1 protein levels were not measured in this 
thesis. The results obtained here can provide beneficial information to the scientific 
community when measuring atrogin-1 and MURF-1 in human skeletal muscle tissue. 
Research groups that have previously published with these antibodies should use 
caution and develop positive controls to test antibody-specificity. Clearly, future work 
is required to develop specific atrogin-1 antibodies and investigate the half-life of 
atrogin-1 protein.  
 
2.4.5 MURF-1 antibody validation  
C2C12 myoblasts overexpressing a FLAG-tagged human MURF-1, C2C12 myoblasts 
overexpressing a GFP (control) and human skeletal muscle tissue were loaded on a gel 
for comparison to validate the MURF-1 antibody (C-terminal region) rabbit polyclonal 
antibody (MP3401, ECM Biosciences, Versailles, KY). After probing the membrane 
with the mouse monoclonal ANTI-FLAG® Clone M2 (F3165, Sigma-Aldrich, Sydney, 
Australia), the presence of the FLAG-hMURF-1 in these lysates was confirmed 
[Fig.2.6A (lane 2)]. No band was detected in C2C12 lysates overexpressing GFP only 
[Fig.2.6A (lane 1)].  
 
To determine if the endogenous level of MURF-1 protein was detected by the MuRF-
1 antibody (C-terminal region) rabbit polyclonal antibody (MP3401, ECM 
Biosciences, Versailles, KY), the membrane was probed with the above-mentioned 
antibody. A band at ~38 kD protein in human muscle tissue lysates [Fig.2.6B (lane 3)] 
was detected, corresponding to molecular weight of the band detected using the same 
antibody in C2C12 myoblast cell lysates overexpressing FLAG-hMuRF1 [Fig.2.6A 
(lane 2)].  
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Figure 2.6 Western blot analysis of C2C12 myoblasts overexpressing GFP (lane 1), C2C12 myoblasts 
overexpressing FLAG-hMURF-1 (lane 2), and human muscle tissue (lane 3) probed with monoclonal 
ANTI-FLAG® M2 (F3165, Sigma-Aldrich, Sydney, Australia) (A), and thereafter probed with MuRF1 
(C-terminal region) rabbit polyclonal antibody (MP3401, ECM Biosciences, Versailles, KY) (B).  
 
The results obtained from this validation confirmed the specificity of the MURF-1 
antibody and MURF-1 protein levels were subsequently measured in all proceeding 
experimental chapters. 
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CHAPTER 3 
 
REGULATION OF UBIQUITIN PROTEASOME PATHWAY 
MOLECULAR MARKERS IN RESPONSE TO ENDURANCE 
AND RESISTANCE EXERCISE AND TRAINING 
 
 
This work has been published prior to the completion of this dissertation Stefanetti RJ, Lamon S, 
Wallace MA, Vendelbo MH, Russell AP, and Vissing K. Regulation of ubiquitin proteasome pathway 
molecular markers in response to endurance and resistance exercise andtraining. Pflugers Archiv : 
European journal of physiology. 2014. 
 
Abstract 
Knowledge on the effects of divergent exercise on ostensibly protein degradation 
pathways may be valuable for counteracting muscle wasting and for understanding 
muscle remodelling. This study examined mRNA and/or protein levels of molecular 
markers of the UPP, including FBXO32 (atrogin-1), MURF-1, FBXO40, FOXO1 and 
FOXO3. Protein substrates of atrogin-1, including EIF3F, MYOG and MYOD1, and 
of MURF-1, including PKM and MHC, were also measured. Subjects completed 10 
weeks of ET or RT followed by a single-bout of EE or RE. Following training, atrogin-
1, FBXO40, FOXO1, and FOXO3 mRNA increased independently of exercise mode, 
whereas MURF-1 mRNA and FOXO3 protein increased following ET only No change 
in other target proteins occurred post-training. In the trained state, single-bout EE, but 
not RE, increased atrogin-1, MURF-1, FBXO40, FOXO1, FOXO3 mRNA, and 
FOXO3 protein In contrast to EE, FBXO40 mRNA and protein decreased following 
single-bout RE. MURF-1 and FOXO1 protein levels as well as the protein substrates 
of atrogin-1 and MURF-1 were unchanged following training and single-bout exercise. 
This study demonstrates that the intracellular signals elicited by ET and RT result in 
an upregulation of UPP molecular markers, with a greater increase following ET. 
However, in the trained state, the expression levels of UPP molecular markers are 
increased following single-bout EE, but are less responsive to single-bout RE. This 
suggests that adaptations following endurance exercise training are more reliant on 
protein UPP degradation processes than adaptations following RT.   
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3.1 Introduction 
Exercise elicits the necessary stimuli to promote positive skeletal muscle adaptations 
and is seen as one of the most potent interventions to maintain whole body health and 
reduce the risk of chronic disease. The mode, duration and intensity of the exercise 
performed, as well as training status, influences the adaptations to exercise [77, 395]. 
Accordingly, regularly performed endurance exercise (EE) predominantly enhances 
substrate utilization, oxidative capacity, capillary density and mitochondrial content 
[162, 181] while resistance exercise (RE) predominantly increases muscle mass and 
strength [162, 181].  
 
The extracellular stress signals elicited by muscle contraction during EE and RE 
constitute potent drivers of intracellular signalling, gene transcription and protein 
translation [237, 337, 395, 396], with EE and RE entailing relatively higher metabolic 
and mechanical stress, respectively. While the intracellular stress generated during 
muscle contractions differs between EE and RE, [427], there is evidence that both 
modes of exercise may regulate similar gene targets and biological processes [62, 395]. 
Indeed, both EE [64] and RE [307] modulate protein turnover by increasing muscle 
protein breakdown (MPB) and muscle protein synthesis (MPS) in the recovery period 
post-exercise. Investigating the regulation of molecular targets involved in MPB and 
MPS to exercise-induced adaptations has been of interest for over a decade. In regards 
to exercise-induced regulation on MPB, recent attention has focused on the regulation 
of muscle-specific E3-ligases, FBXO32 (also known as atrogin-1; muscle atrophy F-
box, MAFbx) and muscle ring finger-1 (MURF-1) [98, 217, 253, 263] principal 
mediators of ubiquitin-proteasome pathway (UPP) protein degradation [161, 233]. 
 
The Forkhead box O (FOXO) family of transcription factors, FOXO1 and FOXO3, 
regulate atrogin-1 and MuRF1 gene transcription [346, 367]. Atrogin-1 and MuRF1 
were identified as targets involved in skeletal muscle atrophy following observations 
that their genetic ablation in mice protects against muscle atrophy [38]. Furthermore, 
atrogin-1 and MuRF1 mRNA levels are increased in numerous in vitro and in vivo 
mouse models of muscle atrophy, [38, 161, 234, 339]. Atrogin-1 and MURF-1 are 
differentially regulated by exercise; however, the direction of their transient regulation 
is influenced by exercise mode, muscle contraction mode and prior training status 
[217, 253, 263]. In humans, single-bout traditional RE increases MURF-1 mRNA 1‒4 
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h post-exercise [47, 154, 253, 265, 320, 325, 366, 429]. In contrast, RE downregulates 
atrogin-1 mRNA 6‒12 h post-exercise [77, 253, 265, 429]. Contraction mode-specific 
RE has a differential effect with MURF-1 and atrogin-1 mRNA exhibiting different 
responses to isolated concentric and eccentric contractions, respectively [217, 288, 
365]. An increase in both atrogin-1 and MURF-1 mRNA is seen 1‒4 h following acute 
EE [253]. Identified substrate targets of atrogin-1 include myogenic differentiation 1 
(MYOD1) [377], myogenin factor 4 (MYOG, myogenin) [199] and eukaryotic 
translation initiation factor 3, subunit F (EIF3F) [226], proteins involved in muscle 
protein synthesis and regeneration. MuRF1 targets contractile and structural muscle 
proteins such as titin [65], troponin 1 [206] and myosin heavy chain (MHC) [75, 78], 
as well as several proteins involved in glycolysis and glycogen metabolism [180]. 
Whether or not atrogin-1 and MuRF1 substrate targets are involved in the post-exercise 
response following divergent modes of exercise is currently unknown.  
 
The precise roles of atrogin-1 and MURF-1 in muscle remodelling and exercise-
induced muscle adaptation are unresolved. Although time course proteolytic gene data 
following single-bout EE and RE have been reported [253], protein measures 
following divergent exercise modalities (i.e. traditional ET versus RT) are lacking, 
especially when removing the influence of stress responses to unaccustomed exercise. 
To date, molecular markers of UPP signalling following divergent exercise training 
have not been assessed. In this regard, high oxidative capacity muscle fibres, when 
compared with lower oxidative capacity fibres, have a greater rate of protein synthesis 
[184, 386]. However, high capacity oxidative fibres exhibit a smaller magnitude of 
growth [389]. This apparent paradox may be an evolutionary adaptation to maintain a 
reduced distance for oxygen diffusion to the mitochondria [389]. The precise 
mechanism/s controlling the reduced growth of high oxidative fibres (when compared 
to lower oxidative capacity fibres) is not known, however the relatively higher levels 
of UPP components in highly oxidative fibres may play a role [89, 389]. In accordance, 
traditional ET may constitute a strong driver of UPP expression to participate in 
skeletal muscle remodelling that limits cell growth to optimize oxygen diffusion in the 
presence of increased mitochondrial biogenesis. In contrast, traditional RT recruits less 
oxidative type II fibres. These fibres are less reliant on oxygen, but may be more prone 
to exercise-induced damage, consequently requiring muscle protein degradation to 
maintain optimal muscle performance and adaptation. Over time, accustomed RE 
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would result in less muscle damage and therefore an attenuated upregulation of UPP 
molecular markers.  
 
Therefore, the aims of the current study were to investigate the regulation of molecular 
markers of UPP signalling, firstly, following long-term ET and RT and secondly, 
following a single-bout of EE and RE in the trained state. The molecular markers of 
UPP signalling measured included atrogin-1, MURF-1, FBXO40, FOXO1, FOXO3, 
as well as protein substrates of atrogin-1 including EIF3F, MYOG and MYOD1, and 
MURF-1, including muscle pyruvate kinase (PKM) and MHC. It was hypothesized 
that prolonged traditional endurance as well as resistance training would both stimulate 
an upregulation of basal levels of UPP molecular markers. However, as prior RT may 
improve resilience towards RE-induced muscle damage, it was hypothesised that in 
the exercise-habituated state (i.e. through training), only EE would stimulate acute 
UPP upregulation, potentially as a mechanism to maintain an optimal size of the type 
I fibres. 
 
3.2 Methods 
3.2.1 Subjects 
Eighteen healthy untrained young men (mean ± SEM; height: 182 ± 0.0 cm, weight: 
79.1 ± 2.4 kg, age 23.3 ± 0.6, years) volunteered to participate in the study. Subjects 
were excluded if they had engaged in organized endurance or resistance exercise 
training within the last six months prior to inclusion in the study. This was assured 
partly by a VO2 max test [inclusion criteria for VO2 max < 50 mL per kg body mass 
(kg BM)-1 per minute (min-1)] in conjunction with an interview/questionnaire on prior 
training history. Further exclusion criteria included any history of musculoskeletal 
injuries and use of prescription medicine. All subjects were informed about the 
purpose and risks of the study and provided written informed consent in accordance 
with the Declaration of Helsinki. The study was approved by the local ethics 
committee of Region Midtjylland, Denmark (M-20080177). The subject details, study 
design and experimental protocols have been published previously [227]. 
 
3.2.2 Experimental design and training protocol  
The subjects were randomly divided into endurance training (ET) or resistance training 
(RT) groups (n = 9 per group). Prior to training, the subjects were tested for aerobic 
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and strength performance measures and underwent magnetic resonance imaging 
(MRI) scanning of the thigh muscle. Muscle biopsies from the vastus lateralis muscle 
were taken using the Bergstrom needle technique prior to (Pre) and after (Post) 
training. Following a few days of recovery, subjects then completed either 10-weeks 
of ET on a cycle ergometer or 10-weeks of progressive conventional RT for lower 
extremity muscle groups.  
 
As published previously [227, 395], ET was performed on stationary bicycles (Kettler 
Ergoracer GT, Kettler, Ense-parsit, Germany) as a progressive overload training 
program. Based on the pre- and midway determinations of VO2 max, maximal 
workload in Watts and maximal heart rate, target Watt and target heart rate for each 
training session were used to aid determination of target training intensity. Three 
weekly sessions consisted of one session each of continuous cycling of 30‒45 min at 
60‒75% of Watt max, a second session consisting of two intervals of 20 min at 70‒
80% of Watt max interspaced by 5 min of light cycling, and a third session consisting 
of 8 x 4 min intervals at 80‒90% of Watt max interspaced by one min of light cycling. 
The RT group completed a conventional progressive overload training program as 
previously described [227, 395]. In brief, the RT program included 30 training 
sessions; with three sessions consisting of lower extremity exercises (leg press, knee 
extension and hamstring curl) performed each week. One and/or 3 repetition maximum 
(RM) (depending on the specific type of exercise inherent of the RT program) was 
determined through initial 1 and 3 RM testing, with repetitions corresponding to RM 
loading. Absolute loads determined through these tests were then used to estimate 
absolute loads corresponding to the designated number of repetitions in the initial part 
of the training program, using RM calculating tools. The first four training sessions 
were conducted as 4 sets x 10 repetitions with 2 min of recovery between sets. 
Progression during the training period then relied on using average absolute load 
performed in the last subset of each session (e.g. the last of sessions 1–4, see [125]), 
to estimate the absolute loads corresponding to desired repetitions/intensity in the 
subsequent subset of training sessions (e.g. sessions 5–10). This procedure is 
commonly used [56, 342]. Over the training period, absolute loadings were adjusted 
according to training-induced improvements in strength. Furthermore, the relative 
intensity was gradually increased over the training period, so that in the final five 
training sessions, 5 sets x 4 repetitions were performed. These principles were 
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employed to provoke changes in muscle morphology as well as in muscle strength. 
During the last 15 training sessions, the subjects were instructed to perform the 
concentric phase of the exercises as fast as possible and recovery was increased to 3 
minutes between sets. All training sessions were supervised by trained exercise 
physiologists to ensure the subjects maintained correct exercise technique, performed 
the exercise at the appropriate intensity and increase the load appropriately when 
required. All training sessions were separated by at least one training-free day. 
Following three days of recovery, the training period was followed by completion of 
a single-bout of EE or a single-bout of RE. 
 
3.2.3 Single-bout exercise protocol  
The subjects had been instructed to abstain from exercise training for at least 3 days 
prior to the trial. A schematic overview of trial procedures immediately pre-exercise, 
during exercise, and during the 22 h post-exercise recovery period have been published 
previously [227, 395]. Subjects arrived after an overnight fast at 8:00 a.m. on day 1 for 
pre-exercise measurements. After 30 min of supine resting, a pre-exercise muscle 
biopsy was taken from the vastus lateralis muscle (corresponding to post-exercise 
basal). At 8:30 a.m., subjects in the endurance exercise (EE) group commenced 120 
min of bicycle exercise at ~60% VO2 max. Subjects in the resistance exercise (RE) 
group remained resting until 10:00 a.m. before completing 4 × 12 RM of three thigh 
muscle exercises with 1.5 min rest between sets. Accordingly, work performed during 
the single-bout EE and RE was identical to what the subjects had been exposed to 
during the training period. The three thigh muscle exercises were: leg press, knee 
extension, and hamstring curl. Minor weight adjustments were allowed to ensure 
performance of 12 RM as precise as possible. To control for potential effects of 
circadian rhythm, the time of day for completing all tests and training was kept 
constant for each individual subject. After exercise, all subjects rested under fasting 
conditions (with water offered ad libitum) until 3:30 p.m. (corresponding to 5 h post-
exercise) on day 1, thereafter meals by own choice were allowed until 10:00 p.m. 
Muscle samples were taken before and 0, 2.5, 5 and 22 h post-exercise. Biopsies were 
sampled from separate incision holes. For the biopsy corresponding to the 0 h time 
point, local anaesthesia of the skin and fascia was performed during a 30 second break 
approximately 10 min before termination of the exercise and the biopsy was taken 
within seconds after termination of exercise. The biopsy sampled at 2.5 h was taken 
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from the same leg as the pre-exercise biopsy, whereas the muscle biopsies sampled at 
0 h and 5 h post-exercise were taken from the opposite leg. On day 2, the subjects 
arrived at the laboratory after an overnight fast at 8:00 a.m. for final measurements. 
After resting for 30 min in the supine position, the final muscle biopsy (corresponding 
to 22 h post-exercise) was obtained. This final post-exercise muscle biopsy was 
sampled from the opposite leg compared with the pre-exercise muscle biopsy. 
 
3.2.4 Exercise capacity measurements  
3.2.4.1 Measures related to capacity for aerobic/endurance exercise  
As published previously [227, 395], VO2 max for all subjects was determined before 
and after training via an incremental exercise test on a Monark Ergomedic 834E 
bicycle ergometer (Monark Ergomedic 894 E, Monark, Varberg, Sweden), with rates 
of oxygen uptake and carbon dioxide release determined by an online respiratory gas 
exchange analyser (AMIS 2001, Innovision, Odense, Denmark). Watt max was 
estimated according to the principles of Andersen [6]. Maximal heart rate and 
submaximal heart rate at 140 Watt were monitored continuously with a heart rate 
monitor (Polar, Oulu, Finland).  
 
3.2.4.2 Measures related to capability for strength/resistance exercise  
Maximal dynamic knee extensor strength (determined as 3 RM knee extensor strength) 
was determined as previously described [394]. Peak torque was determined using an 
isokinetic dynamometer (Humac Norm, CSMI, Stoughton, Wisconsin, USA) with 90 
deg hip flexion. The protocol consisted of three maximal contractions at three different 
angular velocities: 30, 90, and 180 deg s-1, with contractions interspaced with one min 
of recovery time. All trials were sampled at 100 Hz. Peak torque from the best of the 
three trials was used for further analysis.  
 
3.2.5 Whole muscle cross-sectional area- magnetic resonance imaging  
Determination of whole muscle cross-sectional area (CSA) of thigh muscle was 
performed as described previously [227, 395]. MRI was performed with a 1.5-T 
scanner (Philips Achieva, Best, the Netherlands), with scans performed on the left leg 
using a cardiac coil. A T1-weighted, fast spin echo sequence with the following 
parameters was used: scan matrix = 288 x 282, field of view = 230 x 230 mm2, number 
of slices = 20, slice thickness = 7.5 mm, slice gap = 1 mm, repetition time = 2 s, echo 
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time = 5.3 ms, echo train length = 18, number of signal averages = 3, and scan time = 
3:12 min. After an initial frontal scout scan, 20 transversal slices were acquired, with 
a slice at a position corresponding to one-half of the femur length chosen for CSA 
determination of quadriceps muscle using custom made software and standard Philips 
radiological analysis environment (ViewForum rel. 5.1, 2006).  
 
3.2.6 ATPase histochemistry  
Muscle samples were dissected free of visible fat and connective tissue and a part of 
the biopsy was immediately mounted with Tissue-Tek, frozen in isopentane cooled 
with liquid nitrogen, and stored at ‒80 °C until further analysis. Serial sections (10 
μm) of the muscle biopsies were cryocut and ATPase histochemistry analysis was 
performed. To enable the determination of fibre type–specific CSA and fibre type 
distribution, ATPase histochemistry analysis was performed following pre-incubation 
at pH 4.37, 4.60, and 10.30 as described previously [5, 54]. The muscle fibres were 
categorized as 1 of 5 fibre types (I, I/IIa, IIa, IIax, and IIx) and then grouped into the 
3 main fibre types (I, IIa, IIx) according to the following formula: type I = I + ½1/IIa; 
type IIa = ½1/IIa + IIa + ½IIax; type IIx = ½IIax + IIx. For the area measurements, a 
general mean fibre size for all fibre types was combined, and a type I and type II (type 
IIa + type IIx)- specific area measure was calculated. A Leica DM2000 microscope 
(Leica, Stockholm, Sweden) and a Leica Hi-resolution Color DFC camera (Leica, 
Stockholm, Sweden) combined with image-analysis software (Leica Qwin ver. 3, 
Leica, Stockholm, Sweden) were used for visualization and analysis. 
 
3.2.7 Preparation of muscle biopsies  
Muscle biopsies were obtained from the middle section of the m. vastus lateralis 
muscle using the Bergstrom needle technique. Within each leg, a minimum distance 
of 3 cm between biopsy sampling sites was ensured and similar sampling depth of 
biopsies was attempted. Muscle biopsies were quickly divided into smaller parts 
immediately after sampling and were then frozen in liquid nitrogen and stored at 
−80°C until further analysis.  
 
3.2.8 Protein extraction  
Frozen muscle biopsy sample material (40-50 mg) were homogenized in ice-cold 
solubilization buffer containing: 20 mM Tris, 50 mM NaCl, 5 mM Na4P2O7, 50 mM 
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NaF, 250 mM sucrose, 2 mM DTT, 1% Triton-X 100, 2 Pg/mL aprotinin, 5 Pg/mL 
leupeptin, 0.5 Pg/mL pepstatin, 10 Pg/mL antipain, 1.5 mg/mL benzamidine, and 100 
Pmol/L 4-(2-aminoethyl)-benzenesulfonyl fluoride, hydrochloride (pH 7.4). Insoluble 
materials were removed by centrifugation at 16,000×g for 20 min at 4°C. Total protein 
content was determined using the Bradford protein assay kit (BioRad, Hercules, CA, 
USA) according to the manufacturer’s instructions.  
 
3.2.9 Statistical analyses 
Data are presented as mean fold change ± standard error of the mean (SEM). All 
statistical analyses were performed using GraphPad Prism, Version 6.0 (GraphPad 
Software Inc., CA, USA). For variables independent of time, Student’s t tests were 
performed to test for differences in basal levels between groups. For variables 
measured before and after the training period and following the single-bout exercise 
trials, two-way mixed ANOVAs with repeated measures were performed to test for 
changes due to group, time or group × time. When a significant effect of group and 
time was found, significant pairwise differences were assessed using Student-
Newman-Keul´s post hoc test. For all statistical tests, P < 0.05 was considered 
significant. 
 
3.3 Results 
Two subjects from each training group did not complete the training period due to 
exercise-unrelated circumstances, leaving n = 7 in each training group for all data 
presented. 
 
3.3.1 Exercise capacity and muscle morphology 
Changes in exercise capacity and muscle morphological parameters as induced by 10-
weeks of training have been described in detail previously [227, 395]. For the exercise 
capacity parameters, no differences were observed between groups prior to 
commencing the training period. The ET group exhibited a training-induced increase 
in VO2 max [44.9 ± 1.4 to 49.7 ± 2.0 mL (kg BM)-1min-1 (~11 ± 2%; P < 0.001)], in 
maximal workload [330 ± 18 to 374 ± 18 Watts (~13%; P < 0.001)] and a decrease in 
training-induced submaximal intensity exercise heart rate [155 ± 3 to 138 ± 3 bpm at 
140 Watts (~13%; P < 0.01)]. No changes pre- versus post-training occurred in the RT 
group for aerobic exercise capacity parameters with absolute pre- versus post-training 
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values amounting from 46.9 ± 3.0 to 46.9 ± 2.6 mL (kg BM)-1min-1, 322 ± 20 to 332 
± 19 Watts and 162 ± 9 to 152 ± 7 bpm at 140 Watts.  
 
As previously published [125], no significant changes in mean or specific fibre CSA 
were observed with ET. The RT group exhibited training-induced increases in mean 
fibre CSA [(~19 ± 7%; P < 0.05)]. When CSA of individual fibre type was analysed 
only type IIa fibre CSA was significantly increased following RT (P < 0.05). RT 
increased peak torque [214 ± 13 to 255 ± 13 peak torque at 30 deg s-1, Nm (~19%; P 
< 0.001)] and maximal knee extensor strength [96 ± 5 to 133 ± 4 (~40 ± 4%; P < 
0.001)], while no changes pre- versus post-training occurred with ET. The values for 
pre- versus post-ET peak torque and maximal knee extensor strength were 202 ± 20 to 
194 ± 18 peak torque at 30 deg s-1, Nm and 93 ± 9 to 94 ± 8, respectively. No significant 
changes in fibre type distribution occurred following RT or ET as shown previously 
[227]. 
 
3.3.2 Changes in mRNA and protein levels  
Basal pre-training FOXO1 protein was significantly increased in the ET group 
compared to the RT group (48 ± 1%; P = 0.016) (data not shown). Given that a random 
allocation of subjects to exercise training groups was performed pre-training, we 
suggest that this basal pre-training increase in FOXO1 is random. There were no 
differences in basal pre-training mRNA or protein levels for any other targets 
measured. A summary of all mRNA and protein changes following divergent exercise 
training and single-bout exercise are shown in Table 3.1. 
 
The basal level of atrogin-1 mRNA increased following both ET (92 ± 17%) and RT 
(67 ± 16%) (P < 0.001; Fig.3.1A). A single-bout of EE, but not RE, increased atrogin-
1 mRNA by 118 ± 33% at 2.5 h (P < 0.05), 189 ± 22% at h 5 h (P < 0.001) and 131 ± 
45% at 22 h (P < 0.05) compared to basal post-training. Following single-bout EE 
atrogin-1 mRNA levels were greater at 5 and 22 h when compared to single-bout RE 
(Fig. 3.1B).  
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Figure 3.1 Regulation of atrogin-1 mRNA following divergent exercise training [endurance training 
(ET) versus resistance training (RT) (pre-training basal versus post-training normalised to the mean pre-
training basal of the combined exercise training groups) and single-bout exercise [endurance exercise 
(EE) versus resistance exercise (RE) (post-training basal versus post-exercise recovery time points 
normalised to the mean post-training basal of each exercise group). Graphs are shown as fold changes 
± SEM from basal set to a fixed value of 1. Atrogin-1 mRNA increased independent of the exercise 
training mode. Line across groups indicates a general time effect, ***P < 0.001. (A). In the trained state, 
EE but not RE increased atrogin-1 mRNA at 2.5 – 22 h post-exercise (B). Significantly different from 
post-exercise, *P < 0.05, ***P < 0.001. Significantly different between exercise groups, #P < 0.05, ###P 
< 0.001 
 
 
For MURF-1 mRNA, a significant group by time interaction was observed with ET 
only increasing MURF-1 mRNA expression by 138 ± 24% (P < 0.01; Fig. 3.2A). 
Similarly, single-bout EE, but not RE increased MURF-1 mRNA at 2.5 h (340 ± 94%; 
P < 0.001) compared to basal post-training. Following single-bout EE MURF-1 
mRNA levels were greater at 0 h, 2.5 h and 22 h when compared to single-bout RE 
(Fig. 3.2B). No change in MURF-1 protein was observed following training and 
single-bout exercise (data not shown). 
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Figure 3.2 Regulation of MURF-1 mRNA following divergent exercise training [endurance training 
(ET) versus resistance training (RT) (pre-training basal versus post-training normalised to the mean pre-
training basal of the combined exercise training groups) and single-bout exercise [endurance exercise 
(EE) versus resistance exercise (RE) (post-training basal versus post-exercise recovery time points 
normalised to the mean post-training basal of each exercise group). Graphs are shown as fold changes 
± SEM from basal set to a fixed value of 1. Graphs are shown as fold changes ± SEM from basal set to 
a fixed value of 1. ET but not RT increased MURF-1 mRNA. Line across time points indicates a time 
x training interaction, **P < 0.01 (A). In the trained state, EE but not RE increased MURF-1 mRNA at 
2.5 h post-exercise (B). Significantly different from post-exercise, ***P < 0.001. Significantly different 
between exercise groups, #P < 0.05, ####P < 0.0001 
 
FBXO40 mRNA increased following both ET (73 ± 10%) and RT (21 ± 4%) (P < 0.01; 
Fig. 3.3A). FBXO40 protein was unaffected following training (data not shown). In 
response to single-bout EE, FBXO40 mRNA increased immediately post-exercise at 0 
h (83 ± 5%; P < 0.001), 2.5 h (62 ± 3%; P < 0.01), 5 h (54 ± 6%; P < 0.01) and 22 h 
(69 ± 7%; P < 0.01). Following single-bout exercise FBXO40 mRNA levels where 
greater in the EE than the RE group at all time points (Fig. 3.3B). Contrastingly, single-
bout RE downregulated FBXO40 mRNA by 53 ± 11% at 5 h (P < 0.05; Fig. 3.3B) and 
FBXO40 protein at 22 h (28 ± 2%; P < 0.05) compared to basal post-training levels 
(Fig. 3.3C). 
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Figure 3.3 Regulation of FBXO40 mRNA and protein following divergent exercise training [endurance 
training (ET) versus resistance training (RT) (pre-training basal versus post-training normalised to the 
mean pre-training basal of the combined exercise training groups) and single-bout exercise [endurance 
exercise (EE) versus resistance exercise (RE) (post-training basal versus post-exercise recovery time 
points normalised to the mean post-training basal of each exercise group). Graphs are shown as fold 
changes ± SEM from basal set to a fixed value of 1. Graphs are shown as fold changes ± SEM from 
basal set to a fixed value of 1. FBXO40 mRNA increased independent of the exercise training mode. 
Line across groups indicates a general time effect, P < 0.01. (A). In the trained state, EE increased 
FBXO40 mRNA at 0 – 22 h, while RE decreased FBXO40 mRNA at 5 h post-exercise (B). FBXO40 
protein was decreased 22 h post-RE (C). Significantly different from post-exercise, *P < 0.05, **P < 
0.01, ***P < 0.001. Significantly different between exercise groups, #P < 0.05, ##P < 0.01, ####P < 
0.0001 
 
FOXO1 mRNA increased after ET (47 ± 9%) and RT (41 ± 11%) (P < 0.001; Fig. 
3.4A). FOXO1 and phospho-FOXO1 protein were unaltered following exercise 
training (data not shown). Single-bout EE but not RE increased FOXO1 mRNA by 51 
± 4% at 5 h when compared to basal post-training (P < 0.01; Fig. 3.4B). FOXO1 
protein was unaffected in response to single-bout EE and RE (data not shown).  
 
 
 
 
Figure 3.4 Regulation of FOXO1 mRNA following divergent exercise training [endurance training (ET) 
versus resistance training (RT) (pre-training basal versus post-training normalised to the mean pre-
training basal of the combined exercise training groups) and single-bout exercise [endurance exercise 
(EE) versus resistance exercise (RE) (post-training basal versus post-exercise recovery time points 
normalised to the mean post-training basal of each exercise group). Graphs are shown as fold changes 
± SEM from basal set to a fixed value of 1. Graphs are shown as fold changes ± SEM from basal set to 
a fixed value of 1. FOXO1 mRNA increased independent of the exercise training mode. Line across 
groups indicates a general time effect, P < 0.001. (A). In the trained state, EE but not RE increased 
FOXO1 mRNA at 5 h post-exercise (B). Significantly different from post-exercise, **P < 0.01 
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FOXO3 mRNA levels increased after ET (56 ± 13%) and RT (51 ± 3%) (P < 0.0001; 
Fig. 3.5A). A significant group by time interaction was observed for FOXO3 protein 
with a 58 ± 8% increase in FOXO3 protein following ET (P < 0.05; Fig. 3.5B). In 
response to single-bout exercise, FOXO3 mRNA increased 5 h post-EE (50 ± 10%; P 
< 0.05) and decreased at 5 h post-RE (7 ± 1%; P < 0.05), with a significant difference 
observed between exercise modes (P < 0.0001; Fig. 3.5C). FOXO3 protein increased 
at 2.5 h following single-bout EE only when compared to basal post-training (45 ± 
2%; P < 0.05) (Fig. 3.5D). No change in phospho-FOXO3 protein occurred in response 
to training or single-bout exercise (data not shown). 
 
 
 
 
Figure 3.5 Regulation of FOXO3 mRNA and protein following divergent exercise training [endurance 
training (ET) versus resistance training (RT) (pre-training basal versus post-training normalised to the 
mean pre-training basal of the combined exercise training groups) and single-bout exercise [endurance 
exercise (EE) versus resistance exercise (RE) (post-training basal versus post-exercise recovery time 
points normalised to the mean post-training basal of each exercise group). Graphs are shown as fold 
changes ± SEM from basal set to a fixed value of 1. Graphs are shown as fold changes ± SEM from 
basal set to a fixed value of 1. FOXO3 mRNA increased independent of the exercise training mode. 
Line across groups indicates a general time effect, **** P < 0.0001 (A). FOXO3 protein increased 
following ET but not RT. Line across time points indicates a time x training interaction, P < 0.05 (B). 
In the trained state, EE and RE resulted in an increase and decrease in FOXO3 mRNA respectively, 
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measured at 5 h post-exercise (C). FOXO3 protein increased at 2.5 h post-EE (D). Significantly different 
from post-exercise, *P < 0.05. Significantly different between exercise groups at 5 h, ####P < 0.0001 
 
3.3.3 Changes in atrogin-1 and MURF-1 protein substrates 
Quantification of the protein level of atrogin-1 substrate targets, EIF3F, MYOD1, 
MYOG, as well as MURF-1 substrate targets, PKM and MHC, revealed no change in 
response to exercise training and in response to single-bout exercise performed 
following the training period when compared to basal pre-training and post-training, 
respectively (data not shown). Representative western blot images for all proteins 
measured are depicted in Fig. 3.6. 
 
 
 
 
Figure 3.6 Representative western blot images. Examples of MURF-1, FBXO40, phospho-FOXO1 
FOXO1, phospho-FOXO3, FOXO3, EIF3F, MYOD1, MYOGENIN (MYOG), PKM, MHC and 
GAPDH (normalising protein) measured prior to and after training (A) and prior to and after single-
bout exercise (B).  
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Table 3.1 Summary of mRNA and protein results. Exercise mode effects of training (pre-exercise basal 
versus post-exercise) and single-bout exercise (post-training basal versus post-exercise recovery time 
points) are shown as % change (mean ± SEM) from basal set to a fixed value of 100% for measured 
gene and protein targets. Endurance, E. Resistance, R. Different from specified basal levels, ↑/↓ P < 
0.05, ↑↑/↓↓ P < 0.01, ↑↑↑/↓↓↓ P < 0.001, ↑↑↑↑/↓↓↓↓ P < 0.0001. Difference between exercise modes, 
*P < 0.05, ¶P < 0.01, §P < 0.001, #P < 0.0001. No change, - 
 
Mode Training 
 Single-bout exercise  
 0 h 2.5 h 5 h 22 h 
Gene       
Atrogin-1 E ↑↑↑ 92 ± 17% - ↑ 118 ± 33% ↑↑↑ 189 ± 22%§ ↑ 131 ± 45%* 
 R ↑↑↑ 67 ± 16% - - § * 
       
MURF-1 E ↑↑ 138 ± 24% * ↑↑↑ 340 ± 94%# - * 
 R - * # - * 
       
FBXO40 E ↑↑ 73 ± 10% ↑↑↑ 83 ± 5%¶ ↑↑ 62 ± 3%* ↑↑ 54 ± 6%# ↑↑ 69 ± 7%¶ 
 R ↑↑ 21 ± 4% ¶ * ↓ 53 ± 11%# ¶ 
       
FOXO1 E ↑↑↑ 47 ± 9% - - ↑↑ 51 ± 4% - 
 R ↑↑↑ 41 ± 11% - - - - 
       
FOXO3 E ↑↑↑↑ 56 ± 13% - - ↑ 50 ± 10%# - 
 R ↑↑↑↑ 51 ± 3% - - ↓ 7 ± 1%# - 
       
Protein       
MURF-1 E - - - - - 
 R - - - - - 
       
FBXO40 E - - - - - 
 R - - - - ↓ 28 ± 2% 
       
FOXO1 E - - - - - 
 R - - - - - 
       
phospho-
FOXO1 
E - - - - - 
R - - - - - 
       
FOXO3 E ↑ 58 ± 8% - ↑ 45 ± 2% - - 
 R - - - - - 
       
phospho-
FOXO3 
E - - - - - 
R - - - - - 
       
EIF3F E - - - - - 
 R - - - - - 
       
MYOD1 E - - - - - 
 R - - - - - 
       
MYOG E - - - - - 
 R - - - - - 
       
PKM E - - - - - 
 R - - - - - 
       
MHC E - - - - - 
 R - - - - - 
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3.4 Discussion 
The present study investigated the effect of divergent modes of exercise training and 
a single-bout of exercise performed in the trained state on selective molecular markers 
of UPP signalling. The main findings were: 1) atrogin-1, FBXO40, FOXO1 and 
FOXO3 mRNA were upregulated following both ET and RT, by a higher magnitude 
following ET; 2) MURF-1 mRNA and FOXO3 protein levels were increased following 
ET but not RT; 3) in the trained state, single bout EE but not single-bout RE increased 
atrogin-1, MURF-1, FBXO40, FOXO1 and FOXO3 mRNA levels; 4) in the trained 
state, single-bout RE decreased FBXO40 mRNA and protein; 5) protein levels of 
atrogin-1 and MURF-1 substrate targets were not altered following training or single 
bout exercise. The general training-induced increase in atrogin-1, MURF-1 and FOXO 
molecules implies that these systems are not exclusively confined to atrophy processes, 
but may be important for protein turnover and adaptation to exercise.  
 
3.4.1 Effect of divergent exercise training on markers of UPP signalling  
In line with previous findings, ET and RT predominantly drive increases in aerobic 
capacity and muscle hypertrophy, respectively [7]. Despite the fact that the 
extracellular stress, physiological and metabolic responses and resultant training-
induced adaptations to ET and RT differ, the muscle adaptive response at the molecular 
level shares a comparable overall transcriptional upregulation of molecular markers of 
UPP signalling. This is demonstrated by increases in atrogin-1, FBXO40, FOXO1 and 
FOXO3 mRNA following 10-weeks of RT as well as ET. The upregulation of 
molecular markers of UPP signalling in conditions of enhanced skeletal muscle 
function suggests that the UPP is not confined to a role in muscle atrophy processes. 
Rather, it suggests that the UPP system may play an important role in protein turnover 
during exercise-induced skeletal muscle remodelling. This notion is not without 
precedence. Accordingly, RT increases the mRNA level of proteasome 20S α-1 
subunit (Psma1) and ubiquitin B (Ubb), protein coding genes implicated in the UPP 
[237], while ET increases 26S proteasome activity in healthy mice [89]. Additionally, 
an increase in molecular markers of UPP activity has been observed following long-
term training in hunting dogs [406]. 
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The increase post-RT in atrogin-1 mRNA, is consistent with previous observations 
following 8-weeks [237], but not 21-weeks [191] of hypertrophy-inducing RT. In 
contrast, the lack of RT-induced MURF-1 is in difference to a previously observed 
increase in MURF-1 mRNA following 8-weeks of RT [237]. This variance may be due 
to the slightly longer RT program in the present study with the premise being that 
MURF-1 mRNA is attenuated following extended RT [265]. At the protein level, 
MURF-1 was unchanged similarly to this previous report [237]. Although the time 
delay between gene transcription and protein translation may account for discrepancies 
between mRNA and protein levels, an additional explanation is that E3-ubiquitin-
ligases can undergo auto-ubiquitination [344].  
 
A divergent exercise-induced regulation of atrogin-1 and MURF-1 mRNA has 
previously been observed [47, 154, 253, 265, 325]. However, the proteins that these 
E3-ligases target in response to divergent exercise, are unknown. This investigation, 
revealed no change in known atrogin-1 or MURF-1 protein substrate targets, such as 
EIF3F, MYOD1, MYOG, PKM and MHC, was observed following divergent exercise 
training and divergent single-bout exercise performed in the trained state; supporting 
our recent observations following 2 h single-bout RE [366]. This result for MURF-1 
substrate targets may not be surprising given that the MURF-1 protein level was 
unaltered. Atrogin-1 protein levels were not measured due to doubt over the specificity 
of commercially available antibodies. However, we previously observed a decrease in 
EIF3F protein post-concentric-RE; no other atrogin-1/MURF-1 targets were measured 
[365]. It is conceivable that RE performed using divergent muscle-contractions may 
influence atrogin-1 and/or MURF-1 substrates. Moreover, it is likely that other 
currently unidentified substrate targets are involved in the exercise-induced 
regulatieron of these E3-ubiquitin ligases.  
 
FOXO1 and FOXO3 mRNA increased following both ET and RT, while FOXO3 
protein increased in response to ET only. A key adaptation to ET and a response to EE 
is improved energy metabolism. FOXO1 plays an important role in muscle fat 
oxidation under fasting or exercise conditions [321]. Recent evidence also suggests 
that FOXO3 plays an important role in enhanced mitochondrial metabolism [300]. The 
changes in FOXO protein levels with different modes of exercise training is limited. 
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However, Leger et al. previously showed a decrease in the nuclear protein content of 
FOXO1 and no effect on the FOXO3 protein following RT [237].   
 
3.4.2 Effect of divergent single-bout exercise on UPP signalling, following exercise 
training 
In the trained state, single-bout EE, but not RE, increased atrogin-1, MURF-1, 
FBXO40, FOXO1 and FOXO3 mRNA compared to basal post-training levels. A 
minimal induction of molecular markers of the UPP in response to single-bout of RE 
is in line with observations that prior resistance training may attenuate single-bout RE-
induced MPB [308].   
 
Following single-bout EE, atrogin-1 mRNA increased at 2.5, 5 and 22 h post-exercise, 
consistent with the hypothesis that in the endurance trained state, single-bout EE 
upregulates UPP molecular markers. Our observations are similar to an increase 
detected in atrogin-1 2‒4 h post-exercise [253, 296] but in contrast to a return of 
atrogin-1 to baseline levels 24 h post-running [253]. The former study employed 30 
min of running [253] compared to 2 h of cycling in the present study. Hence, the 
greater magnitude of metabolic stress elicited by our longer duration exercise protocol, 
or the fact that running is also comprised of eccentric contractions may have accounted 
for our sustained induction of atrogin-1 mRNA. In line with our data, single-bout 
cycling increases atrogin-1 mRNA in endurance trained subjects, indicating that ET 
does not diminish the acute exercise-induced regulation of atrogin-1 [77].  
 
Unlike EE, atrogin-1 mRNA was unaltered following single-bout RE. This lack of 
increase in atrogin-1 following single-bout RE in the trained state is similarly 
consistent with our hypothesis that in the trained state, molecular markers of the UPP 
will not be responsive to single-bout RE. Previous studies utilising traditional RE have 
observed no change in atrogin-1 mRNA at corresponding time points in untrained [47, 
154, 191, 265, 320, 429], highly trained [77] and moderately trained subjects [253]. 
Others have observed a downregulation in atrogin-1 mRNA 2‒6 h post-exercise in 
untrained [92, 325], 8‒12 h post-exercise in moderately trained [253] and 3 h post-
exercise in highly trained subjects [73]. Therefore, atrogin-1 mRNA is either 
unchanged or decreased following acute RE. However, in studies utilising isolated 
contraction mode, eccentric-muscle contraction RE has been consistently shown to 
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downregulate atrogin-1 mRNA [217, 288, 365]. Furthermore, it has been shown that 
atrogin-1 can be upregulated with concentric contraction mode [217, 288, 365], thus 
supporting our current results from cycling exercise. This suggests that the regulation 
of atrogin-1 may differ with a higher metabolic demand inherent of concentric work 
versus a higher mechanical stress-strain inherent of eccentric work.  
 
MURF-1 mRNA increased at 2.5 h following single-bout-EE, in accord with 
previously observed inductions of MURF-1 mRNA 0‒4 h post-EE [253, 296]. Despite 
EE-induced alterations in mRNA levels, MURF-1 protein levels remained unchanged. 
No change in MURF-1 mRNA or protein was observed in response to single-bout RE. 
In untrained individuals, MURF-1 mRNA increases 1‒4 h following RE [47, 154, 253, 
265, 320, 325, 366, 429], while MURF-1 protein increases 1‒3 h post-RE [47, 154]. 
A lack of RE-induced MURF-1 expression in the current study may reflect the 
subject’s prior training status. Prior training status can alter the acute gene responses 
in skeletal muscle to subsequent exercise [77, 265, 395]. Indeed, MURF-1 mRNA is 
unchanged 3 h post-RE in highly RT subjects [73], indicating that prior RT attenuates 
exercise-induced gene responses to acute exercise. Failure of MURF-1 induction in 
the present study implies that following RT, the demand to increase MPB, at least 
UPP-regulated protein degradation, in response to single-bout RE [33, 35, 307, 308] 
is attenuated. This notion is in line with a blunted exercise-induced increase in mixed 
muscle fractional protein synthesis [209, 308] and protein breakdown [308] in RT 
compared to untrained subjects.  
 
FBXO40 mRNA increased immediately following single-bout EE, and remained 
elevated until 22 h post-exercise. FBXO40 is another E3-ubiquitin ligase, recently 
found to ubiquitinate and degrade insulin receptor substrate 1 (IRS1), a downstream 
effector of insulin and insulin-like growth factor-1 (IGF-1) receptor mediated 
signalling such as PI3K/Akt [353]. Mice lacking FBXO40 demonstrate abnormally 
increased skeletal muscle hypertrophy [353]. In response to acute RE, we previously 
observed an increased FBXO40 mRNA 2 h post-exercise in untrained individuals 
[366]. A lack of FBXO40 mRNA induction in response to RE and hypertrophy-
inducing RT may reflect the training status of our subjects. The decrease in FBXO40 
mRNA following prior RT supports the hypothesis that in the resistance trained state, 
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single-bout RE does not produce a significant upregulation of molecular markers of 
the UPP.  
 
Single-bout EE increased FOXO1 and FOXO3 mRNA at 5 h post-exercise, in 
agreement with a previously observed increase in FOXO1 3 h post-cycling [260] and 
FOXO3 expression 1 h post-running [253]. No changes in FOXO1 or FOXO3 
mRNA/protein occurred in response to single-bout RE, which is in accord with some 
previous studies [92, 253, 320, 366], but not others [325]. In particular, FOXO1 
mRNA increases following isolated concentric, but not eccentric contraction RE [288, 
325, 365]. No change in FOXO1 or phospho-FOXO1 protein occurred in response to 
single-bout exercise. While a recent study by our group similarly showed no change 
in FOXO1 or phospho-FOXO1 protein post-RE [366], another recent study by our 
group observed a downregulation of phospho-FOXO1 following eccentric RE and a 
decrease in FOXO1 protein following both eccentric and concentric-RE [365]. Thus, 
isolated muscle-specific contraction mode as opposed to conventional RE appears to 
regulate FOXO proteins. In response to single-bout EE but not RE, FOXO3 protein 
increased 2.5 h post-exercise. A lack of change in FOXO3 and phospho-FOXO3 in 
response to RE is in accord with data from our group [366] as well as others [154, 
366].  
 
Both ET and RT increased the mRNA levels of molecular markers of UPP. This 
general upregulation of the UPP basal levels following prolonged training suggests 
that atrogin-1 and MURF-1 may play a role in healthy skeletal muscle adaptation and 
remodelling post-exercise, although specific remodelling requirements may relate to 
ET and RT. Accordingly, in the trained state, (i.e., a state in which the muscle is 
presumably less prone to exercise-induced muscle micro-damage requiring less 
protein degradation), only EE elicited an upregulation of molecular markers of the 
UPP. This suggests that EE-induced increases in the UPP reflects an adaptation to ET 
that may play a role in precluding type I fibre growth to optimize oxygen supply to the 
mitochondria. [389]. Our observation of a lack of type I fibre growth with prolonged 
ET, but not RT, supports this. The difference in fibre growth between training modes 
may be logically ascribed to a greater increase in muscle protein synthesis in type II 
fibres. However, high capacity oxidative fibres, when compared with low capacity 
oxidative fibres, possess a greater capacity for protein degradation as well as protein 
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synthesis. This further supports the contention that in response to endurance exercise 
training, protein degradation is greater than protein synthesis in oxidative fibres and 
this response counteracts oxidative fibre growth. In contrast, in resistance exercise 
training, protein synthesis remains greater than protein degradation [389]. Future 
studies combining gene and protein expression molecular markers in single fibres 
and/or including direct measures of protein turnover are required to delineate the 
precise roles and function of E3-ubiquitin ligases and potentially develop specific 
exercise interventions to improve skeletal muscle health. Our observations that 
atrogin-1, MURF-1 and FOXO are increased following exercise-training and sensitive 
to different contraction modes suggest they may play specific roles in the adaptation 
to exercise. Likely roles include the differentiated re-modelling requirements of the 
muscle architecture as well as energy metabolism with divergent exercise.  
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CHAPTER 4 
 
INFLUENCE OF DIVERGENT EXERCISE CONTRACTION 
MODE AND WHEY PROTEIN SUPPLEMENTATION ON 
ATROGIN-1, MURF-1 AND FOXO1/3 IN HUMAN SKELETAL 
MUSCLE 
 
 
This work has been published prior to the completion of this dissertation Stefanetti RJ, Lamon S, 
Rahbek SK, Farup J, Zacharewicz E, Wallace MA, Vendelbo MH, Russell AP, and Vissing K. Influence 
of divergent exercise contraction mode and whey protein supplementation on atrogin-1, MuRF1 and 
FOXO1/3A in human skeletal muscle. Journal of applied physiology 2014. 
 
Abstract 
Knowledge from human exercise studies on regulators of muscle atrophy is lacking, 
but is important to understand the underlying mechanisms influencing skeletal muscle 
protein turnover and net protein gain. This study examined the regulation of muscle 
atrophy‒related factors, including atrogin-1 and MURF-1, their upstream transcription 
factors FOXO1 and FOXO3 and the atrogin-1 substrate EIF3F, in response to 
unilateral isolated eccentric (ECC) versus concentric (CONC) exercise and training. 
Exercise was performed with whey protein hydrolysate (WPH) or isocaloric 
carbohydrate (iCHO) supplementation. Twenty-four subjects were divided into WPH 
and iCHO groups and completed both single-bout exercise and 12-weeks of training. 
Single-bout ECC exercise decreased atrogin-1 and FOXO3 mRNA compared with 
basal and CONC exercise, while MURF-1 mRNA was upregulated compared with 
basal. ECC exercise downregulated FOXO1 and phospho-FOXO1 protein compared 
with basal, and phospho-FOXO3 was downregulated compared with CONC. CONC 
single-bout exercise mediated a greater increase in MURF-1 mRNA and increased 
FOXO1 mRNA compared with basal and ECC. CONC exercise downregulated 
FOXO1, FOXO3, and EIF3F protein compared with basal. Following training, an 
increase in basal phospho-FOXO1 was observed. While WPH supplementation with 
ECC and CONC training further increased muscle hypertrophy, it did not have an 
additional effect on mRNA or protein levels of the targets measured. In conclusion, 
atrogin-1, MURF-1, FOXO1/3 and EIF3F mRNA and protein levels are differentially 
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regulated by exercise contraction mode, but not WPH supplementation combined with 
hypertrophy-inducing training. This highlights the complexity in understanding the 
differing roles these factors play in healthy muscle adaptation to exercise. 
 
4.1 Introduction 
Muscle hypertrophy occurs as a product of the net muscle protein accumulation over 
time [303, 330] when the rate of MPS is greater than MPB. A single-bout of RE 
performed in the fasted state increases MPS and to a smaller degree MPB [34, 35, 
307]. Ingestion of EAAs combined with RE synergistically increases MPS [34, 35, 49, 
307, 308, 319, 381] and inhibits [34, 49, 381] or downregulates MPB [34, 154], 
resulting in an enhanced net muscle protein accumulation [224, 307, 381]. Activation 
of MPS is primarily mediated through MTOR signalling [39, 45, 105, 115, 139, 185, 
309]; however the regulation of the MPB pathways in response to anabolic stimulation 
has been less well defined. 
 
Atrogin-1 and MURF-1 are muscle-specific E3-ubiquitin ligases [38, 161] and 
transcriptional targets of the FOXO family members, FOXO1 and FOXO3 [55, 346, 
367]. Their ablation in mice protects against muscle wasting [38, 161], suggesting that 
they may be primary mediators of MPB and muscle atrophy in disease conditions. 
Atrogin-1 and MURF-1 are elevated in numerous models of rodent and human muscle 
atrophy (reviewed in [130]); however, their levels remain unchanged in some human 
wasting conditions [238, 341]. Similarly, atrogin-1 and MURF-1 mRNA levels are 
elevated following muscle hypertrophy-inducing RT [237]. Known substrate targets 
of atrogin-1 include proteins involved in muscle protein synthesis and regeneration 
such as EIF3F [226], MYOD1 [377], and MYOG [199]. MURF-1 targets proteins 
involved in muscle structure and contraction such as myosin heavy chain (MHC) [75, 
78, 128] as well as several proteins involved in glycolysis and glycogen metabolism 
[180, 218, 219]. Atrogin-1 and MURF-1 regulate distinct components involved in 
skeletal muscle function under basal, catabolic and anabolic conditions. This 
highlights their complex and important role in skeletal muscle health. 
 
Atrogin-1 and MURF-1 levels are differentially regulated by exercise contraction 
mode and amino acid availability. Following single-bout RE, comprising both ECC 
and CONC contraction modes, atrogin-1 mRNA is downregulated 3‒12 h post-
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exercise [77, 253, 265], while MURF-1 mRNA is upregulated 1‒4 h post-exercise 
[154, 253, 265, 429]. Isolated ECC RE decreases atrogin-1, while isolated CONC RE 
increases MURF-1 [217, 288]. This supports the notion that they react to different 
exercise-induced stressors and target different substrates. The effect of essential amino 
acid supplementation combined with RE on the regulation of atrogin-1 and MURF-1 
remains equivocal with reports showing either a decrease in atrogin-1 mRNA only 
[47] or no change in either target [92, 191, 325]. Atrogin-1, MURF-1, as well as 
FOXO1 and FOXO3, protein levels have not been thoroughly investigated following 
contraction mode-specific RE, but such investigation is required to understand the 
potential relevance of their mRNA changes.  
 
Experimental chapter 1 demonstrated that molecular markers of UPP signalling are 
upregulated in response to both ET and RT. However, the UPP showed a greater 
response to single-bout EE compared to single-bout RE in the trained state. Our data 
demonstrated that UPP signalling is sensitive to divergent exercise modality, and is 
responsive to anabolic stimulation. An overall aim of muscle research is to develop 
specific exercise and nutritional interventions to improve skeletal muscle health. 
Following on from experimental chapter 1, the present study aimed to conduct a 
comparative study to investigate the influence of unilateral ECC versus CONC RE on 
the mRNA and/or protein levels of atrogin-1, MURF-1, FOXO1, FOXO3 and EIF3F 
in human skeletal muscle. Measurements were made before and after 1) short-term 
exercise-habituation, 2) single-bout RE and 3) 12-weeks of hypertrophy-inducing 
training. A second aim was to also examine the effect of leucine-enriched whey protein 
hydrolysate (WPH) supplementation combined with RE on the potential single-bout 
exercise and training-induced changes in mRNA and protein, when compared with a 
control isocaloric carbohydrate supplement (iCHO). It was hypothesised that the 
mRNA and/or protein levels of atrogin-1, MURF-1, FOXO1, FOXO3 and EIF3F 
would 1) be regulated to a greater extent in the exercise-habituated fed state following 
acute unilateral ECC RE, when compared with CONC RE; 2) be attenuated with WPH 
supplementation following both single-bout unilateral ECC and CONC RE; and 3) be 
regulated to a greater extent following unilateral ECC hypertrophy-inducing RT, when 
compared with other combinations of contraction mode and supplementation.   
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4.2 Methods 
4.2.1 Subjects 
Twenty-four healthy untrained young men (mean ± SEM; height: 181.5 ± 1.5 cm; 
weight: 78.1 ± 1.8 kg; age 23.9 ± 0.8 years; fat % 16 ± 0.9%) volunteered to participate 
in the study. Subject criteria to be fulfilled to allow participation in the study comprised 
1) no participation in systematic resistance or high intensity training for lower 
extremity muscles 6 months prior to inclusion in the study, 2) no history of lower 
extremity musculoskeletal injuries, and 3) no vegan diet or use of dietary supplements 
or prescription medicine that would potentially influence muscle size. All subjects 
were informed about the purpose and risks of the study and provided written informed 
consent in accordance with the Declaration of Helsinki. The study was approved by 
the local ethical committee of Region Midtjylland (j. no. M-20110003). 
 
4.2.2 Experimental design 
The complete study included the completion of a 7-day exercise-habituation phase to 
accustom the subjects to unilateral ECC and CONC muscle contraction, a single-bout 
exercise trial to investigate acute exercise responses, and a 12-week training study to 
investigate accumulated exercise responses. Among the 24 subjects completing the 
habituation and acute trials, 5 subjects dropped out before the training trial was 
initiated. Another 3 subjects were recruited and completed the training trial with the 
remaining 19 subjects.  
 
To investigate the acute and accumulated effects of ECC contraction mode versus 
CONC contraction mode, the 2 legs of each subject were randomly assigned to ECC 
or CONC contraction mode. This within-subject design was used to minimize the 
potential differences in the training response that are inherent with group designs (e.g., 
initial training status, habitual nutritional intake and/or hormonal status). Furthermore, 
to investigate for acute and accumulated exercise-induced effects of WPH versus a 
control isocaloric carbohydrate (iCHO) supplement, subjects were randomly divided 
into two groups of 12 subjects and dietary supplements were provided in a double 
blinded fashion.  
 
An overview of the pre-single-bout trial procedures and the single-bout trial is shown 
in Fig. 4.1A. Three days prior to commencing the study, the subjects were asked to 
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abstain from any physical activity other than their normal daily activities. Thereafter, 
a basal muscle biopsy was obtained from one randomly chosen leg. Three days 
following the basal muscle biopsy the subjects commenced a period of exercise-
habituation. On three occasions during 7 days the subjects completed ECC and CONC 
exercise on alternate legs using a protocol similar to the single-bout exercise trial. 
Three days following the completion of the exercise-habituation period, muscle 
biopsies were obtained from both legs after an overnight fast and after at least 30 min 
of supine rest. These biopsies provided contraction mode-specific habituated basal 
levels for ECC (Basal ECC) and CONC (Basal CONC) exercise. Three days after these 
biopsies were taken the subjects completed the single-bout exercise trial (see Fig. 
4.1B). Approximately 7 days after the single-bout trial the subjects commenced a 12-
week training period. Three days after the last exercise session of the training period a 
final muscle biopsy was obtained from each leg. 
 
4.2.3 Exercise-habituation and single-bout exercise protocol  
All exercise-habituation and the single-bout exercise sessions were conducted using 
an isokinetic dynamometer (Humac Norm, CSMi Medical Solutions, Stoughton, MA, 
USA). Exercise consisted of 6 sets of 10 maximal ECC or CONC repetitions at 30 deg 
s‒1 angular velocity with 1 min of recovery between sets. One leg completed all sets 
of either isolated ECC or CONC exercise. Following this, the alternate leg completed 
all sets of the alternate mode of contraction; contraction mode was completed in a 
randomized order. The overall protocol of the single-bout trial is represented in Fig. 
4.1. Subjects had been instructed to abstain from physical activity in the days prior to 
the single-bout trial and arrived after an overnight fast at 08.30 h on the day of the 
single-bout trial. Prior to the exercise session, subjects rested in the supine position for 
~30 min. At 09.00 h subjects commenced the exercise session; the same protocol as 
used for the exercise-habituation sessions. Immediately after completion of the 
exercise session the subjects ingested a WPH supplement or control isocaloric CHO 
supplement (see section below). The subjects continued to fast for another 5 h post-
exercise (except water ad libitum) and biopsies were obtained from each leg at time 
points corresponding to 1, 3 and 5 h after exercise. To control for potential effects of 
circadian rhythm, the absolute daily time points and time resolution of the protocol 
were strictly adhered to for all subjects.  
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Figure 4.1 A) Exercise-habituation protocol: Three days prior to obtaining a pre-exercise-habituation 
biopsy, subjects refrained from exercise (‒3 days). A pre-exercise-habituation biopsy (arrow) was then 
obtained from a randomly selected leg (0 days). Subjects then recovered for 3 days prior to initiation of 
the exercise-habituation period (3 days). The exercise-habituation period included three exercise 
sessions during a 7 day period, with 48 h interspacing each exercise session. Exercise sessions were 
conducted as 6 sets of 10 maximal eccentric (ECC) or concentric (CONC) repetitions at 30 deg s‒1 
angular velocity, with 1 min of recovery between sets (10‒13 days). Three days of recovery was then 
interspaced prior to obtaining post-exercise habituation biopsies (13 days). Another 3 days of recovery 
were then interspaced before completion of the single-bout exercise trial (16 days). All pre- and post-
habituation biopsies were obtained after an overnight fast. B) Single-bout-exercise protocol: After an 
overnight fast, the subjects reported to the laboratory at 08:30 h (‒1 h). After 30 min of supine rest (-½ 
to 0 h), subjects completed a single-bout exercise session, conducted exactly as during exercise-
habituation. Immediately post-exercise, a whey protein hydrolysate (WPH) or a control isocaloric 
carbohydrate (iCHO) supplement was ingested (0 h) and during the post-exercise recovery, biopsies 
were obtained at 1, 3, and 5 h from both ECC and CONC exercised legs.  
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4.2.4 Supplementation 
On the single-bout trail day, immediately after completion of the exercise session, 
subjects of the WPH group were given a single bolus solution consisting of 0.30 g 
whey protein + 0.30 g CHO per kilogram lean body mass, while subjects in the iCHO 
supplement group received an isocaloric solution consisting of 0.60 g CHO per 
kilogram lean body mass. The supplements were diluted in artificially flavoured water. 
The BCAA content of the WPH supplement (produced by Arla Foods Ingredients, 
Viby J., Denmark) was 27.7% (leucine 14.2%, isoleucine 6.6%, valine 6.9%), which 
is considered high compared with standard milk-based whey protein sources [192]. On 
all training days, the subjects in both groups received a fixed amount of the respective 
supplements. Each intake consisted of an 8% solution (equal to 663 kJ), with the WPH 
drink consisting of 19.5 g whey protein + 19.5 g of carbohydrate and the CHO drink 
consisting of 39 g of carbohydrate. Half of the solution was ingested just before each 
training session and the other half was ingested immediately after each training 
session. The subjects were instructed not to eat or drink anything calorie-containing 
for 1½ h prior to and during the 1 h immediately after the exercise session. 
 
4.2.5 Training protocol  
The subjects completed 33 exercise sessions over a 12-week training period. Training 
was aimed to promote muscle hypertrophy and was conducted as a progressive 
overload RT program. Exercise training frequency was two to three times per week 
depending on the progression phase. All exercise sessions commenced with a 
standardized warm-up consisting of 5 min light bicycling exercise. The load for the 
ECC leg was aimed at 120% of CONC loading with a training supervisor assisting to 
allow isolated exercise modality of the two legs. This corresponded to the approximate 
strength difference between slow ECC and CONC contractions during isokinetic 
strength testing [1]. Both the ECC and CONC leg training programs consisted of 
isotonic knee extensions (repetition loading equal to RM) with the following set x 
repetitions; 6 x 10-15 RM (sessions 1–4), 8 x 10-15 RM (sessions 5–10), 10 x 10-15 
RM (sessions 11–20), 12 x 6-10 RM (sessions 21–28), and 8 x 6-10 RM (sessions 29–
33) (Technogym-Selection line, Technogym, Italy). Subjects were instructed to 
perform each repetition in a controlled manner (2-s tempo) during both the CONC and 
the ECC phase of the exercise with two min of recovery interspaced between sets. 
Training was supervised by qualified instructors to ensure proper execution/loading.  
  76 
4.2.6 Preparation of muscle biopsies 
Muscle biopsies were obtained from the middle section of the m. vastus lateralis 
muscle using the Bergstrom needle technique, with at least 3 cm between incision sites 
of each biopsy and care taken to reach the identical sampling depth between biopsies. 
The muscle samples were quickly dissected free of visible fat and connective tissue, 
weighed and divided into smaller parts for protein and RNA extraction and stored at ‒
80°C until further investigation. 
 
4.2.7 Protein extraction  
Frozen muscle biopsies (~30 mg) were minced between nitrogen cooled pistons and 
homogenized in an ice-cold buffer containing 20 mM Tris-HCl, 50 mM NaCl, 250 
mM sucrose, 50 mM NaF, 5 mM Na4P2O7, 1% Triton-X 100, 5 μg/ml leupeptin, 1.5 
μg/ml benzamidine, 500 μM PMSF, 50 μg/ml soybean trypsin inhibitor, and 2 mM 
DTT. An automated Precellys 24 (Bertin Technologies, Martillac, France) bead-
based grinder was used for the homogenization. Samples were rotated for 60 min at 
4°C and insoluble materials were centrifuged off at 14,000 g for 20 min at 4°C. Total 
protein content was determined using the Bradford protein assay kit (BioRad, 
Hercules, CA, USA). 
 
4.2.8 Muscle cross-sectional area 
MRI of thigh muscle was performed with a 1.5-T scanner (Philips Achieva, Best, the 
Netherlands), as previously described [126]. Subjects were seated in a resting position 
for 30–45 min before entering the scanner and were instructed not to move when lying 
in the scanner. A minimum of 48–72 h was interspaced between the last training 
session and MRI scanning to minimize the risk of fluid shifts. The later offline analyses 
were conducted using a free software program (Osirix, 4.1.1, Osirix Foundation, 
Geneva, Switzerland). After an initial frontal survey scan, 50 transversal slices were 
acquired, of which only 3 were used for the present study. The first slice was 70 mm 
proximal to the distal part of the femur condyles and the other slices were acquired 
proximally from this point. AT1-weighted, fast spin echo sequence with the following 
parameters was used: scan matrix = 576 x 576, field of view = 46 x 46 cm, number of 
slices = 50, slice thickness = 7 mm, slice gap = 3 mm, repetition time = 2 s, echo train 
length = 18, number of signal averages = 2, TR = 500 ms, TE = 6.2 ms, and pixel size 
= 0.8 x 0.8 mm. From the frontal and transverse scans, the femur length (from the 
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femur condyles to the apex of the trochanter) was calculated. Following this, the knee 
extensor muscle CSA (mm. vastus lateralis, vastus medialis, vastus intermedius, and 
rectus femoris) was manually outlined at ½ of the femur length representing mid-thigh 
level. All analyses were conducted by an investigator blinded to the intervention 
(supplementation and contraction mode).  
 
4.2.9 Isometric strength performance 
Subsequent to a standardized warm-up consisting of 5 min low-intensity exercise on a 
stationary ergometer cycle (Monark, Varberg, Sweden), the subjects were seated in an 
isokinetic dynamometer (Humac Norm, CSMI, Stoughton, USA) with 90q hip flexion 
and restraining straps crossing the torso and tested leg. Both legs were tested since 
they were trained differently, and the test order was randomized between the ECC and 
CONC leg. The transverse axis of the subject’s knee was aligned with the axis of the 
dynamometer. The test leg was attached to the dynamometer arm while the other leg 
was placed behind a stabilization bar. The dynamometer was adjusted individually so 
the contact point between the subjects’ leg and the dynamometer arm was 3 cm 
proximal to the malleolus medialis.  
 
Maximal voluntary contraction (MVC) was measured at 70 deg knee flexion (0 deg 
equals full extension). Before starting the test, the subject’s lower leg was weighed to 
enable gravity correction of the measured torque. The subject was allowed four trials 
(however, if a subject continued to improve, additional trials were provided) and all 
contractions were interspaced with 1 min of recovery time. MVC was determined as 
the highest peak torque from the best of the four trials.  
 
4.2.10 Statistical analyses 
Power analysis was calculated for the change in gene and protein expression, as these 
dependent variables tend to have a lower magnitude of change and higher variability 
following exercise interventions compared with other dependent variables measured. 
From our previous experience we expected a variation of about 20‒30% of the mean 
for all groups. With an alpha level set at P < 0.05 and a required power set at 0.8 we 
calculated that 12 subjects per group would be required to detect a change of 20‒25%.  
 
  78 
Data are presented as mean fold change ± SEM. All statistical analyses were performed 
using IBM SPSS Statistics 20 (SPSS Inc., Chicago, IL, USA).  For all statistical tests 
P < 0.05 was considered significant. The effect of time (pre versus post), group (WPH 
versus iCHO) and contraction mode (ECC versus CONC) and their interactions on 
quadriceps CSA and MVC were assessed using a mixed-effect three-way ANOVA 
with repeated measures for time.  
 
Post-habituation mRNA and protein levels were normalized to pre-habituation basal 
levels (no supplement intervention during exercise-habituation) and were analysed for 
effect of contraction mode only using one-way repeated measures ANOVA.  
 
Post-single-bout mRNA and protein levels were normalized to post-habituation basal 
levels and analysed for contraction mode (ECC versus CONC) x supplement type 
(WPH versus iCHO) x time using the mixed-effect three-way ANOVA with repeated 
measures for time. As no effects of dietary supplementation type were observed during 
the single-bout exercise trial, data were merged by supplementation and the effects of 
contraction mode x time were assessed using two-way repeated measures ANOVA.  
 
Post-training protein levels were normalized to pre-habituation basal levels and were 
shown to be independent of dietary supplementation type. Accordingly, both exercise 
and training changes were analysed for effect of contraction mode using a one-way 
repeated measures ANOVA.  
 
When a significant effect of contraction mode and/or time was found, significant 
pairwise differences were assessed using the Student–Newman–Keuls post hoc test. 
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4.3 Results 
4.3.1 Effect of exercise-habituation  
Compared with basal levels, habituation for isolated ECC and CONC exercise 
increased atrogin-1 mRNA by 50 ± 8% and 70 ± 9%, respectively, (P < 0.05; Fig. 
4.2A), while MURF-1 mRNA increased by 40 ± 9% with CONC only (P < 0.05; Fig. 
4.2B). Additionally, habituation exercise increased FOXO1 mRNA by 28 ±% (P < 
0.01) and 41 ± 8% (P < 0.0001), respectively (Fig. 4.2C) and FOXO3 mRNA by 42 ± 
% and 48 ± 13% following ECC and CONC exercise, respectively (P < 0.01; Fig. 
4.2D).  
 
 
 
Figure 4.2 Effects of exercise-habituation on mRNA expression. Contraction mode- specific effects 
(ECC versus CONC) of exercise-habituation (pre-habituation basal versus post-habituation basal) are 
shown as fold change ± SEM from basal set to a fixed value of 1 for atrogin-1 (A), MURF-1 (B), FOXO1 
(C), and FOXO3 (D). Different from basal pre-habituation. *P < 0.05, **P < 0.01, ***P < 0.001, ****P 
< 0.0001.  
 
No change was observed in MURF-1 protein levels (Fig. 4.3A). The protein levels of 
the atrogin-1 substrate, EIF3F, increased by 34 ± 13% following CONC exercise (P < 
0.05; Fig. 4.3B). Total FOXO1 protein levels increased by 30 ± 14% and 36 ± 14%, 
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respectively (P < 0.05; Fig. 4.3C), while phospho-FOXO1 protein levels increased by 
28 ± 8% (P < 0.01) and 41 ± 8% (P < 0.0001), respectively, following ECC and CONC 
habituation exercise (Fig. 4.3D). No change was observed for FOXO3 (Fig. 4.3E) or 
phospho-FOXO3 protein (Fig. 4.3F). Representative examples of Western blots for all 
protein targets are shown in Fig. 4.4. A summary of gene and protein results following 
exercise-habituation are shown in Table 4.1.  
 
 
 
Figure 4.3 Effects of exercise-habituation on protein expression. Contraction mode- specific effects 
(ECC versus CONC) of exercise-habituation (pre-habituation basal versus post-habituation basal) are 
shown as fold change ± SEM from basal set to a fixed value of 1 for MURF-1 (A), EIF3F (B), FOXO1 
(C), phosphor-FOXO1 (D), FOXO3 (E), and phosphor-FOXO3 (F). Different from basal pre-
habituation. *P < 0.05, **P < 0.01, ****P < 0.0001.  
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Figure 4.4 Examples of representative western blots are shown for MURF-1 (A), EIF3F (B), FOXO1 
(C), phospho-FOXO1 (D), FOXO3 (E), phospho-FOXO3 (F), and GAPDH (G) (normalizing protein) 
for contraction mode-specific effects of exercise-habituation and single-bout exercise  
 
4.3.2 Effect of single-bout exercise, following exercise-habituation 
There were no effects of WPH supplementation on any of the mRNA or protein targets 
measured during the single-bout exercise trial (data not shown). Following ECC and 
CONC exercise-habituation, the effects of single-bout ECC and CONC exercise was 
investigated. Compared with basal levels, ECC, but not CONC exercise, decreased 
atrogin-1 mRNA levels by 52 ± 8% at both 3 and 5 h post-exercise (P < 0.0001; Fig. 
4.5A). Following both ECC and CONC exercise, MURF-1 mRNA levels were 
increased at 1 h by 49 ± 13% (P < 0.001) and 54 ± 15% (P < 0.01), respectively (Fig. 
4.5B). MURF-1 mRNA expression was further increased at 3 h by 74 ± 1% (P < 
0.0001; Fig. 4.5B) in the CONC group only. CONC, but not ECC exercise, increased 
FOXO1 mRNA at 3 h (53 ± 12%; P < 0.001) and 5 h post-exercise (34 ± 12%; P < 
0.01) (Fig. 4.5C). In contrast, following ECC, but not CONC exercise, FOXO3 mRNA 
was decreased 3 h and 5 h post-exercise by 22 ± 8% (P < 0.01) and 51 ± 8 % (P < 
0.0001) respectively (Fig. 4.5D). 
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Figure 4.5 Effects of single-bout exercise on mRNA expression. Contraction mode-specific effects 
(ECC versus CONC) of single-bout exercise (post-habituation basal versus post-exercise recovery time 
points) are shown as fold change ± SEM from basal set to a fixed value of 1 for atrogin-1 (A), MURF-
1 (B), FOXO1 (C), FOXO3 (D). Different from basal post-habituation. **P < 0.01, ***P < 0.001, ****P 
< 0.0001. Difference between contraction modes, #P < 0.05, ##P < 0.01, ###P < 0.001, ####P < 0.0001. 
 
No alterations in MURF-1 protein were observed following ECC or CONC exercise 
(Fig. 4.6A). Compared with basal, EIF3F protein level was reduced by 30 ± 8% (P < 
0.01) at 5 h post CONC-exercise only (Fig. 4.6B). Both CONC and ECC exercise 
downregulated the total FOXO1 protein by 39 ± 11% and 36 ± 11%, respectively (P 
< 0.01) at 5 h (Fig. 4.6C). Phospho-FOXO1 protein was reduced by 19 ± 6% 5 h post-
ECC exercise, but not CONC exercise (P < 0.01; Fig. 4.6D). CONC exercise only 
downregulated FOXO3 protein by 20 ± 7% at 5 h post-exercise (P < 0.05; Fig. 4.6E), 
although the response to ECC exercise was similar. A significant difference in 
phospho-FOXO3 protein was observed between ECC and CONC exercise at 5 h post-
exercise (P < 0.01; Fig. 4.6F). A summary of gene and protein results following single-
bout exercise are shown in Table 4.1. 
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Figure 4.6 Effects of single-bout exercise protein expression. Contraction mode-specific effects (ECC 
versus CONC) of single-bout exercise (post-habituation basal versus post-exercise recovery time 
points) are shown as fold change ± SEM from basal set to a fixed value of 1 for MURF-1 (A), EIF3F 
(B), FOXO1 (C), phospho-FOXO1 (D), FOXO3 (E), and phospho-FOXO3 (F). Different from basal 
post-habituation. *P < 0.05, **P < 0.01. Difference between contraction modes, #P < 0.05, ##P < 0.01. 
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4.3.3 Effect of training, without and with whey protein supplementation 
Greater detail on the effect of contraction mode-specific training and WPH 
supplementation on total volume load of work (i.e., repetitions x sets x load 
accomplished during training), quadriceps CSA, and maximal voluntary contraction 
(MVC) in this cohort has been previously reported (20). Briefly, total volume load for 
the ECC trained leg was 11 ± 0.8% and 10.3 ± 0.8% higher than for the CONC-trained 
leg in the WPH and iCHO groups respectively (P < 0.001). There was no difference 
between the groups in total volume load. A group x time interaction was observed (P 
< 0.001) for quadriceps CSA, whereby WPH supplementation combined with either 
ECC or CONC training had the greater effect on mid-level quadriceps CSA compared 
with iCHO supplementation (P < 0.01). Accordingly, in the WPH supplementation 
group, ECC and CONC training increased quadriceps mid-level CSA by 8.3 ± 1.3% 
and by 6.2 ± 1.4%, respectively (P < 0.001), with no difference observed between 
contraction modes. In the iCHO group, ECC and CONC training increased quadriceps 
mid-level CSA by 2.7 ± 1.1% and 4 ± 1.0%, respectively (P < 0.01), with no 
differences observed between contraction modes. MVC increased by 12.4 ± 3.5% and 
19.0 ± 6.4% (P < 0.001) over time, for WPH and iCHO, respectively, with no 
differences between groups or between contraction modes. 
 
No measurements of mRNA levels were made after training. There were no effects of 
WPH supplementation on any of the protein targets measured following training (data 
not shown); therefore data were pooled and grouped according to exercise contraction 
mode. Following ECC training, the level of phospho-FOXO1 protein increased by 72 
± 13% (P < 0.0001) compared with basal and 62 ± 13% (P < 0.001) compared with 
CONC training (Fig. 4.7). No changes were observed on the levels of MURF-1, EIF3F, 
FOXO1, FOXO3, and phospho-FOXO3 protein levels following ECC and CONC 
training (Fig. 4.4). A summary of the protein results following RT are shown in Table 
4.1.  
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Figure 4.7 Training-induced changes in protein expression. Contraction mode-specific effects (ECC 
versus CONC) of 12-weeks training (pre--habituation basal versus post-training basal) are shown as 
fold change ± SEM from basal set to a fixed value of 1 for phospho-FOXO1. Different from basal pre-
habituation. ****P < 0.0001. Difference between contraction modes, ###P < 0.001. 
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4.4 Discussion 
Atrogin-1 and MURF-1 are involved in MPB and believed to play an important role 
in muscle wasting in disease conditions [38, 161]. Atrogin-1 and MURF-1, and their 
transcriptional regulators FOXO1 and FOXO3, are expressed in non-diseased skeletal 
muscle suggesting they play a role in maintaining muscle homeostasis in healthy 
muscle. RE is a positive regulator of muscle health and regulates atrogin-1 MURF-1, 
FOXO1 and FOXO3 mRNA levels, although this appears to depend on the type of 
exercise and the contraction mode employed. To better understand the exercise-
induced regulation of these atrophy targets we employed unilateral isolated ECC or 
CONC exercise tasks. This permitted us to investigate the effects of contraction mode 
on atrogin-1, MURF-1, FOXO1, FOXO3, and EIF3F following 1) exercise-
habituation, 2) single-bout exercise, and 3) prolonged training. Furthermore, we 
investigated the effect of WPH supplementation combined with both ECC and CONC 
exercise. Atrogin-1, MURF-1, FOXO1, FOXO3, and EIF3F mRNA and/or protein 
were sensitive to single-bout RE in the exercise-habituated state, in a contraction mode 
dependent manner. An acute downregulation of FOXO1 protein occurred 
independently of contraction mode. Prolonged hypertrophy-inducing ECC and CONC 
exercise training resulted in muscle hypertrophy; a response that was augmented with 
WPH supplementation. However atrogin-1, MURF-1, FOXO1, FOXO3, and EIF3F 
were not sensitive to WPH supplementation.  
 
4.4.1 Effect of exercise-habituation  
Unaccustomed exercise, especially ECC RE, inflicts muscle damage [288, 397]. In a 
non-exercise-habituated muscle it may be difficult to distinguish between the effects 
of muscle-damaging exercise and exercise-stimulated responses of our mRNA and 
protein targets. To reduce this potential confounding effect, the subjects completed 
three exercise sessions over a 7 day period followed by 3 days of recovery, prior to 
conducting the single-bout protocol. Exercise-habituation increased basal level of 
atrogin-1, FOXO1, and FOXO3 mRNA levels, independently of the mode of muscle 
contraction. MURF-1 mRNA levels and EIF3F protein levels increased only following 
CONC exercise-habituation. No changes in MURF-1 protein levels were observed. 
Total and phosphorylated FOXO1 protein increased in parallel with the mRNA levels. 
In contrast, total and phosphorylated FOXO3 protein levels did not change. This may 
be explained by insufficient accumulated stimulation or by auto-ubiquitination that can 
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occur for ubiquitin-ligases [343]. Accordingly, as we have shown previously [398], 
short-term exercise-habituation is able to regulate the basal level of many target 
mRNAs and proteins. It supports the need to consider appropriate familiarisation 
procedures for human exercise study designs. This would increase the ability to 
distinguish between true exercise-induced responses and responses due to other 
stressors inherent to an exercise study protocol itself.  
 
4.4.2 Effect of single-bout resistance exercise and whey protein supplementation 
Following the habituation phase, the subjects completed a single-bout of unilateral 
ECC versus CONC RE with WPH or iCHO supplementation. No effects of WPH 
supplementation were observed on any of the mRNA and protein targets measured 
which supports several recent publications [92, 191, 325]. The supplement groups 
were therefore combined and provided a very large sample size of 24 individual legs 
per exercise group. Atrogin-1 mRNA decreased with ECC exercise, while MURF-1 
mRNA increased with CONC exercise. Interestingly, FOXO1 mRNA was increased 
following ECC exercise, while FOXO3 was decreased following CONC exercise. Our 
contraction mode-specific RE changes in atrogin-1, MURF-1, FOXO1, and FOXO3 
support previous observations following conventional RE [288, 377]. The regulation 
of atrogin-1 mRNA may be associated with the mechanical stress specifically 
characteristic of ECC exercise (e.g., stretch-induced damage of sarcomeric protein), 
whereas the regulation of MURF-1 mRNA may be related to the metabolic stress 
specifically characteristic of CONC exercise (e.g., increased turnover of metabolic 
enzymes).   
 
MURF-1 protein levels did not change following single-bout exercise and were not 
influenced by WPH supplementation. This is in contrast to an observed increase in 
MURF-1 protein 3 h following conventional RE and an attenuation when combined 
with BCAA supplementation [47]. This discordance in results may be an effect of our 
subjects completing the exercise-habituation phase. Atrogin-1 protein levels were not 
shown, as we were not convinced of the specificity of the commercially available 
antibodies. Therefore, we measured the protein levels of an atrogin-1 substrate 
involved in protein synthesis, EIF3F [226]. EIF3F protein levels were not influenced 
by ECC exercise but decreased with CONC exercise. Decreasing atrogin-1 may release 
basal suppression on muscle protein synthesis related processes, thereby contributing 
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to a net gain in muscle protein accretion. However, this requires experimental 
validation. The downregulation of the EIF3F protein 5 h following CONC exercise 
appears counterintuitive, considering this exercise stress increases muscle protein 
synthesis. Decreasing EIF3F may be an indication that muscle protein synthesis had 
reached its peak and was beginning to return to basal levels.  It is also possible that the 
atrogin-1/EIF3F regulatory relationship does not exist in human muscle following 
single-bout exercise, and it is not within the scope of this study to establish such a 
possibility. 
 
Following single-bout ECC exercise, phospho-FOXO1 and phospho-FOXO3 levels 
were decreased. Dephosphorylation of FOXO transcription factors allows their 
translocation to the nucleus [46] where they regulate MuRF-1 and atrogin-1 gene 
expression in rodents [346]. The decrease in atrogin-1 mRNA and associated decrease 
in phospho-FOXO1 and phospho-FOXO3 levels following ECC exercise does not 
support this relationship in human muscle following exercise. It is possible that other 
transcription factors are involved in the exercise-induced regulation of atrogin-1 gene 
expression. For example, the Jun B proto-oncogene (JunB) transcription factor can 
prevent FOXO3 binding to the atrogin-1 promoter [316]. Although speculative, the 
exercise performed in the present study may have stimulated a JUNB inhibition of the 
phospho-FOXO3 regulation of atrogin-1 gene expression. Pgc-1alpha can also inhibit 
the FOXO transcriptional activation of atrogin-1 [52, 127] and potentially may have 
played a role during this single-bout exercise trial.  
 
4.4.3 Effect of resistance exercise training and whey protein supplementation 
Following the single-bout exercise trials, participants completed 12-weeks of 
unilateral ECC versus CONC training. Additionally, subjects received a WPH 
supplement or an isocaloric CHO. In line with previous findings, our RT program 
resulted in an increase in muscle hypertrophy that was associated with an increase in 
muscle strength [7, 176]. In regards to WPH supplementation, we found that RT-
induced muscle hypertrophy was augmented with WPH supplementation; an 
observation previously found by some [7, 176], but not others [191]. While WPH 
supplementation augmented muscle hypertrophy, there was no further increase in 
MVC. A lack of consistency between training-induced changes in hypertrophy and 
strength has been observed previously [7, 176, 191, 275] and is in part explained by 
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the influence exerted by complex neuromuscular interactions also affecting muscle 
strength [131]. 
 
An increase in basal level phospho-FOXO1 was observed following ECC training 
only, suggesting a potential reduction in basal active FOXO1 protein post-training. No 
ECC or CONC training-induced changes were observed for any of the other protein 
targets measured. Eight-weeks of traditional hypertrophy-inducing RT has been shown 
to increase atrogin-1 protein and decrease nuclear FOXO1 protein levels [237]. 
Nuclear fractionation analysis in the present study may have provided us with an 
opportunity to more precisely evaluate the potentially activity of the FOXO proteins.  
 
4.4.4 Limitations 
In the present study we investigated the effects of ECC versus CONC training that was 
matched for equal relative intensity. As elegantly shown by Eliasson et al. [115], the 
maximal absolute intensity inherent to ECC, when compared with CONC exercise, 
may be the most important factor initiating intracellular signalling. Increasing the ECC 
training load and therefore its maximal absolute intensity might have allowed the 
detection of additional significant changes in some of our intracellular targets. With 
this in mind, the work by Eliasson et al. investigated AKT/MTOR signalling in the 
fasted state, while the current study investigated the FOXO, atrogin-1, and MURF-1 
targets in the fed state. The sensitivity of dietary conditions, especially towards specific 
amino acids, on AKT/MTOR signalling may be very different than the sensitivity of 
the FOXO/atrogin-1/MURF-1 signalling components. Another limitation of this work 
is the lack of a non-caloric control group. This group was excluded for practical 
reasons. Finally, it could be argued that our protocol did not account for daily protein 
intake, an important parameter in any supplementation intervention. During the 
recovery phase following the single-bout exercise session, the subjects received 
nothing but the supplement to avoid any confounding effect of additional protein or 
carbohydrate intake. During the training period, the subjects were instructed not to 
ingest additional calories for 90 min prior to and during the 60 min following each 
exercise session, although total daily protein or carbohydrate intake was not controlled. 
However, previously published data from this study demonstrated that with the WPH 
supplementation, the subjects developed significantly larger muscle as well as 
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interconnected tendon hypertrophy (20), which support the hypothesis that habitual 
daily protein intake did not overrule net hypertrophy.  
 
4.4.5 Conclusion 
This study investigated the effect of isolated ECC and CONC exercise on members of 
the FOXO/atrogin-1/MURF-1 signalling-axis. Exercise was performed following 
exercise-habituation as a single-bout trial or as training and combined with WPH 
supplementation. Our results suggest the following: 1) exercise-habituation prior to 
investigating the acute responses on exercise-induced FOXO/atrogin-1/MURF-1 
regulation be employed; 2) atrogin-1 and MURF-1 mRNA levels are regulated in a 
contraction mode-dependent manner; 3) a discordance between patterns of FOXO 
phosphorylation and atrogin-1/MURF-1 mRNA levels, as well as discordance between 
acute and chronic responses, suggests other regulatory factors may influence the 
exercise-induced regulation of atrogin-1; and 4) FOXO1, FOXO3, atrogin-1, and 
MURF-1 are not sensitive to WPH supplementation following single-bout exercise 
performed following habituation and during hypertrophy-inducing exercise. 
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CHAPTER 5 
 
AGEING HAS NO EFFECT ON THE REGULATION OF THE UBIQUITIN 
PROTEASOME-RELATED GENES AND PROTEINS FOLLOWING 
RESISTANCE EXERCISE 
 
 
 
This work has been published prior to the completion of this dissertation Stefanetti RJ, Zacharewicz E, 
Della Gatta P, Garnham A, Russell AP, and Lamon S. Ageing has no effect on the regulation of the 
ubiquitin proteasome-related genes and proteins following resistance exercise. Frontiers in physiology 
5: 30, 2014. 
 
Abstract 
Skeletal muscle atrophy is a critical component of the ageing process. Age-related 
muscle wasting is due to disrupted muscle protein turnover, a process mediated in part 
by the UPP. Additionally, older subjects have been observed to have an attenuated 
anabolic response, at both the molecular and physiological levels following a single-
bout of RE. We investigated the expression levels of the UPP-related genes and 
proteins involved in muscle protein degradation in 10 older (60‒75 years) versus 10 
younger (18‒30 years) healthy male subjects at basal as well as 2 h after a single-bout 
of RE. MURF-1, atrogin-1 and FBXO40, their substrate targets PKM, MYOG, 
MYOD1, MHC, and EIF3F as well as MURF-1 and atrogin-1 transcriptional 
regulators FOXO1 and FOXO3 gene and/or protein expression levels were measured 
via real time PCR and western blotting, respectively. At basal, no age-related 
difference was observed in the gene/protein levels of atrogin-1, MURF-1, MYOG, 
MYOD1, and FOXO1/3. However, a decrease in FBXO40 mRNA and protein levels 
was observed in older subjects, while PKM protein was increased. In response to RE, 
MURF-1, atrogin-1, and FBXO40 mRNA were upregulated in both the younger and 
older subjects, with no changes observed in protein levels. In conclusion, UPP-related 
gene/protein expression is comparably regulated in healthy young and old male 
subjects at basal and following RE. These findings suggest that UPP signalling plays 
a limited role in the process of age-related muscle wasting. Future studies are required 
to investigate additional proteolytic mechanisms in conjunction with skeletal MPB 
measurements following RE in older versus younger subjects. 
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5.1 Introduction 
Maintaining skeletal muscle mass is a critical component of health and sustaining life. 
Age-related skeletal muscle wasting is a preferential loss of type II muscle fibres [202, 
242, 243, 392], resulting in a progressive decline in muscle mass, strength and function 
[99, 120]. On average, 0.5‒1.0% of muscle mass is lost per year from 40 years of age, 
with the loss of muscle mass rapidly increasing after 65 years of age [164]. Age-related 
muscle wasting reduces functional independence [81] and increases the risk of falls, 
chronic metabolic disease (obesity, type 2 diabetes) [294] and ultimately, mortality 
[261, 289]. A better understanding of the molecular mechanisms involved in the 
decline of muscle mass as we age is therefore required to aid the development of 
effective countermeasures to prevent, attenuate and/or reverse this process. 
 
In healthy individuals, muscle mass is maintained via the finely regulated balance 
existing between MPS and MPB. An increase in muscle mass is largely due to an 
increase in the size of pre-existing muscle fibres via net accretion of muscle 
sarcoplasmic and myofibrillar proteins [155, 268, 333, 363]. In contrast, the UPP is 
one of the major mechanisms responsible for human MPB [297, 343]. The muscle-
specific E3-ubiquitin ligases, MURF-1 and atrogin-1 [38, 161] are transcriptionally 
regulated by FOXO family members, FOXO1 and FOXO3 [55, 346, 367]. Known 
substrate targets of MURF-1 include PKM [180] and MHC [75, 78, 128], whereas 
known substrate targets of atrogin-1 include EIF3F [226], MYOD1 [377] and MYOG 
[199]. These substrate targets are proteins involved in biological processes essential to 
muscle health and function, such as muscle protein synthesis (EIF3F), [226], 
development and regeneration (MYOD1 and MYOG) [199, 377], metabolism (PKM) 
[180] as well as structure and contraction (MHC) [75, 78, 128].  
 
RT increases muscle mass and strength [187, 268, 333, 363, 414] and is often used as 
an intervention to improve functional capacity [119]. Experimental chapter 1 and 2 
demonstrated that conventional as well as contraction specific RE increases muscle 
mass and strength in young healthy individuals, a response paralleled by an increase 
in UPP signalling targets. The principal response after a single-bout of RE is a rapid 
(within 2‒4 h) transient increase in MPS, particularly in myofibrillar MPS [307]. 
However, MPB also increases following RE, albeit to a lesser extent and of a shorter-
lived duration than MPS [33, 307]. While the aetiology of aged-related muscle atrophy 
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is multifactorial, a disruption in the regulation of skeletal muscle protein turnover 
seems to play a major role [42]. Despite early reports of a large decrease in the basal 
rate of MPS [22, 177, 411, 412] and a large increase in the basal rate of MPB [388] in 
older compared to younger individuals, recent studies demonstrate little or no 
significant difference in basal MPS and MPB between older versus younger 
individuals [90, 177, 204, 205, 225, 292, 318, 402-404]. RE-induced stimulation of 
MPS occurs in both younger and older individuals [177, 352, 403, 413, 430], but with 
an attenuated magnitude in older individuals [225]; a phenomenon referred to as 
anabolic resistance. However the regulation of MPB in older versus younger 
individuals in response to RE and how this may contribute to anabolic resistance is not 
well defined. In particular, the gene and protein expression pattern of the members of 
the UPP pathway at rest and following RE in older and younger individuals has 
received little attention to date. Such investigations will provide a better understanding 
of the activation and regulation of the UPP pathway in older versus younger 
individuals. A greater activation of the proteolytic markers in older subjects may 
indicate an increase in MPB; a phenomenon that might therefore contribute to the 
attenuated MPS response characteristic of anabolic resistance.  
 
Conflicting results have been observed in the age-related mRNA regulation of MURF-
1 and atrogin-1, suggestive of gender, muscle type and species influences (rodent 
versus human muscle). Compared to younger rodent muscle, studies have shown that 
baseline MuRF-1 and atrogin-1 mRNA levels in aged rodents increase in the tibialis 
anterior [76], decrease in the gastrocnemius muscle [114] or do not differ in the 
extensor digitorum longus and soleus muscle [146]. In humans, some studies find an 
increase in MURF-1 baseline mRNA expression in older muscle compared to younger 
muscle [93, 271, 320], while other groups report no differences [138, 165, 238, 410, 
417] Albeit one study showing a subtle elevation in baseline atrogin-1 mRNA 
expression with ageing [271], age-related differences in basal atrogin-1 mRNA 
expression do not occur [93, 138, 165, 238, 320, 344, 410, 417]. In response to single-
bout RE in human muscle, MURF-1 mRNA increases in both younger and older 
subjects 3‒6 h post-RE [138, 320]. Atrogin-1 mRNA is either unchanged between 
older versus younger individuals [138], or increases 4 h post-single-bout RE in older 
individuals only [320]. Although the effect of RE on MURF-1 and atrogin-1 
expression has been well described (for review see [337]), whether the protein levels 
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of muscle-specific E3-ubiquitin ligases as well as their substrate targets are 
differentially altered in younger versus older individuals in human skeletal muscle in 
response to RE is yet to be investigated.  
 
Therefore the aim of the current study was to report the gene and protein expression 
patterns of MURF-1, atrogin-1 and FBXO40, a gene encoding another muscle specific 
F-box protein [431], the substrate targets PKM, MYOG, MYOD1, MHC and EIF3F 
as well as MURF-1 and atrogin-1 transcriptional regulators FOXO1 and FOXO3 in 
older versus younger individuals at basal and in response to a single-bout of RE 
following overnight fasting. 
 
5.2 Methods 
5.2.1 Subjects 
Ten younger (18‒30) and 10 older (60‒75) healthy males participated in the study. 
Physiological characteristics of the subjects are summarized in Table 5.1. The subjects 
were physically active but had not participated in a RT programme within 6 months 
prior to the study. Exclusion criteria included any type of protein supplementation and 
anabolic steroids. All participants gave their informed consent and agreed to engage 
in muscle biopsies and physiological testing. The study was approved by the Deakin 
University Human Research Committee (#2011-043) in accordance to the Declaration 
of Helsinki (2013). 
 
5.2.2 Dual-energy X-ray absorptiometry scan (DXA) 
Total body and regional (arms and legs) body composition [lean mass (LM), fat mass 
(FM) and % body fat] and lumbar spine (L1-L4) and proximal femur (femoral neck 
and total hip) areal bone density (aBMD) were assessed via DXA (Lunar Prodigy, GE 
Lunar Corp., Madison WI), using software version 12.30.008. 
 
5.2.3 Preliminary testing 
At least 2-weeks prior to the single-bout exercise session, the subjects were 
familiarized with the equipment (Nautilus Leg Extension, Fitness Generation, 
Rowville, Australia) and correct lifting technique. Their one-repetition-maximum (1 
RM) was determined using a 5 RM test for leg extension exercise. Estimated 1 RM 
was then calculated using the Brzycki equation:  
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1 RM = weight lifted (kg) / 1.0278  [reps to fatigue x 0.0278) [287]. 
 
5.2.4 Single-bout exercise protocol 
Subjects had been instructed to abstain from strenuous exercise, caffeine and alcohol 
consumption for 24 h prior to the trial. One night before the trial, the subjects were 
instructed to consume a provided standardized meal containing 20% fat, 14% protein 
and 66% carbohydrate. The subjects arrived after an overnight fast and rested in the 
supine position for 2 h prior to the sampling of the first muscle biopsy. Immediately 
following the muscle biopsy, subjects completed a 3 min light cycling warm-up 
followed by a leg extension exercise session. The single-bout exercise protocol 
consisted of 3 sets of 14 repetitions at 60% of maximal voluntary contraction (60% 1 
RM) with 2 min recovery between sets. Immediately following this, subjects 
completed another 3 min light cycling exercise, and were thereafter instructed to rest 
in the supine position again. At 2 h post-exercise, another muscle biopsy was taken 
from the opposite leg to avoid any local effect of the pre-exercise biopsy.  
 
5.2.5 Preparation of muscle biopsies 
Skeletal muscle samples were obtained under local anaesthesia (1% Xylocaine) from 
the belly of the vastus lateralis muscle using a percutaneous needle biopsy technique 
[31] modified to include suction [122]. Following an incision through the skin, muscle 
biopsies were taken using a Bergstrom needle. The muscle samples were immediately 
frozen in liquid nitrogen and used for RNA and protein extraction.  
 
5.2.6 Protein extraction  
Total protein from whole tissue lysates was extracted using RIPA buffer (Millipore, 
North Ryde, Australia) with 1 μL/mL protease inhibitor cocktail (Sigma-Aldrich, 
Sydney, Australia) and 10 μL/mL Halt Phosphatase Inhibitor Single-Use Cocktail 
(Thermo Scientific, Rockford, USA). Total protein content was determined using the 
BCA Protein Assay Kit (Pierce Biotechnology, Rockford, USA) according to the 
manufacturer’s instructions.  
 
5.2.7 Statistical analyses 
All data are reported as mean ± SEM. Unless specified differently, a two-way analysis 
of variance (ANOVA) for age and exercise was used to compare group means. 
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Diagnostic plots of residuals and fitted values were checked to ensure homogeneity of 
variance (a key assumption for ANOVA). Consequently, all data were log10-
transformed and analyses were conducted on these transformed scales. The least 
significant difference (LSD) test was used to compare pairs of means. The significance 
levels for both the F-tests in the ANOVA and the LSD tests were set at P < 0.05. 
 
5.3 Results 
5.3.1 Subjects’ demographics 
Table 5.1 summarizes the subjects’ physiological characteristics. No significant 
difference in body mass, tissue composition and maximal voluntary contraction (1 
RM) could be observed between the two subjects groups. 
 
 
 
Table 5.1 Subjects’ demographics. Values are mean ± SEM. BMC, bone mass content; BMI, bone mass 
index; 1 RM, 1 repetition maximum. Statistical significance was determined by unpaired Student’s t-
tests.  
 
 
 
 
 
 
 
 
 Younger Older P value 
Age (years) 24.2 ± 0.9 66.6 ± 1.1 < 0.05 
Height (cm) 180.0 ± 2.0 174.60 ± 1.8 0.06 
Body mass (kg) 73.8 ± 3.6 83.4 ± 7.1 0.25 
Fat (kg) 13.6 ± 2.7 19.5 ± 3.9 0.23 
Lean (kg) 57.9 ± 1.9 60.2 ± 3.3 0.55 
BMC (kg) 3.3 ± 0.2 3.2 ± 0.2 0.67 
BMI 23.3 ± 0.9 27.7 ± 1.9 0.10 
Lean / total body mass 0.8 ± 0.02 0.7 ± 0.02 0.09 
1 RM (kg) 98.2 ± 7.0 80.9 ± 7.2 0.1 
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5.3.2 Gene expression with exercise and ageing 
In both younger and older subjects MURF-1, atrogin-1 and FBXO40 mRNA levels 
were significantly increased 1.5-fold and 1.3-fold (P < 0.05), 3.8-fold and 2-fold (P < 
0.01) and 1.5-fold and 1.2-fold (P < 0.01), respectively, 2 h following RE (Fig. 5.1). 
In addition, FBXO40 mRNA levels were decreased by 25% in older subjects when 
compared to younger subjects (P < 0.01). Exercise and ageing had no effect on FOXO1 
and FOXO3 mRNA levels (data not shown). No age x exercise interaction was 
observed for any of the genes measured. 
 
 
 
Figure 5.1 MURF-1, atrogin-1 and FBXO40 mRNA expression following a single-bout of resistance 
exercise in younger and older subjects. Note that no changes were observed for the other genes 
measures. Significant exercise effect, *P < 0.05, **P < 0.01. Significantly different from Young, ##P < 
0.01. The reported statistical significance is based on analysis of the transformed data but the reported 
means ± SEM are on the original (untransformed) scale. 
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5.3.3 Protein expression with exercise and ageing 
A single-bout of RE did not influence the expression of any of the proteins measured. 
In relation to the effect of age on protein expression, FBXO40 protein levels were 1.5-
fold higher in younger subjects than in older subjects (P < 0.01). We also observed a 
trend (P = 0.051) for the effect of age on PKM protein levels, which were 1.6-fold 
higher in older subjects when compared to younger subjects. Fig. 5.2 depicts changes 
in protein expression as well as representative western blot pictures for each protein 
measured.  
 
 
 
 
Figure 5.2 A) FBXO40 and PKM protein expression following a single-bout of resistance exercise in 
younger and older subjects. Note that no changes were observed for the other proteins measures. 
Significantly different from Young, ##P < 0.01. The reported statistical significance is based on analysis 
of the transformed data but the reported means ± SEM are on the original (untransformed) scale. B) 
Representative western blot images of MURF-1, total and phospho-FOXO1, total and phospho-FOXO3, 
MYOGENIN (MYOG), MYOD1, MHC, and EIF3F protein measured before and after exercise. 
GAPDH protein was measured as a control for protein loading.    
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5.4 Discussion 
Age-related muscle atrophy is linked to disrupted protein turnover in MPS and MPB 
as well as reduced regenerative capacity [51]. When compared to younger subjects, 
older subjects display an impaired phosphorylation of the members of the MPS 
pathways at rest [238] and impaired MPS following RE [225], a phenomenon referred 
to as anabolic resistance. However, how the UPP-related genes and proteins involved 
in MPB are regulated in older subjects in response to RE and their potential 
contribution to anabolic resistance is currently unknown.  
 
Differences in the baseline expression levels of the skeletal muscle MURF-1 and 
atrogin-1 in younger versus older individuals is a contentious topic. This is due, at least 
partially, to the discrepancies existing between the studied population cohorts in terms 
of sex, age, physiological characteristics and level of fitness. For example, it is 
commonly acknowledged that the older subjects recruited on a voluntary basis for an 
exercise trial protocol are not representative of the average elderly population and that 
their average level of fitness is expected to be higher; a parameter that needs to be 
considered when comparing our results to others. In the present study, we failed to 
observe an upregulation of MURF-1 mRNA or protein in older subjects when 
compared to younger subjects; a result in line with previous results from our group 
[238] and others [165, 410, 417]. However, it has been reported that at baseline, 
MURF-1 mRNA levels were increased in older men displaying a similar average age 
and level of fitness as our subjects [93], as well as in much older women (> 80 years) 
[320] when compared to younger individuals. Consistent with previous findings in 
humans, no age-related difference was found in the basal level of atrogin-1 mRNA 
[93, 138, 165, 238, 320, 344, 410, 417]. Similarly, no age-dependent differences were 
observed at baseline for FOXO1 and FOXO3 mRNA and protein or in the 
phosphorylation levels of FOXO1 and FOXO3 protein, the transcriptional regulators 
of MURF-1 and atrogin-1. Baseline FOXO3 mRNA levels were increased in much 
older women (> 80 years) compared to younger women [320]. At baseline, older 
subjects had a lower cytosolic FOXO3 phosphorylation and a higher total nuclear 
FOXO3 level compared to younger subjects [421]; potentially resulting in more 
transcriptional activity. However, we previously observed a decrease in nuclear 
FOXO1 and FOXO3 protein in sarcopenic human skeletal muscle [238]. Although we 
did not measure nuclear proteins in this study, no differences in FOXO1 and FOXO3 
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phosphorylation levels were observed between younger and older subjects. This 
suggests that the sub-cellular localization of the FOXO proteins might not be a direct 
indication of their activity.  
 
Although other protein degradation mechanisms such as the autophagy-lysosome 
system are unbalanced during age-related muscle atrophy, at least in rodent muscle 
(for review see [46], our observations are consistent with recent work demonstrating 
that the basal MPB rate does not significantly differ with ageing [90, 177, 204, 205, 
225, 292, 318, 402-404]. However, gene and protein expression analysis 2 h post-
exercise cannot be reflective of the whole MPB process occurring following RE. 
Further investigations that include a post-exercise time course and direct measure of 
MPB obtained at similar time points are therefore required. Basic limitations of most 
MPB measures, including the AV balance approach, such as invasiveness, possible 
inclusion of non-muscle tissue or potential variations due to non-steady state 
conditions such as an exercise intervention should yet be taken into account. 
Interestingly, genetic deletion of atrogin-1 in rodents during ageing results in 
significant muscle atrophy and a shortened lifespan, while a reduced muscle force 
occurs in both MuRF-1 and atrogin-1 aged KO mice (Sandri, Barberi et al. 2013); 
suggesting that these UPP genes are essential for normal protein turnover during 
ageing (Sandri, Barberi et al. 2013). 
 
MURF-1, atrogin-1 and FBXO40 mRNA levels were all increased by exercise, with 
no differential effect of exercise between the age groups. MURF-1 and atrogin-1 are 
typically regulated in response to a single-bout of RE. MURF-1 mRNA is commonly 
upregulated 1‒4 h post-RE [154, 253, 265]. In contrast, some studies observed no 
changes in atrogin-1 mRNA at 1‒2 h post-exercise [154, 191] or a decreased atrogin-
1 mRNA 2 h post-exercise [325]. Raue et al. reported an age effect in the increase of 
atrogin-1 mRNA, but not MURF-1 mRNA, 4 h following RE in older women (> 80 
years of age) [320]. However, in line with our findings, another study comparing 
similarly aged women to the study by Raue observed no changes in MURF-1 and 
atrogin-1 mRNA after 2.5 h of RE [165]. Again, different population cohorts and 
exercise protocols may lead to different or temporally shifted gene expression patterns.  
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None of the proteins measured in this study displayed changes in response to a single-
bout of RE in any of the age groups. The effects of single-bout RE on the protein levels 
and activity of FOXO1 and FOXO3 have only been partly described and 
phosphorylation of FOXO3 was unaltered at 1 h following RE [154]. However, 
MURF-1 protein has been reported to slightly increase at 1 h following bilateral leg 
extension exercise (10 x 10 repetitions at 70% 1 RM) [154] and at 3 h after unilateral 
leg press RE (4 x 10 repetitions at 80% followed by 4 x 15 at 65% 1 RM) [47] in 
untrained younger subjects; a difference that might be explained by the lower intensity 
and total volume of work completed in our study. Consistent with this result, the 
expression levels of the MURF-1 substrate targets PKM and MHC did not vary with 
exercise. While atrogin-1 mRNA was induced by exercise, this increase was not 
paralleled by a decrease in its substrate target proteins MYOD1, MYOG and EIF3F. 
A lack of visible change in protein expression at 2 h post-exercise does not reflect a 
lack of functional outcome. With respect to the delay existing between gene 
transcription and protein translation, changes in protein levels might occur later than 
2 h post-exercise, as reported with certain types of exercise protocols [47]. MPB 
measured after a single-bout of RE has been shown to be maximal at 3 h post-exercise 
[307], suggesting that an increase in the proteolytic activity of MURF-1 and atrogin-1 
might occur concomitantly. In addition, E3-ubiquitin-ligases are reported to self- 
ubiquitinate, so that protein levels may not always mirror mRNA levels [343].  
 
We report a decrease in FBXO40 gene and protein levels in the muscle of older 
subjects when compared to younger subjects. Similar to atrogin-1, FBXO40 is a gene 
encoding a muscle specific F-box protein [431]. F-box proteins associate with other 
proteins to form SKP1–CUL1–F-box (SCF) complexes that regulate proteasome-
mediated protein breakdown via their ubiquitin ligase activity. In skeletal muscle, 
FBXO40 ubiquitinates and degrades insulin receptor substrate 1 (IRS1); the latter 
being an upstream positive regulator of the PI3K/AKT pathway activity [353]. Mice 
lacking FBXO40 demonstrate abnormal skeletal muscle hypertrophy. However, in 
humans, FBXO40 gene expression decreases in the muscle of Limb-girdle muscular 
dystrophy (LGMD) patients [431]. Attenuated FBXO40 expression in the skeletal 
muscle of older subjects might therefore reflect a compensatory mechanism to limit 
the amount of age-related muscle wasting. It would be of interest to determine if a RT 
intervention, potentially combined with amino acid supplementation, would be able to 
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rescue, at least partially, the levels of FBXO40 in old muscle. Although we observed 
no age-related change in MURF-1 protein levels, PKM protein expression tended to 
be higher in the older subjects when compared to younger subjects. PKM is a substrate 
target for MURF-1 [180] and a molecular switch towards a more glycolytic phenotype 
fibre type [144]. A possible hypothesis is that elevated PKM protein levels might 
account for the reduced oxidative metabolism associated with muscle wasting in older 
people [284, 331, 354], even if oxidative metabolism or fibre type composition have 
not been assessed in this study; however, PKM regulation is probably multi-factorial. 
 
In conclusion, we demonstrate that the UPP-related genes involved in MPB display 
comparable regulation in healthy younger and older subjects following RE. However, 
the lack of significant difference in the physiological characteristics, body composition 
and level of fitness of our older subjects when compared to younger subjects must be 
considered when interpreting these findings. We did not observe a change in the 
baseline levels of atrogin-1 and MURF-1 mRNA and protein of younger versus older 
individuals, but identified an age-related decline in FBXO40, another recently 
described muscle specific F-box protein. Our observations support the hypothesis that 
the UPP plays a limited role in the disruption of the protein synthesis/degradation 
balance that is characteristic of age-related muscle atrophy. However, future 
investigations are required to measure skeletal MPB following RE in the ageing 
population. Additionally, measurements of proteasomal content and/or proteasomal 
activity as well as investigation of the role of other protein degradation mechanisms, 
such as the autophagy-lysosome system, will aid in gaining a deeper understanding of 
the contribution of the ubiquitin-proteasome system in anabolic resistance.  
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CHAPTER 6 
 
CONCLUSIONS AND FUTURE DIRECTIONS 
 
 
6.1 Introduction 
The maintenance of skeletal muscle mass is essential for physical health, mobility and 
ageing. NMPB is determined by both MPS and MPB processes. However, knowledge 
of the mechanisms that regulate human MPB in response to exercise and nutritional 
stimulation as well as during ageing remain unclear. 
 
 
 
Figure 6.1 Skeletal muscle has the profound ability to adapt to extracellular demands. The effect of 
divergent exercise with and without nutritional supplementation on muscle protein synthesis (MPS) 
signalling pathways is well characterized, whereas the influence on muscle protein breakdown (MPB) 
mechanisms is less clear. Understanding the underlying mechanisms influencing muscle protein 
turnover will aid in the development of therapeutic targets to prevent and attenuate muscle loss.  
 
6.2 Summary of the major findings 
The broad aims of this thesis were to examine mRNA and/or protein levels of the 
predominant MPB pathway, UPP signalling, in response to exercise, nutrition and 
ageing in human skeletal muscle (Figure 6.1). The present findings showed that 
markers of the UPP are sensitive to divergent single-bout exercise, muscle contraction 
mode, habituation/training status. The results also demonstrated that the regulation of 
the UPP is not affected by whey protein supplementation combined with RE, or ageing 
at basal and in response to single-bout RE. Collectively, the observations that mRNA 
 
 
  106 
makers of the UPP are upregulated following exercise-training and are sensitive to 
different exercise contraction modes, suggests that they may play a role in exercise 
induced-adaptations.  
 
The specific aims of the thesis were:  
 
1. To investigate the mRNA and/or protein expression of molecular markers of 
UPP signalling following 1) long-term endurance and resistance training and 
2) a single-bout of EE and RE following training. The markers of UPP 
signalling measured included atrogin-1, MURF-1, FBXO40, FOXO1, FOXO3, 
as well as protein substrates of atrogin-1 including, EIF3F, MYOGENIN 
(MYOG) and MYOD1, and MURF-1 including, pyruvate kinase, muscle 
(PKM) and MHC. 
 
2. To investigate the mRNA and/or protein expression of molecular markers of 
UPP signalling in response to unilateral CONC versus ECC RE before and 
after 1) short-term exercise-habituation, 2) single-bout RE and 3) 12-weeks of 
hypertrophy-inducing training. In addition, the effects of whey protein 
supplementation were investigated. A second aim was to also examine the 
effect of leucine-enriched whey protein hydrolysate (WPH) supplementation 
combined with RE on the potential single-bout exercise and training-induced 
changes in mRNA and protein, when compared with a control isocaloric 
carbohydrate supplement (iCHO). The markers of UPP signalling measured 
included atrogin-1, MURF-1, FOXO1, FOXO3, as well the atrogin-1 protein 
substrate, EIF3F. 
 
3. To investigate the mRNA and/or protein expression of markers of UPP 
signalling in older versus younger individuals at basal and in response to a 
single-bout of bilateral leg extension RE following overnight fasting. The 
markers of UPP signalling measured included atrogin-1, MURF-1, FBXO40, 
FOXO1, FOXO3, as well as protein substrates of atrogin-1 including, EIF3F, 
MYOGENIN (MYOG) and MYOD1, and MURF-1 including, pyruvate 
kinase, muscle (PKM) and MHC. 
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In experimental chapter 1, chronic ET and RT comparably induced the mRNA levels 
of the UPP. The general training-induced increase in molecular markers of the UPP in 
conditions of enhanced skeletal muscle function implies that the UPP is not exclusively 
confined to a role in muscle atrophy processes, but may be important for protein 
turnover during healthy skeletal muscle adaptation and remodelling post-exercise. 
MURF-1 mRNA and FOXO3 protein were selectively increased with ET. Moreover, 
in the trained state, single-bout EE produced a greater induction of UPP signalling 
compared to RE. These results suggest that chronic RT attenuates RE-induced UPP 
gene responses. This notion is supported by FBXO40 mRNA levels, which increased 
following single-bout RE in untrained individual in experimental chapter 3, but were 
unchanged in the trained state post-RE in experimental chapter 2.   
 
In experimental chapter 2, single-bout ECC exercise decreased atrogin-1 mRNA, 
FOXO3 mRNA, and phospho-FOXO1, FOXO1 protein. Both ECC and CONC 
exercise increased MURF-1 mRNA, albeit a greater response was elicited following 
CONC exercise. CONC single-bout exercise increased FOXO1 mRNA and 
downregulated FOXO3, FOXO1, and EIF3F protein. The regulation of atrogin-1 
mRNA may be associated with the mechanical stress characteristic of ECC exercise, 
whereas the regulation of MURF-1 mRNA may be related to the metabolic stress 
characteristic of CONC exercise. Following chronic ECC training, an increase in 
phospho-FOXO1 was observed. WPH supplementation with ECC and CONC training 
augmented skeletal muscle hypertrophy. However, mRNA and/or protein levels of 
atrogin-1, MURF-1, FOXO1/3 and EIF3F were not sensitive to WPH supplementation 
following single-bout exercise performed following habituation and during 
hypertrophy-inducing exercise. This highlights the complexity in understanding the 
different roles these factors play in healthy muscle adaptation.  
 
In experimental chapter 3, no age-related differences in the baseline gene/protein 
levels of UPP signalling were observed. However, an age-related decrease in FBXO40 
mRNA and protein was observed, which may reflect a compensatory mechanism to 
limit the amount of age-related muscle wasting. A substrate target of MURF-1, PKM 
protein was increased in older subjects, which may account for a reduced oxidative 
metabolism associated with muscle wasting in older people. In response to RE, MURF-
1, atrogin-1, and FBXO40 mRNA were upregulated independently of age, suggesting 
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that these markers of the UPP play a limited role in the process of age-related muscle 
wasting associated with anabolic resistance.  
 
6.3 Consideration for future research 
It is important to note that the data from the studies of this thesis are associative rather 
than causative. As such, future studies will require a combination of molecular and 
physiological measurements to establish the underlying mechanism of such 
interactions.  
 
6.3.1 Measuring E3-ubiquitin ligase mRNA levels is not reflective of MPB  
There are an increasing number of in vitro [96] and in vivo [123, 220, 390] reports that 
show no correlation between atrogin-1/MURF-1 mRNA levels and protein 
breakdown. In fact, proteasome activity is actually increased rather than decreased in 
MuRF1 KO mice compared to wild type mice following denervation [160]. Therefore, 
the mRNA level of atrogin-1/MURF-1 may not be a reliable marker of UPP-mediated 
protein degradation. Moreover, a change in the mRNA of atrogin-1/MURF-1 does not 
necessarily correspond to a change in the respective protein level [103]. This may be 
partly explained by the fact that E3-ubiquin ligase have the ability to auto-ubiquitinate 
[38]. Collectively, this highlights the need for direct measurements of MPB and MPS 
in conjunction with mRNA and protein levels, as well as physiological changes in 
skeletal muscle adaptations. This is required to delineate the precise roles and 
functions of E3-ubiquitin ligases and potentially develop specific exercise 
interventions to improve skeletal muscle health. No studies have made direct measures 
of MPB under circumstances similar to the studies of the thesis, making it difficult to 
place the findings in context.  
 
6.3.2 Additional measurements are required to assess skeletal MPB  
In this thesis, well known markers of the UPP as an indication of UPP-mediated 
degradation, as well as known substrate targets of atrogin-1 and MuRF1 in mouse 
catabolic conditions, were measured. However, a potential limitation of the current 
work is that ubiquitin proteasome activity was not measured. This does not appear to 
be a routine measurement in the comparable literature and should be considered in the 
future. Rather, mRNA/protein levels are routinely measured to indicate UPP 
proteolysis. However, recent data observed an increase in ubiquitin proteasome 
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activity throughout chronic overload induced- muscle hypertrophy in mice, suggesting 
that chronic loading increases MPB mechanisms [19]. Surprisingly, the increase in 
proteasome activity remained elevated throughout chronic loading after atrogin-1 and 
MuRF1 mRNA levels returned to baseline, suggesting that atrogin-1 and MuRF1 are 
not required to increase proteasome activity following loading [19]. This recent data 
highlights that atrogin-1 and MuRF1 are not reliable indicators of UPP-degradation, 
and emphasizes the importance of additional measurements such as proteasome 
activity in future studies which measure UPP markers.  
 
The sole degradation pathway measured in this thesis was the UPP, which is the main 
proteolytic system responsible for bulk MPB. Consequently, we cannot draw 
assertions about the influence of the other proteolytic pathways in skeletal muscle, 
such as the autophagic-lysosomal or the calpain proteolytic pathways. To gain a deeper 
understanding of MPB mechanisms, an integrative approach will require 
measurements of all skeletal MPB pathways, in conjunction with an in vivo measures 
of MPB.   
 
6.4 Future directions 
This thesis has shown that markers of the UPP are regulated in response to divergent 
exercise stimulation following both acute and chronic exercise training. Previous 
research identified the UPP as a critical regulator of MPB during skeletal muscle 
atrophy. The studies performed here have demonstrated that UPP signalling is 
upregulated in a healthy state of training-induced skeletal muscle adaptation, 
indicating an additional role for atrogin-1 and MuRF1 in skeletal muscle remodelling 
post-exercise. However, our understanding of the precise roles of various components 
of the UPP remain limited. Identification of proteins modified by atrogin-1/MURF-1, 
as well as regulators of their expression is required to identify potential functions of 
atrogin-1 and MuRF1 within skeletal muscle. Additionally, future in vivo studies using 
various exercise stimulation models in atrogin-1, MuRF-1 and FBXO40 KO mice are 
required to assess the involvement of atrogin-1 in skeletal muscle exercise-
remodelling.  
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6.4.1 Identifying novel substrate targets of atrogin-1 and MURF-1  
Aim: To identify atrogin-1 and/or MURF-1 protein targets in response to anabolic 
and/or catabolic stimuli.  
 
Rationale: Our data revealed a comparable upregulation of mRNA UPP markers 
following both ET and RT. Given the specificity of the extracellular exercise signals 
and the physiological adaptations inherent following exercise training, this was 
surprising. However, whether or not there is a specificity in the type of proteins been 
synthesised and degraded following acute and/or chronic EE and RE is unknown. 
There is a need for a better understanding of the precise role of atrogin-1 and MURF-
1 in skeletal muscle function. This will require identification of their novel substrate 
targets.  
 
Methodology: Stable isotope labelling by amino acids in cell culture (SILAC) has been 
used extensively [291], and has been extended in vivo using mice labelled with 13C6-
Lys (SILAC mice) [222]. Application of the SILAC technique based on mass 
spectrometry would enable precise quantification of alterations in protein abundance 
among samples from various models. Differences in any proteins would be further 
investigated via a protein affinity purification assay, such as a glutathione S-
transferases (GST), and/or western blot analysis, ubiquitination assays with/without 
the UPP inhibitor.  
  
6.4.2 Identifying transcriptional regulators of atrogin-1 and MURF-1  
Aim: To identify transcriptional regulators of atrogin-1 and/or MURF-1 in response to 
anabolic and/or catabolic stimuli 
 
Rationale: The data from this thesis demonstrated that the FOXO and atrogin-
1/MURF-1 mRNA regulatory relationship is not consistently observed in response to 
anabolic stimulation, suggesting that that other regulatory factors influence the 
exercise-induced regulation of atrogin-1 and MURF-1 expression. Additionally, 
mounting evidence shows an incongruent relationship between atrogin-1/MURF-1 
levels and proteolysis [19]. Therefore, future research is required to investigate 
potential regulators of atrogin-1 and MURF-1 in human skeletal muscle in response to 
both catabolic and anabolic stimuli.  
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Methodology: Using the MatInspector, TFSEARCH and TRANSFAC transcription 
factor search program, potential binding sites on the human atrogin-1 and/or MURF-
1 promoter will be identified, with interest in proteins found to increase in human 
skeletal muscle anabolic and catabolic conditions. Five kilobases (kb) upstream of the 
transcriptional start site of the human atrogin-1 and MURF-1 genes, which is sufficient 
to induce robust expression as determined by luciferase reporter experiments, will be 
cloned and ligated into the reporter plasmid pGL4 (Promega Corporation, Wisconsin, 
USA). Human myoblasts will be transfected with the reporter constructs, using 
conditions that reproducibly provide transfection efficiencies of 30-60%. Human 
myotubes will be infected with the identified potential transcriptional regulators via 
adenoviral constructs for 48 h [346]. Luciferase activity, myotube diameter and 
atrogin-1 and MURF-1 mRNA and protein content will be measured. To confirm 
direct interactions between the selected transcription factors and the atrogin-1 and 
MURF-1 promoters, electrophoretic mobility shift assay (EMSA) will be performed 
using both normal and 4-base pair mutated sequences derived from the promoter 
sequence. Chromatin Immunoprecipitation (ChIP) assays will be performed to 
establish the specificity of the protein-DNA binding with PCR used to measure the 
atrogin-1 and MURF-1 promoter levels in the DNA template [345]. 
 
6.4.3 The role of atrogin-1 in exercise adaptation and skeletal muscle remodelling  
Aim: To investigate the role of atrogin-1 in skeletal muscle remodelling in atrogin-1, 
MuRF-1, and FBXO40 KO mice in vivo 
 
Rationale: Although we revealed a general upregulation of UPP signalling in response 
to diverse skeletal muscle adaptations, the significance is unknown, particularly in the 
absence of direct measures of MPB and MPS. However, an increase in the basal rate 
of protein turnover is not likely given that data shows a reduction in basal MPS and 
MPB in trained subjects compared to untrained individuals [307]. In response to 
single-bout RE (in the fasted state), an increase in MPB occurs [33, 35, 307, 308]. 
Despite an increase in proteasomal activity following functional overload [19] and 
increases in the mRNA and/or protein expression of markers of the UPP in response 
to divergent acute and/or chronic exercise, whether or not the exercise-induced MPB 
is due to an increase in UPP-mediated signalling remains unknown. 
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Our data revealed that atrogin-1, MURF-1 and FBXO40 E3-ubiquitin ligases are all 
increased following chronic RT and ET. However, recent data shows that in response 
to functional overload, atrogin-1 KO mice have an attenuated muscle growth but 
MURF-1 KO mice do not [19]. This suggests that atrogin-1 may be required for normal 
remodelling and growth. Therefore, future studies are required to investigate the 
underlying mechanisms in atrogin-1 KO mice in response to diverse exercise stimuli.  
 
Methodology: A null deletion (KO) of atrogin-1, MuRF-1 and FBXO40 will be 
examined in mice. Three month old mice will be randomly allocated to a 10-week 
endurance training protocol [207], a functional overload protocol [19] or a wild-type 
(control) which would not undertake any exercise. Both exercise protocols have 
previously shown to invoke skeletal muscle hypertrophy [19, 207]. Standard 
laboratory chow will be provided, changed and monitored daily, water will be 
available ad libitum. Skeletal muscles of the hind-limb will be weighed and 
histological analysis will be performed on serial muscle sections. Muscle function 
would be examined via assessing muscle contractile force [344]. Fractional rates of 
MPB and MPS will be assessed and gene and protein analysis of key proteins of major 
MPB and MPS pathways will be performed. Proteasome activity will be measured to 
assess the involvement of the UPP in MPB. Calpain activity and cathepsin L activity 
will also be assessed to gain a greater insight into MPB mechanisms [160] A 
microarray will be performed to provide information pertaining to the role of atrogin-
1 in skeletal muscle remodelling, and would inform future investigations, whether it is 
the role of atrogin-1 in muscle architecture and/or energy metabolism etc.   
 
6.4.4 Effects of chronic exercise and muscle protein turnover in ageing   
Aim: Investigate chronic anabolic effects in ageing atrogin-1 KO mice in vivo 
 
Rationale: The loss of skeletal muscle mass with ageing results in a reduction in muscle 
strength and the loss of functional capacity. The molecular mechanisms that regulate 
MPB in aged skeletal remain largely unresolved. Our data in experimental chapter 3 
demonstrated no age-related differences atrogin-1, MURF-1 or FOXO signalling at 
basal and in response to a single-bout of RE. However, gene and protein expression 
analysis 2 hours post-exercise cannot be truly reflective of the regulation of these UPP 
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molecular markers occurring following RE. Future investigations that include genetic 
modification in vivo with simultaneous direct measures of MPB are therefore required. 
 
Interestingly, genetic deletion of atrogin-1 in aged mice significantly reduces muscle 
weight when compared to age-matched control mice. Muscle weight could only be 
measured at in 15 month old mice because the absence of atrogin-1 shortened lifespan. 
A reduced muscle force occurred in both MuRF-1 and atrogin-1 aged KO mice, 
suggesting that these UPP genes are essential for normal protein turnover during 
ageing [344]. RT is an effective method to increase skeletal muscle mass and strength 
in both healthy young and aged individuals. Accordingly, chronic effects of exercise 
(with or without nutritional ingestion) in the elderly compared to young individuals, is 
yet to be investigated with an investigation into MPB mechanisms. It will be 
interesting to determine if the combination of chronic exercise and whey protein 
supplementation can rescue muscle loss in atrogin-1 ageing and young KO mice.  
 
Methodology: A null deletion (KO) of atrogin-1 will be examined in mice at 3, 9 and 
15 months. All mice will undertake a 10-week functional overload protocol, previously 
shown to invoke skeletal muscle hypertrophy. Mice will be randomly allocated to a 
standard laboratory chow group or a whey protein supplemented chow [259]. Whey 
proteins have positive effects in re-stimulating protein accretion and increasing muscle 
mass during ageing [259, 298]. Chow will be changed and monitored daily, water will 
be available ad libitum. A group of age-matched wild-type (control) littermates will 
feed on standard chow and not undertake any exercise. Skeletal muscles of the hind-
limb will be weighed and histological analysis will be performed on serial muscle 
sections. Muscle function would be examined via assessing muscle contractile force 
[344]. Fractional rates of MPB and MPS will be assessed and gene and protein analysis 
of key proteins of major MPB and MPS pathways will be performed. Proteasome 
activity will be measured to assess the involvement of the UPP in MPB. Calpain 
activity and cathepsin L activity will also be assessed to gain a greater insight into 
MPB mechanisms [160] A microarray will be performed to provide information 
pertaining to the role of atrogin-1 in skeletal muscle remodelling, and would inform 
future investigations, whether it is the role of atrogin-1 in muscle architecture and/or 
energy metabolism etc.   
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Expected outcomes and Significance 
These comprehensive physiological, molecular, and biochemical studies will generate 
new information characterising the role and regulation of atrogin-1 and MURF-1 in 
human skeletal muscle. Identifying the relevant transcriptional regulators and substrate 
targets of human atrogin-1 and MURF-1 will provide therapeutic targets to alter the 
levels of these genes. While we know that atrogin-1 is critical in age-related 
maintenance of skeletal muscle, this future research will work towards unravelling its 
precise role in skeletal muscle remodelling in response to anabolic stimulation. 
Understanding the relationship between exercise, nutrition, and skeletal muscle 
adaptations is required to develop effective interventions to prevent and attenuate age-
dependant skeletal muscle wasting.  
 
6.5 Conclusions 
In summary the main findings of this thesis are: 
 
x Atrogin-1, FBXO40, FOXO1 and FOXO3 mRNA are upregulated in response 
to ET and RT, with a greater increase following ET. MURF-1 mRNA and 
FOXO3 protein increased following ET only.  
x ‘Atrogenes’ are not exclusively confined to atrophy processes, but may be 
important for muscle protein turnover and adaptation to divergent exercise. 
x In the trained state, single-bout EE, but not RE, increased atrogin-1, MURF-1, 
FBXO40 and FOXO1, FOXO3 mRNA, and FOXO3 protein. In contrast, 
FBXO40 mRNA and protein decreased following single-bout RE. This data 
suggests that prior RT, but not ET, attenuates single bout-induced UPP 
responses.  
x Single-bout ECC exercise decreased atrogin-1 and FOXO3 mRNA, as well as 
FOXO1 and phospho-FOXO1 protein, while MURF-1 mRNA was 
upregulated. CONC single-bout exercise mediated a greater increase in 
MURF-1 mRNA, increased FOXO1 mRNA and downregulated FOXO1, 
FOXO3, and EIF3F protein. Following ECC-training, an increase in basal 
phospho-FOXO1 was observed. 
x Whey protein hydrolysate (WPH) supplementation with eccentric (ECC) and 
concentric (CONC) training augmented skeletal muscle hypertrophy. 
However, it did not have an additional effect on mRNA and/or protein levels 
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atrogin-1, MURF-1, FBXO40, FOXO1, FOXO3, PKM, MYOG, MYOD1, 
MHC, and EIF3F following single-bout exercise performed following 
habituation, and during hypertrophy-inducing ECC and CONC training.  
x A discordance between patterns of FOXO levels and atrogin-1/MURF-1 
mRNA levels, as well as discordance between acute and chronic responses, 
suggests other regulatory factors may influence the exercise-induced 
regulation of atrogin-1 and MURF-1. 
x Atrogin-1, MURF-1 and FBXO40 mRNA levels were comparably upregulated 
in healthy younger and older subjects following 2 h of single-bout RE; FOXO1, 
FOXO3, PKM, MYOG, MYOD1, MHC, and EIF3F were unchanged in both 
older and younger individuals. 
x At basal, older subjects had an attenuated FBXO40 mRNA and protein level 
which may reflect a compensatory mechanism to limit age-related skeletal 
muscle loss. In addition, an increased PKM protein was observed in older 
compared to younger subjects. This may account for the reduced oxidative 
metabolism associated with muscle wasting in older people. 
x The data presented here highlight the complexity in understanding the different 
roles of members of UPP degradation in healthy skeletal muscle adaptation. 
Future studies combining gene and protein expression markers with direct 
measures of protein turnover are required to delineate the precise roles and 
function of atrogin-1 and MURF-1 E3-ubiquitin ligases and potentially 
develop specific exercise interventions to improve skeletal muscle health. 
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Abstract Knowledge on the effects of divergent exercise on
ostensibly protein degradation pathways may be valuable for
counteracting muscle wasting and for understanding muscle
remodelling. This study examined mRNA and/or protein
levels of molecular markers of the ubiquitin proteasome path-
way (UPP), including FBXO32 (atrogin-1), MURF-1,
FBXO40, FOXO1 and FOXO3. Protein substrates of
atrogin-1—including EIF3F, MYOG and MYOD1—and of
MURF-1—including PKM and MHC—were also measured.
Subjects completed 10 weeks of endurance training (ET) or
resistance training (RT) followed by a single-bout of endur-
ance exercise (EE) or resistance exercise (RE). Following
training, atrogin-1, FBXO40, FOXO1 and FOXO3 mRNA
increased independently of exercise mode, whereas MURF-1
mRNA and FOXO3 protein increased following ET only. No
change in other target proteins occurred post-training. In the
trained state, single-bout EE, but not RE, increased atrogin-1,
MURF-1, FBXO40, FOXO1, FOXO3 mRNA and FOXO3
protein. In contrast to EE, FBXO40 mRNA and protein de-
creased following single-bout RE. MURF-1 and FOXO1
protein levels as well as the protein substrates of atrogin-1
and MURF-1 were unchanged following training and single-
bout exercise. This study demonstrates that the intracellular
signals elicited by ETand RT result in an upregulation of UPP
molecular markers, with a greater increase following ET.
However, in the trained state, the expression levels of UPP
molecular markers are increased following single-bout EE,
but are less responsive to single-bout RE. This suggests that
adaptations following endurance exercise training are more
reliant on protein UPP degradation processes than adaptations
following resistance exercise training.
Keywords Resistance training . Endurance training .
Degradation signalling . Exercise . Human skeletal muscle
Introduction
Exercise elicits the necessary stimuli to promote positive
skeletal muscle adaptations and is seen as one of the most
potent interventions to maintain whole body health and reduce
the risk of chronic disease. The mode, duration and intensity
of the exercise performed, as well as training status, influence
the adaptations to exercise [64, 16]. Accordingly, regularly
performed endurance exercise (EE) predominantly enhances
substrate utilization, oxidative capacity, capillary density and
mitochondrial content [24, 26] while resistance exercise (RE)
predominantly increases muscle mass and strength [24, 26].
The extracellular stress signals elicited by muscle contrac-
tion during EE and RE constitute potent drivers of intracellular
signalling, gene transcription and protein translation [37, 64,
50, 63], with EE and RE entailing relatively higher metabolic
and mechanical stress, respectively. While the intracellular
stress generated during muscle contractions differs between
EE and RE [66], there is evidence that both modes of exercise
may regulate similar gene targets and biological processes [64,
10]. Indeed, both EE [11] and RE [45] modulate protein
turnover by increasing muscle protein breakdown (MPB)
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and muscle protein synthesis (MPS) in the recovery period
post-exercise. Investigating the regulation of molecular targets
involved in MPB and MPS to exercise-induced adaptations
has been of interest for over a decade. In regards to exercise-
induced regulation on MPB, recent attention has focused on
the regulation of muscle-specific E3-ligases, FBXO32 (also
known as atrogin-1; muscle atrophy F-box, MAFbx) and
muscle ring finger-1 (MURF-1) [32, 38, 40, 20], principal
mediators of ubiquitin proteasome pathway (UPP) protein
degradation [36, 23]. The Forkhead box O (FOXO) family
of transcription factors, FOXO1 and FOXO3, regulate
atrogin-1 and MuRF1 gene transcription [58, 53].
Atrogin-1 and MuRF1 were identified as targets involved
in skeletal muscle atrophy following observations that their
genetic ablation in mice protects against muscle atrophy [6].
Furthermore, atrogin-1 and MuRF1 mRNA levels are in-
creased in numerous in vitro and in vivo mouse models of
muscle atrophy [51, 6, 23, 35]. With respect to exercise,
atrogin-1 and MURF-1 are differentially regulated; however,
the direction of their transient regulation is influenced by
exercise mode, muscle contraction mode and prior training
status [32, 38, 40]. In humans, single-bout traditional RE
increases MURF-1 mRNA 1–4 h post-exercise [38, 47, 49,
7, 22, 41, 67, 57]. In contrast, RE downregulates atrogin-1
mRNA 6–12 h post-exercise [38, 67, 41, 16]. Contraction
mode-specific RE has a differential effect with MURF-1 and
atrogin-1 mRNA exhibiting different responses to isolated
concentric and eccentric contractions, respectively [42, 32,
56]. Furthermore, an increase in both atrogin-1 and MURF-1
mRNA is seen 1–4 h following acute EE [38]. Identified
substrate targets of atrogin-1 include myogenic differentiation
1 (MYOD1) [59], myogenin factor 4 (MYOG, myogenin)
[29] and eukaryotic translation initiation factor 3, subunit F
(EIF3F) [33], proteins involved in muscle protein synthesis
and regeneration. MuRF1 targets contractile and structural
muscle proteins such as titin [12], troponin 1 [30] and myosin
heavy chain (MHC) [15, 17], as well as several proteins
involved in glycolysis and glycogen metabolism [25]. Wheth-
er or not atrogin-1 and MuRF1 substrate targets are involved
in the post-exercise response following divergent modes of
exercise is currently unknown.
The precise roles of atrogin-1 and MURF-1 in muscle
remodelling and exercise-induced muscle adaptation are unre-
solved. Although time course proteolytic gene data following
single-bout EE and RE have been reported [38], protein mea-
sures following divergent exercise modalities [i.e. traditional
endurance exercise (EE) versus traditional resistance exercise
(RE)] are lacking, especially when removing the influence of
stress responses to unaccustomed exercise. To date, molecular
markers of UPP signalling following divergent exercise training
have not been assessed. In this regard, high oxidative capacity
muscle fibres, when compared with lower oxidative capacity
fibres, have a greater rate of protein synthesis [60, 27].
However, high capacity oxidative fibres exhibit a smaller mag-
nitude of growth [61]. This apparent paradox may be an evo-
lutionary adaptation to maintain a reduced distance for oxygen
diffusion to the mitochondria [61]. The precise mechanism/s
controlling the reduced growth of high oxidative fibres (when
compared to lower oxidative capacity fibres) is not known;
however, the relatively higher levels of UPP components in
highly oxidative fibres may play a role [61, 18]. In accordance,
traditional endurance exercise training may constitute a strong
driver of UPP expression to participate in skeletal muscle
remodelling that limits cell growth to optimize oxygen diffu-
sion in the presence of increased mitochondrial biogenesis. In
contrast, traditional resistance exercise training recruits less
oxidative type II fibres. These fibres are less reliant on oxygen,
but may be more prone to exercise-induced damage, conse-
quently requiring muscle protein degradation to maintain opti-
mal muscle performance and adaptation. Over time, accus-
tomed RE would result in less muscle damage and therefore
an attenuated upregulation of UPP molecular markers.
Therefore, the aims of the current study were to investigate
the regulation of molecular markers of UPP signalling, firstly,
following long-term ET and RT and, secondly, following a
single-bout of EE and RE in the trained state. The molecular
markers of UPP signalling measured included atrogin-1,
MURF-1, FBXO40, FOXO1, FOXO3 mRNA and/or protein,
as well as protein substrates of atrogin-1, including EIF3F,
MYOG and MYOD1, and MURF-1, including muscle pyru-
vate kinase (PKM) and MHC.
We hypothesized that prolonged traditional endurance and
resistance training would both stimulate an upregulation of
basal levels of UPP molecular markers. However, as prior RT
may improve resilience towards RE-induced muscle damage,
we hypothesized that in the exercise-habituated state (i.e.
through training), only EE would stimulate acute UPP upreg-
ulation, potentially as a mechanism to maintain an optimal
size of the type I fibres.
Methods
Subjects
Eighteen healthy untrained young men (mean±SEM; height,
182±0 cm; weight, 79.1±2.4 kg, age 23.3±0.6 years)
volunteered to participate in the study. Subjects were excluded
if they had engaged in organized endurance or resistance
exercise training within the last 6 months prior to inclusion
in the study. This was assured partly by a VO2 max test
[inclusion criteria for VO2 max<50 mL per kg body mass
(kg BM)−1 per minute (min−1)] in conjunction with an
interview/questionnaire on prior training history. Further ex-
clusion criteria included any history of musculoskeletal inju-
ries and use of prescription medicine. All subjects were
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informed about the purpose and risks of the study and provid-
ed written informed consent in accordance with the Declara-
tion of Helsinki. The study was approved by the local ethics
committee of Region Midtjylland, Denmark (M-20080177).
The subject details, study design and experimental protocols
have been published previously [34].
Experimental design and training protocol
The subjects were randomly divided into endurance training
(ET) or resistance training (RT) groups (n=9 per group). Prior
to training, the subjects were tested for aerobic and strength
performance measures and underwent magnetic resonance
imaging (MRI) scanning of the thigh muscle. Muscle biopsies
from the vastus lateralis muscle were taken using the
Bergstrom needle technique prior to (pre) and after (post)
training. Following a few days of recovery, subjects then
completed either 10 weeks of ET on a cycle ergometer or
10 weeks of progressive conventional RT for lower extremity
muscle groups.
As published previously [64, 34], ET was performed on
stationary bicycles (Kettler Ergoracer GT, Kettler, Ense-parsit,
Germany) as a progressive overload training programme.
Based on the pre- and midway determinations of VO2 max,
maximal workload in Watts and maximal heart rate and target
Watt and target heart rate for each training session were used
to aid determination of target training intensity. Three weekly
sessions consisted of one session each of continuous cycling
of 30–45 min at 60–75 % of Watt max, a second session
consisting of two intervals of 20 min at 70–80 % of Watt
max interspaced by 5 min of light cycling and a third session
consisting of 8×4 min intervals at 80–90 % of Watt max
interspaced by 1 min of light cycling. The RT group complet-
ed a conventional progressive overload training programme as
previously described [64, 34]. In brief, the RT programme
included 30 training sessions, with three sessions consisting of
lower extremity exercises (leg press, knee extension and ham-
string curl) performed each week. One and/or three repetition
maximum (RM) (depending on the specific type of exercise
inherent of the RT programme) was determined through initial
one and three RM testing, with repetitions corresponding to
RM loading. Absolute loads determined through these tests
were then used to estimate absolute loads corresponding to the
designated number of repetitions in the initial part of the
training programme using RM calculating tools. The first four
training sessions were conducted as 4 sets×10 repetitions with
2 min of recovery between sets. Progression during the train-
ing period then relied on using average absolute load per-
formed in the last session adhering to a subset of sessions (e.g.
the last of sessions 1–4; see [21]) to estimate the absolute loads
corresponding to the desired repetitions/intensity in the sub-
sequent subset of training sessions (e.g. sessions 5–10). This
procedure is commonly used [9, 52]. Over the training period,
absolute loadings were adjusted according to training-induced
improvements in strength. Furthermore, the relative intensity
was gradually increased over the training period so that in the
final five training sessions, 5 sets×4 repetitions were per-
formed. During the last 15 training sessions, the subjects were
instructed to perform the concentric phase of the exercises as
fast as possible, and recovery was increased to 3 min between
sets. These principles were employed to provoke changes in
muscle morphology as well as in muscle strength. All training
sessions were supervised by trained exercise physiologists to
ensure that the subjects maintained correct exercise technique,
performed the exercise at the appropriate intensity and in-
creased the load appropriately when required. All training
sessions were separated by at least one training free day.
Following 3 days of recovery, the training period was follow-
ed by completion of a single-bout of endurance exercise (EE)
or a single-bout of resistance exercise (RE).
Single-bout exercise protocol
The subjects had been instructed to abstain from physical
activity for at least 3 days prior to the trial. A schematic
overview of trial procedures immediately pre-exercise, during
exercise and during the 22-h post-exercise recovery period
have been published previously [64, 34]. Subjects arrived
after an overnight fast at 8:00 a.m. on day 1 for pre-exercise
measurements. After 30 min of supine resting, a pre-exercise
muscle biopsy was taken from the vastus lateralis muscle (i.e.
also corresponding to post-training basal). At 8:30 a.m.,
subjects in the EE group commenced 120 min of bicycle
exercise at ∼60 % VO2 max. Subjects in the RE group
remained resting until 10:00 a.m. before completing 4×12
RM of three thigh muscle exercises with 1.5 min rest
between sets. Accordingly, work performed during the
single-bout EE and RE was identical to what the subjects
had been exposed to during the training period. The three
thigh muscle exercises were leg press, knee extension and
hamstring curl. Minor weight adjustments were allowed to
ensure performance of 12 RM as precise as possible. To
control for potential effects of circadian rhythm, the time of
day for completing all tests and training was kept constant for
each individual subject. After exercise, all subjects rested
under fasting conditions (except for water offered ad libitum)
until 3:30 p.m. (corresponding to 5 h post-exercise) on day 1;
thereafter, meals by own choice were allowed until 10:00 p.m.
Muscle samples were taken before and 0, 2.5, 5 and 22 h post-
exercise. Biopsies were sampled from separate incision holes.
For the biopsy corresponding to the 0 h time point, local
anaesthesia of the skin and fascia was performed during a
30-s break approximately 10 min before termination of the
exercise, and the biopsy was taken within seconds after ter-
mination of exercise. The biopsy sampled at 2.5 h was taken
from the same leg as the pre-exercise biopsy, whereas the
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muscle biopsies sampled at 0 and 5 h post-exercise were taken
from the opposite leg. On day 2, the subjects arrived at the
laboratory after an overnight fast at 8:00 a.m. for final mea-
surements. After resting for 30 min in the supine position, the
final muscle biopsy (corresponding to 22 h post-exercise) was
obtained. This final post-exercise muscle biopsy was sampled
from the opposite leg compared with the pre-exercise muscle
biopsy.
Exercise capacity measurements
Measures related to capacity for aerobic/endurance exercise
As published previously [64, 34], VO2 max for all subjects
was determined before and after training via an incremental
exercise test on a Monark Ergomedic 834E bicycle ergometer
(Monark Ergomedic 894 E, Monark, Varberg, Sweden), with
rates of oxygen uptake and carbon dioxide release determined
by an online respiratory gas exchange analyzer (AMIS 2001,
Innovision, Odense, Denmark). Watt max was estimated ac-
cording to the principles of Andersen [1]. Maximal heart rate
and submaximal heart rate at 140 W were monitored contin-
uously with a heart rate monitor (Polar, Oulu, Finland).
Measures related to capability for strength/resistance exercise
Maximal dynamic knee extensor strength (determined as three
RM knee extensor strength) was determined as previously
described [62]. Peak torque was determined using an
isokinetic dynamometer (Humac Norm, CSMI, Stoughton,
Wisconsin, USA) with 90° hip flexion. The protocol consisted
of three maximal contractions at three different angular veloc-
ities: 30, 90, and 180° s−1, with contractions interspaced with
1 min of recovery time. All trials were sampled at 100 Hz.
Peak torque from the best of the three trials was used for
further analysis.
Whole muscle cross-sectional area analysis—magnetic
resonance imaging
Determination of whole muscle cross-sectional area (CSA) of
the thigh muscle was performed as described previously [64,
34]. MRIwas performedwith a 1.5-Tscanner (Philips Achieva,
Best, the Netherlands), with scans performed on the left leg
using a cardiac coil. A T1-weighted, fast spin echo sequence
with the following parameters was used: scan matrix=288×
282, field of view=230×230 mm2, number of slices=20, slice
thickness=7.5 mm, slice gap=1 mm, repetition time=2 s, echo
time=5.3 ms, echo train length=18, number of signal aver-
ages=3 and scan time=3.12 min. After an initial frontal scout
scan, 20 transversal slices were acquired, with a slice at a
position corresponding to one half of the femur length chosen
for CSAdetermination of quadricepsmuscle using custom-made
software and standard Philips radiological analysis environ-
ment (ViewForum rel. 5.1, 2006).
ATPase histochemistry
Muscle samples were dissected free of visible fat and connec-
tive tissue, and a part of the biopsy was immediately mounted
with Tissue-Tek, frozen in isopentane cooled with liquid ni-
trogen and stored at −80 °C until further analysis. Serial
sections (10 μm) of the muscle biopsies were cryocut, and
ATPase histochemistry analysis was performed. To enable the
determination of fibre type-specific CSA and fibre type dis-
tribution, ATPase histochemistry analysis was performed fol-
lowing pre-incubation at pH 4.37, 4.60 and 10.30 as described
previously [8, 2]. Themuscle fibres were categorized as one of
five fibre types (I, I/IIa, IIa, IIax and IIx) and then grouped into
the three main fibre types (I, IIa and IIx) according to the
following formulas: type I=I+1/21/IIa, type IIa=1/21/IIa+
IIa+1/2 IIax, type IIx=1/2 IIax+IIx. For the area measure-
ments, a general mean fibre size for all fibre types was
combined, and a type I and type II-specific area (type IIa+
type IIx) measure was calculated. A Leica DM2000 micro-
scope (Leica, Stockholm, Sweden) and a Leica Hi-resolution
Color DFC camera (Leica, Stockholm, Sweden) combined
with image analysis software (Leica Qwin ver. 3, Leica,
Stockholm, Sweden) were used for visualization and analysis.
Preparation of muscle biopsies
Muscle biopsies were obtained from the middle section of the m.
vastus lateralis muscle using the Bergstrom needle technique.
Within each leg, a minimum distance of 3 cm between biopsy
sampling sites was ensured, and similar sampling depth of biop-
sies was attempted. Muscle biopsies were quickly divided into
smaller parts immediately after sampling and were then frozen in
liquid nitrogen and stored at −80 °C until further analysis.
Western blot analysis
Frozen muscle biopsy sample materials (40–50 mg) were ho-
mogenized in ice-cold solubilization buffer containing 20 mM
Tris, 50 mM NaCl, 5 mM Na4P2O7, 50 mM NaF, 250 mM
sucrose, 2 mM DTT, 1 % Triton-X 100, 2 μg/mL aprotinin,
5 μg/mL leupeptin, 0.5 μg/mL pepstatin, 10 μg/mL antipain,
1.5 mg/mL benzamidine and 100 μmol/L 4-(2-aminoethyl)-
benzenesulfonyl fluoride, hydrochloride (pH 7.4). Insoluble
materials were removed by centrifugation at 16,000×g for
20 min at 4 °C. Total protein content was determined using
the Bradford protein assay kit (BioRad, Hercules, CA, USA)
according to the manufacturer’s instructions.
Proteins from whole tissue lysates were separated by SDS-
polyacrylamide gel (PAGE) in a buffer containing 12 mM
Tris–HCl (pH 8.8), 200 mM glycine and 0.1 % SDS. All time
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points from each of two subjects (subjects randomized be-
tween gels) were run on the same gel. Proteins were trans-
ferred onto an Immobilon-FL PDVF membrane (Millipore,
Billerica, MA) in a Bjerrum buffer containing 50 mM Tris,
17mMglycine and 10%methanol. Membranes were blocked
with 5 % BSA in PBS for 1 h at room temperature and were
thereafter incubated at 4 °C overnight with the following
primary antibodies diluted in 5 % BSA in PBS: MURF-1
(MP3401, ECM Biosciences, Versailles, KY) at 1:1,000,
FBXO40 (H00051725-B01P, Abnova, Taipei City, Taiwan)
at 1:250, FOXO1 (C29H4, Cell Signaling Technology, Dan-
vers, MA) at 1:500, FOXO3 (ab17026, Abcam, Cambridge,
MA, USA) at 1:500, EIF3F (Jomar Bioscience, Adelaide,
Australia) at 1:500, MYOD1 (M-318: sc-760, Santa Cruz
Biotechnology) at 1:200, MYOGENIN (MYOG)
(MAB3876, Merck Millipore, Billerica, MA) at 1:500, PKM
(3198, Cell Signaling Technology, Danvers, MA) at 1:1,000
and MHC/sarcomeric myosin (MF 20, Developmental Stud-
ies Hybridoma Bank, Iowa City, IA) at 1:1,000. Alternatively,
membranes were blocked with 5 % BSA in TBST for 1 h at
room temperature and were thereafter incubated at 4 °C over-
night with the following primary antibodies diluted in 5 %
BSA in TBST: phospho-FOXO1 (Ser256, 9461, Cell Signal-
ing Technology, Danvers,MA) at 1:500 and phospho-FOXO3
(Ser253, 9466, Cell Signaling Technology, Danvers, MA) at
1:400. Following overnight primary antibody incubation,
membranes were washed with either PBS or TBST (4×
5 min) and were subsequently incubated for 1 h with the
following infrared fluorescent conjugated secondary antibod-
ies diluted at 1:5,000 in PBS or TBST containing 50 %
Odyssey® Blocking Buffer (LI-COR Biosciences, Lincoln,
USA) and 0.01 % SDS: IRDye 800CW goat anti-rabbit IgG
(LI-COR Biosciences, Lincoln, USA) for MURF-1, FOXO1,
phospho-FOXO1, phospho-FOXO3, EIF3F, MYOD1 and
PKM; IRDye 800CW donkey anti-goat IgG (LI-COR
Biosciences, Lincoln, USA) for FOXO3; and Alexa Fluor®
680 rabbit anti-mouse IgG (Invitrogen, Carlsbad, CA) for
FBXO40, MYOG, MHC and GAPDH. After washing, pro-
teins were exposed on an Odyssey® Infrared Imaging System
(LI-COR Biosciences, Lincoln, USA), and individual protein
band optical densities were quantified using Odyssey® Infra-
red Imaging System software. To control for protein loading,
all blots were normalized against GAPDH protein (G8795,
Sigma-Aldrich, Sydney, Australia). We have previously
established that GAPDH protein is stable following resistance
exercise training and single-bout resistance exercise [56, 57].
RNA extraction and reverse transcription
RNA was extracted from ∼20 mg of muscle using the
guanidinium thiocyanate-phenol-chloroform extraction meth-
od, as previously described [13], and the RNA concentration
was determined spectrophotometrically using a Nanodrop 1000
(Thermo Fischer Scientific, Wilmington, DE, USA). One mi-
crogram of RNAwas reverse transcribed to cDNA using High
Capacity RNA-to-cDNA kit (Applied Biosystems, Forster City,
CA) according to the manufacturer’s protocol. Prior to PCR,
1 μL ribonuclease H (RNase H) (Life Technolgies, Mulgrave,
VIC) was added to each sample and incubated at 37 °C for
30 min. The cDNAwas stored at −20 °C until further analysis.
Real-time PCR
Real-time PCR was performed using the Stratagene MX3000
PCR system (Agilent Technologies, Santa Clara, CA) to mea-
sure atrogin-1, MURF-1, FBX040, FOXO1 and FOXO3
mRNA levels. To compensate for variations in input RNA
amounts and efficiency of the reverse transcription, data was
normalized to large ribosomal protein PO (RPLPO, also
known as 36B4) mRNA. We have previously established
RPLPO to be stable following resistance exercise training
and single-bout resistance exercise [37, 56]. All primers were
used at a final concentration of 300 nM and probes at 100 nM.
Primer details are provided in Table 1. The PCR condition
conditions were 1 cycle of 10min at 95 °C, 40 cycles of 30 s at
95 °C and 60 s at 60 °C.
Statistical analyses
Data are presented as mean fold change±standard error of the
mean (SEM). All statistical analyses were performed using
GraphPad Prism, Version 6.0 (GraphPad Software Inc., CA,
USA). For variables independent of time, Student’s t tests
were performed to test for differences in basal levels between
groups. For variables measured before and after the training
period and following the single-bout exercise trials, two-way
mixed ANOVAs with repeated measures were performed to
test for changes due to group, time or group×time. When a
significant effect of group and time was found, significant
pairwise differences were assessed using Student–Newman-
Keul’s post hoc test. For all statistical tests, P<0.05 was
considered significant.
Results
Two subjects from each training group did not complete the
training period due to exercise-unrelated circumstances, leav-
ing n=7 in each training group for all data presented.
Exercise capacity and muscle morphology
Changes in exercise capacity and muscle morphological pa-
rameters as induced by 10 weeks of training have been de-
scribed in detail previously [64, 34]. For the exercise capacity
parameters, no differences were observed between groups
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prior to commencing the training period. The ET group ex-
hibited a training-induced increase in VO2 max [44.9±1.4 to
49.7±2.0 mL (kg BM)−1min−1 (∼11±2 %; P<0.001)] in
maximal workload [330±18 to 374±18 W (∼13 %;
P<0.001)] and a decrease in training-induced submaximal
intensity exercise heart rate [155±3 to 138±3 bpm at 140 W
(∼13 %; P<0.01)]. No changes pre- versus post-training oc-
curred in the RT group for aerobic exercise capacity parame-
ters with absolute pre- versus post-training values amounting
from 46.9±3.0 to 46.9±2.6 mL (kg BM)−1min−1, 322±20 to
332±19 W and 162±9 to 152±7 bpm at 140 W.
As previously published [21], no significant changes in
mean or specific fibre CSA were observed with ET. The RT
group exhibited training-induced increases in mean fibre CSA
(∼19±7 %; P<0.05). When CSA of individual fibre type was
analyzed, only type IIa fibre CSAwas significantly increased
following RT (P<0.05) (see also fibre type-specific raw CSA
data provided in supplementary Table 1). RT increased peak
torque [214±13 to 255±13 peak torque at 30° s−1 Nm (∼19%;
P<0.001)] and maximal knee extensor strength [96±5 to 133±
4 (∼40±4 %; P<0.001)], while no changes pre- versus post-
training occurred with ET. The values for pre- versus post-ET
peak torque and maximal knee extensor strength were 202±20
to 194±18 peak torque at 30° s−1 Nm and 93±9 to 94±8,
respectively. No significant changes in fibre-type distribution
occurred following RT or ET as shown previously [34].
Changes in mRNA and protein levels
Basal pre-training FOXO1 protein was significantly increased
in the ET group compared to the RT group (48±1 %;
P=0.016). Given that a random allocation of subjects to
exercise training groups was performed pre-training, we sug-
gest that this basal pre-training increase in FOXO1 is random.
There were no differences in basal pre-training mRNA or
protein levels for any other targets measured. A summary of
all mRNA and protein changes following divergent exercise
training and single-bout exercise are shown in Table 2. The
basal level of atrogin-1 mRNA increased following both ET
(92±17 %) and RT (67±16 %) (P<0.001; Fig. 1a). A single-
bout of EE, but not RE, increased atrogin-1 mRNA by 118±
33% at 2.5 h (P<0.05), 189±22% at 5 h (P<0.001) and 131±
45 % at 22 h (P<0.05) compared to basal post-training. Fol-
lowing single-bout EE atrogin-1 mRNA levels were greater at
5 and 22 h when compared to single-bout RE (Fig. 1b). For
MURF-1 mRNA, a significant group by time interaction was
observed with ETonly increasingMURF-1mRNA expression
by 138±24% (P<0.01; Fig. 2a). Similarly, single-bout EE, but
not RE, increased MURF-1 mRNA at 2.5 h (340±94 %;
P<0.001) compared to basal post-training. Following single-
bout EE,MURF-1mRNA levels were greater at 0 h, 2.5 h and
22 h when compared to single-bout RE (Fig. 2b). No change in
MURF-1 protein was observed following training and single-
bout exercise (data not shown). FBXO40 mRNA increased
following both ET (73±10 %) and RT (21±4 %) (P<0.01;
Fig. 3a). FBXO40 protein was unaffected following training
(data not shown). In response to single-bout EE, FBXO40
mRNA increased immediately post-exercise at 0 h (83±5 %;
P<0.001), 2.5 h (62±3 %; P<0.01), 5 h (54±6 %; P<0.01)
and 22 h (69±7 %; P<0.01). Following single-bout exercise,
FBXO40 mRNA levels were greater in the EE than the RE
group at all time points (Fig. 3b). Contrastingly, single-bout RE
Table 1 Human primer and probe sequences used for PCR analysis
Gene GenBank accession number Sequences
Atrogin-1 NM_058229.3 Forward GCAGCTGAACAACATTCAGATCAC
Reverse CAGCCTCTGCATGATGTTCAGT
Probe (FAM)-CTTCAAAGGCACCTTCACTGACCTG(BHQ-1)
MURF-1 NM_032588.3 Forward CCTGAGAGCCATTGACTTTGG
Reverse CTTCCCTTCTGTGGACTCTTCCT
Probe (Texas Red)- AGGAAGAATTCATTGAAGAAGAAGATCAGG(BHQ-2)
FBXO40 NM_016298.3 Forward AGTCCACAGAGAGATCTG
Reverse TGTGCTCTACAATGTTGAA
Probe (HEX)-AGTTCAGCAGCCTCTTCTCCA(BHQ)
FOXO1 NM_002015 Forward AAGAGCGTGCCCTACTTCAA
Reverse CTGTTGTTGTCCATGGATGC
FOXO3 NM_001455 Forward CTTCAAGGATAAGGGCGACA
Reverse TCTTGCCAGTTCCCTCATT
RPLPO NM_053275.3 Forward TCTACAACCCTGAAGTGCTTGATATC
Reverse GCAGACAGACACTGGCAACATT
FBXO32 atrogin-1 muscle atrophy F-box,MURF-1muscle ring finger-1, FBXO40 F-box protein 40, FOXO1 forkhead box O1,; FOXO3 forkhead box
O3, RPLPO acidic ribosomal phosphoprotein PO
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downregulated FBXO40 mRNA by 53±11 % at 5 h (P<0.05;
Fig. 3b) and FBXO40 protein at 22 h (28±2 %; P<0.05)
compared to basal post-training levels (Fig. 3c).
FOXO1mRNA increased after ET (47±9 %) and RT (41±
11 %) (P<0.001; Fig. 4a). FOXO1 and phospho-FOXO1
protein were unaltered following exercise training (data not
shown). Single-bout EE, but not RE, increased FOXO1
mRNA by 51±4 % at 5 h when compared to basal post-
training (P<0.01; Fig. 4b). FOXO1 protein was unaffected
in response to single-bout EE and RE (data not shown).
FOXO3 mRNA levels increased after ET (56±13 %) and
RT (51±3 %) (P<0.0001; Fig. 5a). A significant group by
time interaction was observed for FOXO3 protein with a 58±
8 % increase in FOXO3 protein following ET (P<0.05;
Fig. 5b). In response to single-bout exercise, FOXO3 mRNA
increased 5 h post-EE (50±10 %; P<0.05) and decreased at
5 h post-RE (7±1 %; P<0.05), with a significant difference
observed between exercise modes (P<0.0001; Fig. 5c).
FOXO3 protein increased at 2.5 h following single-bout EE
only when compared to basal post-training (45±2%; P<0.05)
(Fig. 5d). No change in phospho-FOXO3 protein occurred in
response to training or single-bout exercise (data not shown).
Table 2 Summary of mRNA and
protein results following
divergent exercise training and
single-bout exercise
Exercise mode effects of training
(pre-exercise basal versus post-
exercise) and single-bout exercise
(post-training basal versus post-
exercise recovery time points) are
shown as percent change (mean±
SEM) from basal set to a fixed
value of 100% for measured gene
and protein targets
E endurance, R resistance, NC no
change
↑/↓ P<0.05; ↑↑/↓↓ P<0.01; ↑↑↑/
↓↓↓ P < 0 .001 ; ↑↑↑↑ /↓↓↓↓
P<0.0001 (different from
specified basal levels); *P<0.05;
¶P<0.01; §P<0.001; #P<0.0001
(difference between exercise
groups)
Mode Training (%) Single-bout exercise
0 h (%) 2.5 h (%) 5 h (%) 22 h (%)
Gene
Atrogin-1 E ↑↑↑ 92±17 NC ↑ 118±33 ↑↑↑ 189±22§ ↑ 131±45*
R ↑↑↑ 67±16 NC NC –§ –*
MURF-1 E ↑↑ 138±24 –* ↑↑↑ 340±94# NC –*
R NC –* –# NC –*
FBXO40 E ↑↑ 73±10 ↑↑↑ 83±5¶ ↑↑ 62±3* ↑↑ 54±6# ↑↑ 69±7¶
R ↑↑ 21±4 –¶ –* ↓ 53±11# –¶
FOXO1 E ↑↑↑ 47±9 NC NC ↑↑ 51±4 NC
R ↑↑↑ 41±11 NC NC NC NC
FOXO3 E ↑↑↑↑ 56±13 NC NC ↑ 50±10# NC
R ↑↑↑↑ 51±3 NC NC ↓ 7±1# NC
Protein
MURF-1 E NC NC NC NC NC
R NC NC NC NC NC
FBXO40 E NC NC NC NC NC
R NC NC NC NC ↓ 28±2
FOXO1 E NC NC NC NC NC
R NC NC NC NC NC
phospho-FOXO1 E NC NC NC NC NC
R NC NC NC NC NC
FOXO3 E ↑ 58±8 NC ↑ 45±2 NC NC
R NC NC NC NC NC
phospho-FOXO3 E NC NC NC NC NC
R NC NC NC NC NC
EIF3F E NC NC NC NC NC
R NC NC NC NC NC
MYOD1 E NC NC NC NC NC
R NC NC NC NC NC
MYOG E NC NC NC NC NC
R NC NC NC NC NC
PKM E NC NC NC NC NC
R NC NC NC NC NC
MHC E NC NC NC NC NC
R NC NC NC NC NC
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Changes in atrogin-1 and MuRF1 protein substrates
Quantification of the protein level of atrogin-1 substrate tar-
gets, EIF3F, MYOD1, MYOG, as well as MURF-1 substrate
targets, PKM and MHC, revealed no change in response to
exercise training and in response to single-bout exercise per-
formed following the training period when compared to basal
pre-training and post-training, respectively (data not shown).
Representative Western blot images for all proteins measured
are depicted in Fig. 6.
Discussion
The present study investigated the effect of divergent modes
of exercise training and a single-bout of exercise performed in
the trained state on selective molecular markers of UPP sig-
nalling. The main findings were: (1) atrogin-1, FBXO40,
FOXO1 and FOXO3mRNAwere upregulated following both
ET and RT, but by a higher magnitude following ET; (2)
MURF-1 mRNA and FOXO3 protein levels were increased
following ET, but not RT; (3) in the trained state, single-bout
EE, but not single-bout RE, increased atrogin-1, MURF-1,
FBXO40,FOXO1 andFOXO3mRNA levels; (4) in the trained
state, single-bout RE decreased FBXO40 mRNA and protein;
and (5) protein levels of atrogin-1 and MURF-1 substrate
targets were not altered following training or single-bout exer-
cise. The general training-induced increase in atrogin-1,
MURF-1 and FOXO molecules implies that these systems
are not exclusively confined to atrophy processes, but may
be important for protein turnover and adaptation to exercise.
Effect of divergent exercise training on molecular markers
of UPP signalling
In line with previous findings, ET and RT predominantly drive
increases in aerobic capacity and muscle hypertrophy, respec-
tively [3]. Despite the fact that the extracellular stress, physio-
logical and metabolic responses and resultant training-induced
Fig. 1 Regulation of atrogin-1 mRNA following divergent exercise
training [endurance training (ET) versus resistance training (RT) (pre-
training basal versus post-training normalized to the mean pre-training
basal of the combined exercise training groups)] and single-bout exercise
[endurance exercise (EE) versus resistance exercise (RE) (post-training
basal versus post-exercise recovery time points normalized to the mean
post-training basal of each exercise group)]. Graphs are shown as fold
changes±SEM from basal set to a fixed value of 1. a Atrogin-1 mRNA
increased independent of the exercise training mode. Line across groups
indicates a general time effect, ***P<0.001. b In the trained state, EE, but
not RE, increased atrogin-1 mRNA at 2.5–22 h post-exercise. Signifi-
cantly different from post-exercise, *P<0.05; ***P<0.001. Significantly
different between exercise groups, #P<0.05; ###P<0.001
Fig. 2 Regulation of MURF-1 mRNA following divergent exercise
training [endurance training (ET) versus resistance training (RT) (pre-
training basal versus post-training normalized to the mean pre-training
basal of the combined exercise training groups)] and single-bout exercise
[endurance exercise (EE) versus resistance exercise (RE) (post-training
basal versus post-exercise recovery time points normalized to the mean
post-training basal of each exercise group)]. Graphs are shown as fold
changes±SEM from basal set to a fixed value of 1. a ET, but not RT,
increased MURF-1 mRNA. Line across time points indicates a time×
training interaction, **P<0.01. b In the trained state, EE, but not RE,
increased MURF-1 mRNA at 2.5 h post-exercise. Significantly different
from post-exercise, ***P<0.001. Significantly different between exercise
groups, #P<0.05; ####P<0.0001
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adaptations to ETandRT differ, themuscle adaptive response at
the molecular level shares a comparable overall transcriptional
upregulation of molecular markers of UPP signalling. This is
demonstrated by increases in atrogin-1, FBXO40, FOXO1 and
FOXO3 mRNA following 10 weeks of RT as well as ET. The
upregulation of molecular markers of UPP signalling in condi-
tions of enhanced skeletal muscle function suggests that the
UPP system may play an important role in protein turnover
during exercise-induced skeletal muscle remodelling. This no-
tion is not without precedence. Accordingly, RT has previously
been shown to increase the mRNA level of proteasome 20Sα-
1 subunit (Psma1) and ubiquitin B (Ubb), genes implicated in
the UPP [37], while ET increases 26S proteasome activity in
healthy mice [18]. Additionally, an increase in molecular
markers of UPP activity has been observed following
long-term training in hunting dogs [65].
The increase post-RT in atrogin-1 mRNA is consistent with
previous observations following 8 weeks [37], but not
21 weeks [28], of hypertrophy-inducing RT. In contrast, the
lack of RT-induced MURF-1 is differs from a previously
Fig. 3 Regulation of FBXO40 mRNA and protein following divergent
exercise training [endurance training (ET) versus resistance training (RT)
(pre-training basal versus post-training normalized to the mean pre-train-
ing basal of the combined exercise training groups)] and single-bout
exercise [endurance exercise (EE) versus resistance exercise (RE) (post-
training basal versus post-exercise recovery time points normalized to the
mean post-training basal of each exercise group)]. Graphs are shown as
fold changes±SEM from basal set to a fixed value of 1. a FBXO40
mRNA increased independent of the exercise training mode. Line across
groups indicates a general time effect, **P<0.01. b In the trained state,
EE increased FBXO40 mRNA at 0–22 h, while RE decreased FBXO40
mRNA at 5 h post-exercise. c FBXO40 protein was decreased 22 h post-
RE. Significantly different from post-exercise, *P<0.05; **P<0.01;
***P<0.001. Significantly different between exercise groups, #P<0.05;
##P<0.01; ####P<0.0001
Fig. 4 Regulation of FOXO1mRNA following divergent exercise train-
ing [endurance training (ET) versus resistance training (RT) (pre-training
basal versus post-training normalized to the mean pre-training basal of the
combined exercise training groups)] and single-bout exercise [endurance
exercise (EE) versus resistance exercise (RE) (post-training basal versus
post-exercise recovery time points normalized to the mean post-training
basal of each exercise group)]. Graphs are shown as fold changes±SEM
from basal set to a fixed value of 1. a FOXO1 mRNA increased inde-
pendent of the exercise training mode. Line across groups indicates a
general time effect, ***P<0.001. b In the trained state, EE, but not RE,
increased FOXO1 mRNA at 5 h post-exercise. Significantly different
from post-exercise, **P<0.01
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Fig. 5 Regulation of FOXO3 mRNA and protein following divergent
exercise training [endurance training (ET) versus resistance training (RT)
(pre-training basal versus post-training normalized to the mean pre-train-
ing basal of the combined exercise training groups)] and single-bout
exercise [endurance exercise (EE) versus resistance exercise (RE) (post-
training basal versus post-exercise recovery time points normalized to the
mean post-training basal of each exercise group)]. Graphs are shown as
fold changes±SEM from basal set to a fixed value of 1. a FOXO3mRNA
increased independent of the exercise trainingmode. a Line across groups
indicates a general time effect, ****P<0.0001. b FOXO3 protein in-
creased following ET, but not RT. Line across time points indicates a
time×training interaction, *P<0.05. c In the trained state, EE and RE
resulted in an increase and decrease in FOXO3 mRNA, respectively,
measured at 5 h post-exercise. d FOXO3 protein increased at 2.5 h
post-EE. Significantly different from post-exercise, *P<0.05. Signifi-
cantly different between exercise groups at 5 h, ####P<0.0001
Fig. 6 Representative Western
blot images of MURF-1,
FBXO40, phospho-FOXO1,
FOXO1, phospho-FOXO3,
FOXO3, EIF3F, MYOD1,
MYOGENIN (MYOG), PKM,
MHC and GAPDH (normalizing
protein) measured prior to and
after training (a) and prior to and
after single-bout exercise (b)
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observed increase in MURF-1 mRNA following 8 weeks of
RT [37]. This variance may be due to the slightly longer RT
programme in the present study with the premise being that
MURF-1mRNA is attenuated following extended RE training
[41]. At the protein level, MURF-1 was unchanged similarly
to this previous report [37]. Although the time delay between
gene transcription and protein translation may account for
discrepancies between mRNA and protein levels, an
additional explanation is that E3-ubiquitin ligases can
undergo auto-ubiquitination [54].
A divergent exercise-induced regulation of atrogin-1 and
MURF-1 mRNA has previously been observed [22, 49, 41,
38, 7]. However, the proteins that these E3-ligases target in
response to divergent exercise are unknown. Our investigation
revealed no change in known atrogin-1 or MURF-1 protein
substrate targets, such as EIF3F, MYOD1, MYOG, PKM and
MHC following divergent exercise training and divergent
single-bout exercise performed in the trained state, supporting
our recent observations following 2 h single-bout RE [57].
This result for MURF-1 substrate targets may not be surpris-
ing given that the MURF-1 protein level was unaltered.
Atrogin-1 protein levels were not measured due to doubt over
the specificity of commercially available antibodies. Howev-
er, we previously observed a decrease in EIF3F protein post-
concentric-RE; whereas no other atrogin-1/MURF-1 targets
were measured [56]. It is conceivable that RE performed using
divergent muscle contractions may influence atrogin-1 and/or
MURF-1 substrates. Moreover, it is also likely that other
currently unidentified substrate targets are involved in the
exercise-induced regulation of these E3-ubiquitin ligases.
FOXO1 and FOXO3 mRNA increased following both ET
and RT, while FOXO3 protein increased in response to ET
only. A key adaptation to ETand a response to EE is improved
energymetabolism. FOXO1 plays an important role in muscle
fat oxidation under fasting or exercise conditions [48]. Recent
evidence also suggests that FOXO3 plays an important role in
enhanced mitochondrial metabolism [44]. The changes in
FOXO protein levels with different modes of exercise training
are limited. However, Leger et al. previously showed a de-
crease in the nuclear protein content of FOXO1 and no effect
on the FOXO3 protein following RT [37].
Effect of divergent single-bout exercise on UPP signalling
following exercise training
In the trained state, single-bout EE, but not RE, increased
atrogin-1, MURF-1, FBXO40, FOXO1 and FOXO3 mRNA
compared to basal post-training levels. A minimal induction
of molecular markers of the UPP in response to single-bout of
RE is in line with observations that prior resistance training
may attenuate single-bout RE-induced MPB [46].
Following single-bout EE, atrogin-1 mRNA increased at
2.5, 5 and 22 h post-exercise, which is consistent with our
hypothesis that in the endurance-trained state, single-bout EE
upregulates UPP molecular markers. Our observations are
similar to an increase detected in atrogin-1 2–4 h post-
exercise [38, 43] but in contrast to a return of atrogin-1 to
baseline levels 24 h post-running [38]. The former study
employed 30 min of running [38] compared to 2 h of cycling
in the present study. Hence, the greater magnitude of meta-
bolic stress elicited by our longer duration exercise protocol or
the fact that running is also comprised of eccentric contrac-
tions may have accounted for our sustained induction of
atrogin-1 mRNA. In line with our data, single-bout cycling
increases atrogin-1 mRNA in endurance-trained subjects, in-
dicating that ET does not diminish the acute exercise-induced
regulation of atrogin-1 [16].
Unlike EE, atrogin-1 mRNA was unaltered following
single-bout RE. This lack of increase in atrogin-1 following
single-bout RE in the trained state is similarly consistent with
our hypothesis that in the trained state, molecular markers of
the UPP will not be responsive to single-bout RE. Previous
studies utilizing traditional RE have observed no change in
atrogin-1 mRNA at corresponding time points in untrained
[41, 22, 7, 67, 47, 28], highly trained [16] and moderately
trained subjects [38]. Others have observed a downregulation
in atrogin-1 mRNA 2–6 h post-exercise in untrained [49, 19],
8–12 h post-exercise in moderately trained [38] and 3 h post-
exercise in highly trained subjects [14]. Therefore, atrogin-1
mRNA is either unchanged or decreased following acute RE.
However, in studies utilizing isolated contraction mode, ec-
centric muscle contraction RE has been consistently shown to
downregulate atrogin-1 mRNA [56, 32, 42]. Furthermore, it
has been shown that atrogin-1 can be upregulated with con-
centric contraction mode [56, 32, 42], thus supporting our
current results from cycling exercise. This suggests that the
regulation of atrogin-1 may differ with a higher metabolic
demand inherent of concentric work versus a higher mechan-
ical stress–strain inherent of eccentric work.
MURF-1 mRNA increased at 2.5 h following single-bout-
EE in accord with previously observed inductions ofMURF-1
mRNA 0–4 h post-EE [38, 43]. Despite EE-induced alter-
ations in mRNA levels, MURF-1 protein levels remained
unchanged. No change in MURF-1 mRNA or protein was
observed in response to single-bout RE. In untrained individ-
uals, MURF-1 mRNA has been observed to increase 1–4 h
following RE [38, 47, 67, 22, 41, 57, 7, 49], while MURF-1
protein has been observed to increase 1–3 h post-RE [7, 22]. A
lack of RE-induced MURF-1 expression in the current study
may reflect the subject’s prior training status. Prior training
status can alter the acute gene responses in skeletal muscle to
subsequent exercise [16, 41, 64]. Indeed, MURF-1 mRNA is
unchanged 3 h post-RE in highly RE trained subjects [14],
indicating that prior RT attenuates exercise-induced gene re-
sponses to acute exercise. Failure of MURF-1 induction in the
present study implies that following RT, the demand to
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increase MPB, at least UPP-regulated protein degradation, in
response to single-bout RE [4, 5, 45, 46] is attenuated. This
notion is in line with a blunted exercise-induced increase in
mixed muscle fractional protein synthesis [31, 46] and protein
breakdown [46] in RE trained compared to untrained subjects.
FBXO40 mRNA increased immediately following single-
bout EE and remained elevated until 22 h post-exercise.
FBXO40 is another E3-ubiquitin ligase that was recently
found to ubiquitinate and degrade insulin receptor substrate
1 (IRS1), a downstream effector of insulin and insulin-like
growth factor-1 (IGF-1) receptor-mediated signalling such as
PI3K/Akt [55]. Mice lacking FBXO40 demonstrate abnor-
mally increased skeletal muscle hypertrophy [55]. In response
to acute RE, we previously observed an increased FBXO40
mRNA 2 h post-exercise in untrained individuals [57]. A lack
of FBXO40 mRNA induction in response to RE and
hypertrophy-inducing RT may once again reflect the training
status of our subjects. The decrease in FBXO40 mRNA fol-
lowing prior RT supports the hypothesis that in the resistance-
trained state, single-bout RE does not produce a significant
upregulation of molecular markers of the UPP.
Single-bout EE increased FOXO1 and FOXO3 mRNA at
5 h post-exercise in agreement with a previously observed
increase in FOXO1 3 h post-cycling [39] and FOXO3 expres-
sion 1 h post-running [38]. No changes in FOXO1 or FOXO3
mRNA/protein occurred in response to single-bout RE, which
is in accord with some previous studies [38, 47, 57, 19], but
not others [49]. In particular, FOXO1 mRNA increases fol-
lowing isolated concentric, but not eccentric contraction RE
[49, 42, 56]. No change in FOXO1 or phospho-FOXO1
protein occurred in response to single-bout exercise. While a
recent study by our group similarly showed no change in
FOXO1 or phospho-FOXO1 protein post-RE [57], another
recent study by our group observed a downregulation of
phospho-FOXO1 following eccentric RE and a decrease in
FOXO1 protein following both eccentric and concentric RE
[56]. Thus, isolated muscle-specific contraction mode as op-
posed to conventional RE appears to regulate FOXO proteins.
In response to single-bout EE, but not RE, FOXO3 protein
increased 2.5 h post-exercise. A lack of change in FOXO3 and
phospho-FOXO3 in response to RE is in accord with data
from our group [57] as well as others [22, 57].
Both ET and RT increased the mRNA levels of molecular
markers of UPP. This general upregulation of the UPP basal
levels following prolonged training suggests that atrogin-1
and MURF-1 may play a role in healthy skeletal muscle
adaptation and remodelling post-exercise, although specific
remodelling requirements may relate to ET and RT. Accord-
ingly, in the trained state (i.e. a state in which the muscle is
presumably less prone to exercise-induced muscle micro-
damage requiring less protein degradation), only EE elicited
an upregulation of molecular markers of the UPP. This sug-
gests that EE-induced increases in the UPP reflects an
adaptation to ET that may play a role in precluding type I
fibre growth to optimize oxygen supply to the mitochondria.
[61]. Our observation of a lack of oxidative fibre growth with
prolonged ET, but not RT, supports this. The difference in
fibre growth between training modes may be logically as-
cribed to a greater increase in muscle protein synthesis in type
II fibres. However, high capacity oxidative fibres, when com-
pared with low capacity oxidative fibres, possess a greater
capacity for protein degradation as well as protein synthesis.
This further supports the contention that in response to endur-
ance exercise training, protein degradation is greater than
protein synthesis in oxidative fibres, and this response coun-
teracts oxidative fibre growth. In contrast, in resistance exer-
cise training, protein synthesis remains greater than protein
degradation [61]. Future studies combining gene and protein
expressionmolecular markers in single fibres and/or including
direct measures of protein turnover are required to delineate
the precise roles and function of E3-ubiquitin ligases and
potentially develop specific exercise interventions to improve
skeletal muscle health. Our observations that atrogin-1,
MURF-1 and FOXO are increased following exercise training
and sensitive to different contraction modes suggest they may
play specific roles in the adaptation to exercise. Likely roles
include the differentiated re-modelling requirements of the
muscle architecture as well as energy metabolism with
divergent exercise.
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ABSTRACT 26
Knowledge from human exercise studies on regulators of muscle atrophy is lacking, but is 27
important to understand the underlying mechanisms influencing skeletal muscle protein turnover 28
and net protein gain. This study examined the regulation of muscle atrophy-related factors, 29
including atrogin-1 and MuRF1, their upstream transcription factors FOXO1 and FOXO3A and the 30
atrogin-1 substrate eIF3-f, in response to unilateral isolated eccentric (ECC) versus concentric 31
(CONC) exercise and training. Exercise was performed with whey protein hydrolysate (WPH) or 32
isocaloric carbohydrate (CHO) supplementation. Twenty-four subjects were divided into WPH and 33
CHO groups and completed both single-bout exercise and 12-weeks of training. Single-bout ECC 34
exercise decreased atrogin-1 and FOXO3A mRNA compared to basal and CONC exercise, while 35
MuRF1 mRNA was upregulated compared to basal. ECC exercise downregulated FOXO1 and 36
phospho-FOXO1 protein compared to basal and phospho-FOXO3A was downregulated compared 37
to CONC. CONC single-bout exercise mediated a greater increase in MuRF1 mRNA and increased 38
FOXO1 mRNA compared to basal and ECC. CONC exercise downregulated FOXO1, FOXO3A, 39
and eIF3-f protein compared to basal. Following training, an increase in basal phospho-FOXO1 was 40
observed. While WPH supplementation with ECC and CONC training further increased muscle 41
hypertrophy, it did not have an additional affect on mRNA or protein levels of the targets measured. 42
In conclusion, atrogin-1, MuRF1, FOXO1/3A and eIF3-f mRNA and protein levels are 43
differentially regulated by exercise contraction mode, but not WPH supplementation combined with 44
hypertrophy-inducing training. This highlights the complexity in understanding the differing roles 45
these factors play in healthy muscle adaptation to exercise. 46
47
48
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INTRODUCTION 50
Muscle hypertrophy occurs as a product of the net muscle protein accumulation over time (45, 52) 51
when the rate of muscle protein synthesis (MPS) is greater than muscle protein breakdown (MPB). 52
A single-bout of resistance exercise (RE) performed in the fasted state increases MPS and to a 53
smaller degree MPB (3, 4, 46). Ingestion of essential amino acids (EAA) combined with RE 54
synergistically increases MPS (3, 4, 10, 46, 47, 50, 58) and inhibits (3, 10, 58) or downregulates 55
MPB (3, 26), resulting in an enhanced net muscle protein accumulation (37, 46, 58). Activation of 56
MPS is primarily mediated through mammalian target of rapamycin (mTOR) signalling (6, 7, 18, 57
19, 25, 30, 48), however the regulation of the MPB pathways in response to anabolic stimulation 58
has been less well defined. 59
60
Atrogin-1 (also known as muscle atrophy F-box; MAFbx) and muscle ring finger-1 (MuRF1) are 61
muscle-specific E3-ubiquitin ligases (5, 27) and transcriptional targets of the Forkhead box O 62
(FOXO) family members, FOXO1 and FOXO3A (12, 55, 56). Their ablation in mice protects 63
against muscle wasting (5, 27), suggesting that they may be primary mediators of MPB and muscle 64
atrophy in disease conditions. Atrogin-1 and MuRF1 are elevated in numerous models of rodent and 65
human muscle atrophy (reviewed in (23)); however, their levels remain unchanged in some human 66
wasting conditions (40, 53). Similarly, atrogin-1 and MuRF1 mRNA levels are elevated following 67
muscle hypertrophy-inducing RE training (39). Known substrate targets of atrogin-1 include 68
proteins involved in muscle protein synthesis and regeneration such as elongation initiation factor 3 69
subunit 5 (eIF3-f) (38), MyoD (57), and myogenin (33). MuRF1 targets proteins involved in muscle 70
structure and contraction such as myosin heavy chain (MHC) (14, 16, 22) as well as several 71
proteins involved in glycolysis and glycogen metabolism (29, 35, 36). Atrogin-1 and MuRF1 72
regulate distinct components involved in skeletal muscle function under basal, catabolic and 73
anabolic conditions. This highlights their complex and important role in skeletal muscle health. 74
75
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Atrogin-1 and MuRF1 levels are differentially regulated by exercise contraction mode and amino 76
acid availability. Following single-bout RE, comprising both eccentric (ECC) and concentric 77
(CONC) contraction modes, atrogin-1 mRNA is downregulated 3-12 h post-exercise (15, 41, 42), 78
while MuRF1 mRNA is upregulated 1-4 h post-exercise (26, 41, 42, 61). Isolated ECC RE 79
decreases atrogin-1, while isolated CONC RE increases MuRF1 (34, 44). This supports the notion 80
that they react to different exercise-induced stressors and target different substrates. The effect of 81
essential amino acid supplementation combined with RE on the regulation of atrogin-1 and MuRF1 82
remains equivocal with reports showing either a decrease in atrogin-1 mRNA only (9) or no change 83
in either target (17, 31, 51). Atrogin-1, MuRF1 as well as FOXO1 and FOXO3A protein levels have 84
not been thoroughly investigated following contraction mode-specific RE, but such investigation is 85
required to understand the potential relevance of their mRNA changes.  86
 87
The present study aimed to conduct a comparative study to investigate the influence of unilateral 88
ECC versus CONC RE on the mRNA and/or protein levels of atrogin-1, MuRF1, FOXO1, 89
FOXO3A and eIF3-f in human skeletal muscle. Measurements were made before and after i) short-90
term exercise-habituation, ii) single-bout RE, and iii) 12-weeks of hypertrophy-inducing training. A 91
second aim was to also examine the effect of leucine-enriched whey protein hydrolysate (WPH) 92
supplementation combined with RE on the potential single-bout exercise and training-induced 93
changes in mRNA and protein, when compared to a control isocaloric carbohydrate supplement 94
(CHO). We hypothesised that the mRNA and/or protein levels of atrogin-1, MuRF1, FOXO1, 95
FOXO3A and eIF3-f would (1), be regulated to a greater extent in the exercise-habituated fed state 96
following acute unilateral ECC RE, when compared to CONC RE; (2), be attenuated with WPH 97
supplementation following both single-bout unilateral ECC and CONC RE; and (3), be regulated to 98
a greater extent following unilateral ECC hypertrophy-inducing RE training, when compared to 99
other combinations of contraction mode and supplementation.  100
101
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METHODS 102
Ethical approval 103
All subjects were informed about the purpose and risks of the study and provided written informed 104
consent in accordance with the Declaration of Helsinki. The study was approved by the local ethical 105
committee of Region Midtjylland (j. no. M-20110003).106
107
Subjects 108
Twenty four healthy untrained young men (mean ± SEM; height: 181.5 ± 1.5 cm, weight: 78.1 ± 109
1.8 kg, age 23.9 ± 0.8 years, fat % 16 ± 0.9 %) volunteered to participate in the study. Subject 110
criteria to be fulfilled to allow participation in the study comprised; 1) no participation in systematic 111
resistance or high intensity training for lower extremity muscles 6 months prior to inclusion in the 112
study; 2) no history of lower extremity musculoskeletal injuries; 3) no vegan diet or use of dietary 113
supplements or prescription medicine that would potentially influence muscle size. 114
115
Experimental design 116
The complete study included the completion of a 7 day exercise-habituation phase to accustom the 117
subjects to unilateral ECC and CONC muscle contraction, a single-bout exercise trial to investigate 118
acute exercise responses and a 12-week training study to investigate accumulated exercise 119
responses. Among the 24 subjects completing the habituation and acute trials, five subjects dropped 120
out before the training trial was initiated. Another three subjects were recruited and completed the 121
training trial with the remaining 19 subjects.  122
 123
To investigate the acute and accumulated effects of ECC contraction mode versus CONC 124
contraction mode, the two legs of each subject were randomly assigned to ECC or CONC 125
contraction mode. This within-subject design was used to minimize the potential differences in the 126
training response that are inherent with group designs (e.g. initial training status, habitual nutritional 127


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intake and/or hormonal status). Furthermore, to investigate for acute and accumulated exercise-128
induced effects of whey protein hydrolysate (WPH) versus a control isocaloric carbohydrate (CHO) 129
supplement, subjects were randomly divided into two groups of 12 subjects and dietary 130
supplements were provided in a double blinded fashion.  131
 132
An overview of the pre-single-bout trial procedures and the single-bout trial is shown in Fig. 1A. 133
Three days prior to commencing the study, the subjects were asked to abstain from any physical 134
activity other than their normal daily activities. Thereafter, a basal muscle biopsy was obtained 135
from one randomly chosen leg. Three days following the basal muscle biopsy the subjects 136
commenced a period of exercise-habituation. On three occasions during 7 days the subjects 137
completed ECC and CONC exercise on alternate legs using a protocol similar to the single-bout 138
exercise trial. Three days following the completion of the exercise-habituation period muscle 139
biopsies were obtained from both legs after an overnight fast and after at least 30 min of supine rest. 140
These biopsies provided contraction mode specific habituated basal levels for ECC (Basal ECC) 141
and CONC (Basal CONC) exercise. Three days after these biopsies were taken the subjects 142
completed the single-bout exercise trial (see Fig. 1B). Approximately 7 days after the single-bout 143
trial the subjects commenced a 12-week training period. Three days after the last exercise session of 144
the training period a final muscle biopsy was obtained from each leg. 145
146
Exercise-habituation and single-bout exercise protocol  147
All exercise-habituation and the single-bout exercise sessions were conducted using an isokinetic 148
dynamometer (Humac Norm, CSMi Medical Solutions, Stoughton, MA, USA). Exercise consisted 149
of 6 sets of 10 maximal ECC or CONC repetitions at 30 deg s-1 angular velocity with 1 min of 150
recovery between sets. One leg completed all sets of either isolated ECC or CONC exercise. 151
Following this, the alternate leg completed all sets of the alternate mode of contraction; contraction 152
mode was completed in a randomized order. The overall protocol of the single-bout trial is 153

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represented in Fig. 1B. Subjects had been instructed to abstain from physical activity in the days 154
prior to the single-bout trial and arrived after an overnight fast at 08.30 h on the day of the single-155
bout trial. Prior to the exercise session, subjects rested in the supine position for approximately 30 156
min. At 09.00 h subjects commenced the exercise session; the same protocol as used for the 157
exercise-habituation sessions. Immediately after completion of the exercise session the subjects 158
ingested a WPH supplement or control isocaloric CHO supplement (see below). The subjects 159
continued to fast for another 5 h post-exercise (except water ad libitum) and biopsies were obtained 160
from each leg at time points corresponding to 1, 3 and 5 h after exercise. To control for potential 161
effects of circadian rhythm, the absolute daily time points and time resolution of the protocol were 162
strictly adhered to for all subjects.  163
164
Supplementation 165
On the single-bout trail day, immediately after completion of the exercise session, subjects of the 166
WPH group were given a single bolus solution consisting of 0.30 g whey protein + 0.30 g CHO per 167
kilogram lean body mass, while subjects in the CHO supplement group received an isocaloric 168
solution consisting of 0.60 g CHO per kilogram lean body mass. The supplements were diluted in 169
artificially flavored water. The BCAA content of the WPH supplement (produced by Arla Foods 170
Ingredients, Viby J., Denmark) was 27.7 % (leucine 14.2 %, isoleucine 6.6 %, valine 6.9 %), which 171
is considered high compared to standard milk-based whey protein sources (32). On all training 172
days, the subjects in both groups received a fixed amount of the respective supplements. Each 173
intake consisted of an 8 % solution (equal to 663 kJ), with the WPH drink consisting of 19.5 g whey 174
protein + 19.5 g of carbohydrate and the CHO drink consisting of 39 g of carbohydrate. Half of the 175
solution was ingested just before each training session and the other half was ingested immediately 176
after each training session. The subjects were instructed not to eat or drink anything calorie-177
containing for 1½ h prior to and during the 1 h immediately after the exercise session.178
179

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Training protocol  180
The subjects completed 33 exercise sessions over a 12-week training period. Training was aimed to 181
promote muscle hypertrophy and was conducted as a progressive overload RE training program. 182
Exercise training frequency was two to three times per week depending on the progression phase. 183
All exercise sessions commenced with a standardized warm-up consisting of 5 min light bicycling 184
exercise. The load for the ECC leg was aimed at 120 % of CONC loading with a training supervisor 185
assisting to allow isolated exercise modality of the two legs. This corresponded to the approximate 186
strength difference between slow ECC and CONC contractions during isokinetic strength testing 187
(1). Both the ECC and CONC leg training programs consisted of isotonic knee extensions 188
[repetition loading equal to repetition maximum (RM)] with the following set x repetitions; 6 x 10-189
15 RM (sessions 1–4), 8 x 10-15 RM (sessions 5–10), 10 x 10-15 RM (sessions 11–20), 12 x 6–10 190
RM (sessions 21–28), and 8 x 6-10 RM (sessions 29–33) (Technogym-Selection line, Technogym, 191
Italy). Subjects were instructed to perform each repetition in a controlled manner (2 s tempo) during 192
both the CONC and the ECC phase of the exercise with two min of recovery interspaced between 193
sets. Training was supervised by qualified instructors to ensure proper execution and loading.  194
195
Preparation of muscle biopsies 196
Muscle biopsies were obtained from the middle section of the m. vastus lateralis muscle using the 197
Bergström needle technique, with at least 3 cm between incision sites of each biopsy and care taken 198
to reach the identical sampling depth between biopsies. The muscle samples were quickly dissected 199
free of visible fat and connective tissue, weighed and divided into smaller parts for protein and 200
RNA extraction and stored at -80 °C until further investigation.  201
202
Western blot analysis 203
Frozen muscle biopsies (approximately 30 mg) were minced between nitrogen cooled pistons and 204
homogenized in an ice-cold buffer containing: 20 mM Tris–HCl, 50 mM NaCl, 250 mM sucrose, 205


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50 mM NaF, 5 mM Na4P2O7, 1 % Triton x-100, 5 ȝg/ml leupeptin, 1.5 ȝg/ml benzamidine, 500 206
ȝM, PMSF, 50 ȝg/ml soybean trypsin inhibitor, and 2 mM DTT. An automated Precellys 24 (Bertin 207
Technologies, France) bead-based grinder was used for the homogenization. Samples were rotated 208
for 60 min at 4°C and insoluble materials were centrifuged off at 14,000×g for 20 min at 4 °C. Total 209
protein content was determined using the Bradford protein assay kit (BioRad, Hercules, CA, USA). 210
 211
Proteins from whole tissue lysates were separated by SDS-polyacrylamide gel (PAGE) in a buffer 212
containing 12 mM Tris-HCl (pH 8.8), 200 mM glycine and 0.1 % SDS. Proteins were transferred 213
onto an Immobilon-FL PDVF membrane (Millipore, Billerica, MA) in a Bjerrum buffer containing 214
50 mM Tris, 17 mM glycine and 10 % methanol. Membranes were blocked with 5 % BSA in PBS 215
for 1 h at room temperature and were thereafter incubated at 4 °C overnight with the following 216
primary antibodies (diluted in 5 % BSA in PBS): MuRF1 (MP3401, ECM Biosciences, Versailles, 217
KY) at 1:1000; FOXO1 (C29H4, Cell Signaling Technology, Danvers, MA) at 1:500; FOXO3A 218
(ab17026, Abcam, Cambridge, MA, USA) at 1:500; and eIF3-f (Jomar Bioscience, Adelaide, 219
Australia) at 1:500. Membranes blocked with 5 % BSA in TBST for 1 h at room temperature were 220
thereafter incubated at 4 °C overnight with the following primary antibodies (diluted in 5 % BSA in 221
TBST): phospho-FOXO1 (Ser256, 9461, Cell Signaling Technology, Danvers, MA) at 1:500; and 222
phospho-FOXO3A (Ser253, 9466, Cell Signaling Technology, Danvers, MA) at 1:400. Following 223
overnight primary antibody incubation, membranes were washed with either PBS or TBST (4 u 5 224
min) and were subsequently incubated for 1 h with the following infrared-fluorescent conjugated 225
secondary antibodies, diluted at 1:5000 in PBS or TBST, containing 50 % Odyssey® Blocking 226
Buffer (LI-COR Biosciences, Lincoln, USA) and 0.01 % SDS: IRDye 800CW goat anti-rabbit IgG 227
(LI-COR Biosciences, Lincoln, USA) for MuRF1, phospho-FOXO1, phospho-FOXO3A, FOXO1, 228
and eIF3-f; IRDye 800CW donkey anti-goat IgG (LI-COR Biosciences, Lincoln, USA) for 229
FOXO3A; and Alexa Fluor® 680 rabbit anti-mouse IgG (Invitrogen, Carlsbad, CA) for GAPDH. 230
Following another series of washing, proteins were exposed using the Odyssey® Infrared Imaging 231

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System (LI-COR Biosciences, Lincoln, USA) and individual protein band optical densities were 232
quantified using Odyssey® Infrared Imaging System software. To control for protein loading, all 233
blots were normalized against GAPDH protein (G8795, Sigma-Aldrich, Sydney, Australia). The 234
specificity of the MuRF1 antibody was established and results are shown in Supplementary Fig. 1.  235
236
RNA extraction and real-time PCR 237
Total RNA (from approximately 20 mg of muscle) was extracted using the guanidinium 238
thiocyanate-phenol-chloroform extraction method, as previously described (13) and the 239
concentration was determined spectrophotometrically using a Nanodrop 1000 (Thermo Fischer 240
Scientific, Wilmington, DE, USA). One μg of RNA was reverse transcribed to cDNA using High 241
Capacity RNA-to-cDNA kit (Applied Biosystems, Forster City, CA) according to manufacturer’s 242
protocol. Prior to PCR, 1 μL ribonuclease H (RNase H) (Life Technolgies, Mulgrave, VIC) was 243
added to each sample and incubated at 37 °C for 30 min. Real-time PCR was performed using the 244
Stratagene MX3000 PCR system (Agilent Technologies, Santa Clara, CA). All PCR runs were 245
performed in triplicate with reaction volumes of 20 μl, containing Fast SYBR® Green Master Mix 246
(Life Technolgies, Mulgrave, VIC), forward and reverse primers, and cDNA template. To 247
compensate for variations in input RNA amounts and efficiency of the reverse transcription, data 248
was normalized to large ribosomal protein PO (RPLPO, 36B4) mRNA. PCR primer sequences are 249
provided in Table 1. PCR conditions for the amplified genes have been published previously (39).  250
251
Muscle cross-sectional area 252
Magnetic resonance imaging (MRI) of thigh muscle was performed with a 1.5-T scanner (Philips 253
Achieva, Best, the Netherlands), as previously described (20). Subjects were seated in a resting 254
position for 30–45 min before entering the scanner and were instructed not to move when lying in 255
the scanner. A minimum of 48–72 h was interspaced between the last training session and MRI 256
scanning to minimize the risk of fluids shift. The MRI scans were performed on both legs using 257

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either the body coil for muscle CSA. The later offline analyses were conducted using a free 258
software program (Osirix, 4.1.1, Osirix Foundation, Geneva, Switzerland). After an initial frontal 259
survey scan, 50 transversal slices were acquired, of which only three were used for the present 260
study. The first slice was 70 mm proximal to the distal part of the femur condyles and the other 261
slices were acquired proximally from this point. AT1-weighted, fast spin echo sequence with the 262
following parameters was used: scan matrix = 576 x 576, field of view = 46 x 46 cm, number of 263
slices = 50, slice thickness = 7 mm, slice gap = 3 mm, repetition time = 2 s, echo train length = 18, 264
number of signal averages = 2, TR = 500 ms, TE = 6.2 ms, and pixel size = 0.8 x 0.8 mm. From the 265
frontal and transverse scans, the femur length (from the femur condyles to the apex of the 266
trochanter) was calculated. Following this, the knee extensor muscle CSA (mm. vastus lateralis, 267
vastus medialis, vastus intermedius, and rectus femoris) was manually outlined at ½ of the femur 268
length representing mid-thigh level. All analyses were conducted by an investigator blinded with 269
regards to intervention (supplementation and contraction mode).  270
271
Isometric strength performance 272
Subsequent to a standardized warm-up consisting of 5 min low intensity exercise on a stationary 273
ergometer cycle (Monark, Varberg, Sweden), the subjects were seated in an isokinetic 274
dynamometer (Humac Norm, CSMI, Stoughton, USA) with 90q hip flexion and restraining straps 275
crossing the torso and tested leg. Both legs were tested since they were trained differently and the 276
test order was randomized between the ECC and CONC leg. The transverse axis of the subject’s 277
knee was aligned with the axis of the dynamometer. The test leg was attached to the dynamometer 278
arm while the other leg was placed behind a stabilization bar. The dynamometer was adjusted 279
individually so the contact point between the subjects’ leg and the dynamometer arm was 3 cm 280
proximal to the malleolus medialis. 281
 282

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Maximal voluntary contraction (MVC) was measured at 70 deg knee flexion (0 deg equals full 283
extension). Before starting the test the subject’s lower leg was weighed to enable gravity correction 284
of the measured torque. The subject was allowed four trials (however, if a subject continued to 285
improve, additional trials were provided) and all contractions were interspaced with one min 286
recovery time. MVC was determined as the highest peak torque from the best of the four trials. 287
 288
Statistical analyses 289
Power analysis was calculated for the change in gene and protein expression, as these dependent 290
variables tend to have a lower magnitude of change and higher variability following exercise 291
interventions compared to other dependent variables measured.  From our previous experience we 292
expected a variation of about 20-30% of the mean for all groups. With an alpha level set at P < 0.05 293
and a required power set at 0.8 we calculated that 12 subjects per group would be required to detect 294
a change of 20-25 %.  295
 296
Data are presented as mean fold change + standard error of the mean (SEM). All statistical analyses 297
were performed using IBM SPSS Statistics 20 (SPSS Inc., Chicago, IL, USA).  For all statistical 298
tests P < 0.05 was considered significant.  The effect of time (pre versus post), group (WPH versus 299
CHO) and contraction mode (ECC versus CONC) and their interactions on quadriceps CSA and 300
MVC were assessed using a mixed-effect three-way ANOVA with repeated measures for time.  301
 302
Post-habituation mRNA and protein levels were normalized to pre-habituation basal levels (no 303
supplement intervention during exercise-habituation) and were analyzed for effect of contraction 304
mode only using one-way repeated measures ANOVA.  305
 306
Post-single-bout mRNA and protein levels were normalized to post-habituation basal levels and 307
analyzed for contraction mode (ECC versus CONC) x supplement type (WPH versus CHO) x time 308



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using the mixed-effect three-way analysis of variance (ANOVA) with repeated measures for time. 309
As no effects of dietary supplementation type was observed during the single-bout exercise trial, 310
data were merged by supplementation and the effects of contraction mode x time were assessed 311
using two-way repeated measures ANOVA.  312
 313
Post-training protein levels were normalized to pre-habituation basal levels and were shown to be 314
independent of dietary supplementation type. Accordingly, both exercise and training changes were 315
analyzed for effect of contraction mode using a one-way repeated measures ANOVA.  316
 317
When a significant effect of contraction mode and/or time was found, significant pairwise 318
differences were assessed using the Student–Newman–Keuls post hoc test. 319
320
RESULTS 321
Effect of exercise-habituation  322
When compared to basal levels, habituation for isolated ECC and CONC exercise increased 323
atrogin-1 mRNA by 50 ± 8 % and 70 ± 9 %, respectively, (P < 0.05; Fig. 2A), while MuRF1 mRNA 324
increased by 40 ± 9 % with CONC only (P < 0.05; Fig. 2B). Additionally, habituation exercise 325
increased FOXO1 mRNA by 28 ± 8 % (P < 0.01) and 41 ± 8 % (P < 0.0001), respectively (Fig. 2C) 326
and FOXO3A mRNA by 42 ± 13 % and 48 ± 13 % following ECC and CONC exercise, 327
respectively (P < 0.01; Fig 2D).328
329
No change was observed in MuRF1 protein levels (Fig. 3A). The protein levels of the atrogin-1 330
substrate, eIF3-f, increased by 34 ± 13 % following CONC exercise (P < 0.05; Fig. 3B). Total 331
FOXO1 protein levels increased by 30 ± 14 % and 36 ± 14 %, respectively (P < 0.05; Fig. 3C), 332
while phospho-FOXO1 protein levels increased by 28 ± 8 % (P < 0.01) and 41 ± 8 % (P < 0.0001), 333
respectively following ECC and CONC habituation exercise (Fig. 3D). No change was observed for 334

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FOXO3A (Fig. 3E) or phospho-FOXO3A protein (Fig. 3F). Representative examples of Western 335
blots for all protein targets are shown in Fig. 4. A summary of gene and protein results following 336
exercise-habituation are shown in Table 2.  337
338
Effect of single-bout exercise, following exercise-habituation 339
There were no effects of WPH supplementation on any of the mRNA or protein targets measured 340
during the single-bout exercise trial (data not shown). Following ECC and CONC exercise-341
habituation, the effects of single-bout ECC and CONC exercise was investigated.  When compared 342
to basal levels, ECC, but not CONC exercise, decreased atrogin-1 mRNA levels by 52 ± 8 % at 343
both 3 and 5 h post-exercise (P < 0.0001; Fig. 5A). Following both ECC and CONC exercise 344
MuRF1 mRNA levels were increased at 1 h by 49 ± 13 % (P < 0.001) and 54 ± 15 % (P < 0.01), 345
respectively (Fig. 5B). MuRF1 mRNA expression was further increased at 3 h by 74 ± 14 % (P < 346
0.0001; Fig. 5B) in the CONC group only. CONC, but not ECC exercise, increased FOXO1 mRNA 347
at 3 h (53 ± 12 %; P < 0.001) and 5 h post-exercise (34 ± 12 %; P < 0.01) (Fig 5C). In contrast, 348
following ECC, but not CONC exercise, FOXO3A mRNA was decreased 3 h and 5 h post exercise 349
by 22 ± 8 % (P < 0.01) and 51 ± 8 % (P < 0.0001) respectively (Fig 5D). 350
 351
No alterations in MuRF1 protein were observed following ECC or CONC exercise (Fig. 6A). When 352
compared to basal, eIF3-f protein level was reduced by 30 ± 8 % (P < 0.01) at 5 h post CONC-353
exercise only (Fig. 6B). Both CONC and ECC exercise downregulated the total FOXO1 protein by 354
39 ± 11 % and 36 ± 11 %, respectively (P < 0.01) at 5 h (Fig 6C). Phospho-FOXO1 protein was 355
reduced by 19 ± 6 % 5 h post-ECC exercise, but not CONC exercise (P < 0.01; Fig. 6D). CONC 356
exercise only downregulated FOXO3A protein by 20 ± 7 % at 5 h post-exercise (P < 0.05; Fig. 6E), 357
although the response to ECC exercise was similar. ECC, but not CONC exercise, downregulated 358
phospho-FOXO3A protein levels 5 h post exercise (26 ± 8 %) (P < 0.01; Fig 6F). A summary of 359
gene and protein results following single-bout exercise are shown in Table 2. 360

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Effect of training, without and with whey protein supplementation 361
We have previously reported in more detail the effect of contraction mode specific training and 362
WPH supplementation on total volume load of work (i.e. repetitions x sets x load accomplished 363
during training), quadriceps cross sectional area (CSA) and maximal voluntary contraction (MVC) 364
in this cohort (20). Briefly, total volume load for the ECC trained leg was 11 ± 0.8 % and 10.3 ± 0.8 365
% higher than for the CONC trained leg in the WPH and CHO groups respectively (P < 0.001). 366
There was no difference between the groups in total volume load. A group x time interaction was 367
observed (P < 0.001) for quadriceps CSA, whereby WPH supplementation combined with either 368
ECC or CONC training had the greater effect on mid-level quadriceps CSA compared to CHO 369
supplementation (P < 0.01). Accordingly, in the WPH supplementation group, ECC and CONC 370
training increased quadriceps mid-level CSA by 8.3 ± 1.3 % and by 6.2 ± 1.4 %, respectively (P < 371
0.001), with no difference observed between contraction modes. In the CHO group, ECC and 372
CONC training increased quadriceps mid-level CSA by 2.7 ± 1.1 % and 4 ± 1.0 %, respectively (P 373
< 0.01); with no differences observed between contraction modes. MVC increased by 12.4 ± 3.5% 374
and 19.0 ± 6.4% (P < 0.001) over time, for WPH and CHO, respectively, with no differences 375
between groups or between contraction modes. 376
 377
No measurements of mRNA levels were made after training. There were no effects of WPH 378
supplementation on any of the protein targets measured following training (data not shown); 379
therefore data were pooled and grouped according to exercise contraction mode. Following ECC 380
training, the level of phospho-FOXO1 protein increased by 72 ± 13 % (P < 0.0001) compared to 381
basal and 62 ± 13 % (P < 0.001) compared to CONC training (Fig. 7). No changes were observed 382
on the levels of MuRF1, eIF3-f, FOXO1, FOXO3A and phospho-FOXO3A protein levels following 383
ECC and CONC training (Fig. 5). A summary of the protein results following RE training are 384
shown in Table 2.  385
386

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DISCUSSION 387
Atrogin-1 and MuRF1 are involved in MPB and believed to play an important role in muscle 388
wasting in disease conditions (5, 27). Atrogin-1 and MuRF1, and their transcriptional regulators 389
FOXO1 and FOXO3A, are expressed in non-diseased skeletal muscle suggesting they play a role in 390
maintaining muscle homeostasis in healthy muscle. RE is a positive regulator of muscle health and 391
regulates atrogin-1, MuRF1, FOXO1 and FOXO3A mRNA levels, although this appears to depend 392
on the type of exercise and the contraction mode employed. To better understand the exercise-393
induced regulation of these atrophy targets we employed unilateral isolated ECC or CONC exercise 394
tasks. This permitted us to investigate the effects of contraction mode on atrogin-1, MuRF1, 395
FOXO1, FOXO3A and eIF3-f following (1) exercise-habituation, (2) single-bout exercise and (3) 396
prolonged training. Furthermore, we investigated the effect of WPH supplementation combined 397
with both ECC and CONC exercise. Atrogin-1, MuRF-1, FOXO1, FOXO3A and eIF3-f mRNA 398
and/or protein were sensitive to single-bout RE in the exercise-habituated state, in a contraction 399
mode dependent manner. An acute downregulation of phospho-FOXO1 and phospho-FOXO3A 400
occurred independently of contraction mode. Prolonged hypertrophy-inducing ECC and CONC 401
exercise training resulted in muscle hypertrophy; a response that was augmented with WPH 402
supplementation. However atrogin-1, MuRF-1, FOXO1, FOXO3A and eIF3-f were not sensitive to 403
WPH supplementation.  404
405
Effect of exercise-habituation  406
Unaccustomed exercise, especially ECC RE, inflicts muscle damage (44, 59). In a non-exercise-407
habituated muscle it may be difficult to distinguish between the effects of muscle-damaging 408
exercise and exercise-stimulated responses of our mRNA and protein targets. To reduce this 409
potential confounding effect, the subjects completed three exercise sessions over a 7 day period 410
followed by three days of recovery, prior to conducting the single-bout protocol. Exercise-411
habituation increased basal level of atrogin-1, FOXO1 and FOXO3A mRNA levels, independently 412

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of the mode of muscle contraction. MuRF1 mRNA levels and eIF3-f protein levels increased only 413
following CONC exercise-habituation. No changes in MuRF1 protein levels were observed. Total 414
and phosphorylated FOXO1 protein increased in parallel with the mRNA levels. In contrast, total 415
and phosphorylated FOXO3A protein levels did not change. This may be explained by insufficient 416
accumulated stimulation or by auto-ubiquitination that can occur for ubiquitin-ligases (54). 417
Accordingly, as we have shown previously (60), short-term exercise-habituation is able to regulate 418
the basal level of many target mRNAs and proteins. It supports the need to consider appropriate 419
familiarisation procedures for human exercise study designs. This would increase the ability to 420
distinguish between true exercise-induced responses and responses due to other stressors inherent to 421
an exercise study protocol itself.  422
 423
Effect of single-bout resistance exercise and whey protein supplementation 424
Following the habituation phase, the subjects completed a single-bout of unilateral ECC versus 425
CONC RE with WPH or CHO supplementation. No effects of WPH supplementation were 426
observed on any of the mRNA and protein targets measured which supports several recent 427
publications (17, 31, 51). The supplement groups were therefore combined and provided a very 428
large sample size of 24 individual legs per exercise group. Atrogin-1 mRNA decreased with ECC 429
exercise, while MuRF1 mRNA increased with CONC exercise. Interestingly, FOXO1 mRNA was 430
increased following ECC exercise, while FOXO3A was decreased following CONC exercise. Our 431
contraction mode-specific RE changes in atrogin-1, MuRF1, FOXO1 and FOXO3A support 432
previous observations following conventional RE (44, 57). The regulation of atrogin-1 mRNA may 433
be associated with the mechanical stress specifically characteristic of ECC exercise (e.g. stretch-434
induced damage of sarcomeric protein), whereas the regulation of MuRF1 mRNA may be related to 435
the metabolic stress specifically characteristic of CONC exercise (e.g. increased turnover of 436
metabolic enzymes).   437
 438

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MuRF1 protein levels did not change following single-bout exercise and were not influenced by 439
WPH supplementation. This is in contrast to an observed increase in MuRF1 protein 3 h following 440
conventional RE and an attenuation when combined with BCAA supplementation (9). This 441
discordance in results may be an effect of our subjects completing the exercise-habituation phase. 442
Atrogin-1 protein levels were not shown, as we were not convinced of the specificity of the 443
commercially available antibodies. Therefore, we measured the protein levels of an atrogin-1 444
substrate involved in protein synthesis, translation initiation factor, elongation initiation factor 3 445
subunit 5 (eIF3-f) (38). EIF3-f protein levels were not influenced by ECC exercise, but decreased 446
with CONC exercise. Decreasing atrogin-1 may release basal suppression on muscle protein 447
synthesis related processes, thereby contributing to a net gain in muscle protein accretion. However 448
this requires experimental validation. The downregulation of the eIF3-f protein 5 h following 449
CONC exercise appears counterintuitive, considering this exercise stress increases muscle protein 450
synthesis. Decreasing eIF3-f may be an indication that muscle protein synthesis had reached its 451
peak and was beginning to return to basal levels.  It is also possible that the atrogin-1/eIF3-f 452
regulatory relationship does not exist in human muscle following single-bout exercise and it is not 453
within the scope of this study to establish such as possibility. 454
 455
Following single-bout ECC exercise, phospho-FOXO1 and phospho-FOXO3A levels were 456
decreased. Dephosphorylation of FOXO transcription factors allows their translocation to the 457
nucleus (8) where they regulate MuRF1 and atrogin-1 gene expression in rodents (55). The decrease 458
in atrogin-1 mRNA and associated decrease in phospho-FOXO1 and phospho-FOXO3A levels 459
following ECC exercise does not support this relationship in human muscle following exercise. It is 460
possible that other transcription factors are involved in the exercise-induced regulation of atrogin-1 461
gene expression. For example, the JunB transcription factor can prevent FOXO3A binding to the 462
atrogin-1 promoter (49). Although speculative, the exercise performed in the present study may 463
have stimulated a JunB inhibition of the phospho-FOXO3A regulation of atrogin-1 gene expression. 464


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PGC1Į can also inhibit the FOXO transcriptional activation of atrogin-1 (11, 21) and potentially 465
may have played a role during this single-bout exercise trial.  466
467
Effect of resistance exercise training and whey protein supplementation 468
Following the single-bout exercise trials, participants completed 12-weeks of unilateral ECC versus 469
CONC RE training. Additionally, subjects received a WPH supplement or an isocaloric CHO. In 470
line with previous findings, our RE training program resulted in an increase in muscle hypertrophy 471
that was associated with an increase in muscle strength (2, 28). In regards to WPH supplementation, 472
we found that RE training-induced muscle hypertrophy was augmented with WPH 473
supplementation; an observation previously found by some (2, 28), but not others (31). While WPH 474
supplementation augmented muscle hypertrophy, there was no further increase in MVC. A lack of 475
consistency between training-induced changes in hypertrophy and strength has been observed 476
previously (2, 28, 31, 43) and is in part explained by the influence exerted by complex 477
neuromuscular interactions also affecting muscle strength (24). 478
An increase in basal level phospho-FOXO1 was observed following ECC training only, suggesting 479
a potential reduction in basal active FOXO1 protein post-training. No ECC or CONC training-480
induced changes were observed for any of the other protein targets measured. Eight weeks of 481
traditional hypertrophy-inducing RE training has been shown to increase atrogin-1 protein and 482
decrease nuclear FOXO1 protein levels (39). Nuclear fractionation analysis in the present study 483
may have provided us with an opportunity to more precisely evaluate the potentially activity of the 484
FOXO proteins.  485
 486
Limitations 487
In the present study we investigated the effects of ECC versus CONC RE training that was matched 488
for equal relative intensity. As elegantly shown by Eliasson and co-workers (2006) (19), the 489
maximal absolute intensity inherent to ECC, when compared with CONC exercise, may be the most 490

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important factor initiating intracellular signalling. Increasing the ECC training load and therefore its 491
maximal absolute intensity might have allowed the detection of additional significant changes in 492
some of our intracellular targets. With this in mind, the work by Eliasson et al. investigated 493
Akt/mTOR signalling in the fasted stated, while the current study investigated the FOXO, atrogin-1 494
and MuFR1 targets in the fed state. The sensitivity of dietary conditions, especially towards specific 495
amino acids, on Akt/mTOR signalling may be very different than the sensitivity of the 496
FOXO/atrogin-1/MuFR1 signalling components. Another limitation of this work is the lack of a 497
non-caloric control group. This group was excluded for practical reasons. Finally, it could be argued 498
that our protocol did not account for daily protein intake, an important parameter in any 499
supplementation intervention. During the recovery phase following the single-bout exercise session, 500
the subjects received nothing but the supplement to avoid any confounding effect of additional 501
protein or carbohydrate intake. During the training period, the subjects were instructed to not ingest 502
additional calories for 90 min prior to and during the 60 min following each exercise session, 503
although total daily protein or carbohydrate intake was not controlled. However, previously 504
published data from this study demonstrate that with the WPH supplementation, the subjects 505
developed significantly larger muscle as well as interconnected tendon hypertrophy (20), which 506
support the hypothesis that habitual daily protein intake did not overrule net hypertrophy.  507
508
Conclusion 509
This study investigated the effect of isolated ECC and CONC exercise on members of the 510
FOXO/atrogin-1/MuRF1 signaling-axis. Exercise was performed following exercise-habituation as 511
a single-bout trial or as training and combined with WPH supplementation. Our results suggest the 512
following: (1) that exercise-habituation prior to investigating the acute responses on exercise-513
induced FOXO/atrogin-1/MuRF1 regulation be employed; (2) that atrogin-1 and MuRF1 mRNA 514
levels are regulated in a contraction mode-dependent manner; (3) a discordance between patterns of 515
FOXO phosphorylation and atrogin-1/MuRF1 mRNA levels, as well as discordance between acute 516



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and chronic responses, suggests other regulatory factors may influence the exercise-induced 517
regulation of atrogin-1 and (4) that FOXO1, FOXO3A, atrogin-1 and MuRF1 are not sensitive to 518
WPH supplementation following single bout exercise performed following habituation and during 519
hypertrophy-inducing exercise. 520
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531
Fig. 1. Exercise-habituation and single-bout exercise protocols 532
A) Exercise-habituation protocol: Three days prior to obtaining a pre-exercise-habituation biopsy, 533
subjects refrained from exercise (-3 days). A pre-exercise-habituation biopsy (arrow) was then 534
obtained from a randomly selected leg (0 days). Subjects then recovered for three days prior to 535
initiation of the exercise-habituation period (3 days). The exercise-habituation period included 3 536
exercise sessions during a 7 day period, with 48 h interspacing each exercise session. Exercise 537
sessions were conducted as 6 sets of 10 maximal ECC or CONC repetitions at 30 deg s-1 angular 538
velocity, with 1 min of recovery between sets (10-13 days). Three days of recovery was then 539
interspaced prior to obtaining post-exercise-habituation biopsies (13 days). Another 3 days of 540
recovery were then interspaced before completion of the single-bout exercise trial (16 days). All 541
pre- and post-habituation biopsies were obtained after an overnight fast.  B) Single-bout-exercise 542



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protocol: After an overnight fast, the subjects reported to the laboratory at 08.30 h (-1 h). After 30 543
min of supine rest (-½ to 0 h), subjects completed a single-bout exercise session, conducted exactly 544
as during exercise-habituation. Immediately after exercise, a whey protein hydrolysate (WPH) or a 545
control isocaloric carbohydrate (CHO) supplement was ingested (0 h) and during the post-exercise 546
recovery, biopsies were obtained at 1, 3, and 5 h from both ECC and CONC exercised legs.  547
 548
Fig. 2.  Effect of exercise-habituation on mRNA expression 549
Contraction mode-specific effects (ECC versus CONC) of exercise-habituation (pre-habituation 550
basal versus post-habituation basal) are shown as fold change ± SEM from basal set to a fixed value 551
of 1 for: atrogin-1 (A); MuRF1 (B); FOXO1 (C) and FOXO3A (D).  552
Different from basal pre-habituation. * P < 0.05, ** P < 0.01, *** P < 0.001, ****, P < 0.0001.  553
554
Fig. 3.  Effect of exercise-habituation on protein expression 555
Contraction mode-specific effects (ECC versus CONC) of exercise-habituation (pre-habituation 556
basal versus post-habituation basal) are shown as fold change ± SEM from basal set to a fixed value 557
of 1 for: MuRF1 (A); eIF3-f (B); FOXO1 (C); phospho-FOXO1 (D); FOXO3A (E) and phospho-558
FOXO3A. Different from basal pre-habituation. * P < 0.05, ** P < 0.01, ****, P < 0.0001. 559
 560
Fig. 4.  Examples of Western blots  561
Examples of representative Western blots are shown for MuRF1 (A); eIF3-f (B); FOXO1 (C); 562
phospho-FOXO1 (D); FOXO3A (E); phospho-FOXO3A (F) and GAPDH (G) (normalizing 563
protein) for contraction mode-specific effects of exercise-habituation and single-bout exercise. 564
 565
Fig. 5.  Effect of single-bout exercise on mRNA expression 566
Contraction mode-specific effects (ECC versus CONC) of single-bout exercise (post-habituation 567
basal versus post-exercise recovery time points) are shown as fold change ± SEM from basal set to 568



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a fixed value of 1 for: atrogin-1 mRNA (A); MuRF1 mRNA (B); FOXO1 mRNA (C); FOXO3A 569
mRNA (D). Different from basal post-habituation. ** P < 0.01, *** P < 0.001, ****, P < 0.0001. 570
Difference between contraction modes, ## P < 0.01, ### P < 0.001, #### P < 0.0001. 571
 572
Fig. 6.  Effect of single-bout exercise on protein expression 573
Contraction mode-specific effects (ECC versus CONC) of single-bout exercise (post-habituation 574
basal versus post-exercise recovery time points) are shown as fold change ± SEM from basal set to 575
a fixed value of 1 for: MuRF1 (A); eIF3-f (B); FOXO1 (C); phospho-FOXO1 (D); FOXO3A (E) 576
and phospho-FOXO3A (F). Different from basal post-habituation. * P < 0.05, ** P < 0.01. 577
Difference between contraction modes, # P < 0.05, ## P < 0.01. 578
579
Fig. 7. Training-induced changes in protein expression 580
Contraction mode-specific effects (ECC versus CONC) of 12-weeks training (pre-habituation basal 581
versus post-training basal) are shown as fold change ± SEM from basal set to a fixed value 1 for, 582
phospho-FOXO1 (A). Different from basal pre-habituation. **** P < 0.0001. Difference between 583
contraction modes, ### P < 0.001. 584
 585
 586
 587
 588
 589
 590
 591
 592
 593
 594

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Table. 1.  Primer and probe sequences used for PCR analysis 595
Gene  Sequences
Atrogin-1 Forward GCAGCTGAACAACATTCAGATCAC 
Reverse CAGCCTCTGCATGATGTTCAGT 
Probe (FAM)-CTTCAAAGGCACCTTCACTGACCT G(BHQ-1) 
MuRF1 Forward CCTGAGAGCCATTGACTTTGG 
Reverse CTTCCCTTCTGTGGACTCTTCCT 
Probe (Texas Red)-AGGAAGAATTCATTGAAGAAGAAGATCAGG(BHQ-2) 
FOXO1 Forward AAGAGCGTGCCCTACTTCAA 
Reverse CTGTTGTTGTCCATGGATGC 
FOXO3A Forward CTTCAAGGATAAGGGCGACA 
Reverse TCTTGCCAGTTCCCTCAT T 
RPLPO Forward TCTACAACCCTGAAGTGCTTGATATC 
Reverse GCAGACAGACACTGGCAACATT 
________________________________________________________________________________________________________________________ 596
Atrogin-1, muscle atrophy F-box; MuRF1, muscle ring finger-1; FOXO1, forkhead transcription factor-1; FOXO3A, 597
forkhead transcription factor-3; RPLPO, ribosomal protein, large, PO. 598
599
600
601
602
603
604
605
606
607
608
609
610

 
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Skeletal muscle atrophy is a critical component of the ageing process. Age-related muscle
wasting is due to disrupted muscle protein turnover, a process mediated in part by the
ubiquitin proteasome pathway (UPP). Additionally, older subjects have been observed
to have an attenuated anabolic response, at both the molecular and physiological levels,
following a single-bout of resistance exercise (RE). We investigated the expression levels
of the UPP-related genes and proteins involved in muscle protein degradation in 10 older
(60–75 years) vs. 10 younger (18–30 years) healthy male subjects at basal as well as
2 h after a single-bout of RE. MURF1, atrogin-1 and FBXO40, their substrate targets
PKM2, myogenin, MYOD, MHC and EIF3F as well as MURF1 and atrogin-1 transcriptional
regulators FOXO1 and FOXO3 gene and/or protein expression levels were measured via
real time PCR and western blotting, respectively. At basal, no age-related difference was
observed in the gene/protein levels of atrogin-1, MURF1, myogenin, MYOD and FOXO1/3.
However, a decrease in FBXO40 mRNA and protein levels was observed in older subjects,
while PKM2 protein was increased. In response to RE, MURF1, atrogin-1 and FBXO40
mRNAwere upregulated in both the younger and older subjects, with changes observed in
protein levels. In conclusion, UPP-related gene/protein expression is comparably regulated
in healthy young and old male subjects at basal and following RE. These ﬁndings suggest
that UPP signaling plays a limited role in the process of age-related muscle wasting.
Future studies are required to investigate additional proteolytic mechanisms in conjunction
with skeletal muscle protein breakdown (MPB) measurements following RE in older vs.
younger subjects.
Keywords: skeletal muscle, resistance exercise, muscle protein breakdown, ubiquitin-proteasome, atrogene
signaling
INTRODUCTION
Maintaining skeletal muscle mass is a critical component of health
and sustaining life. Age-related skeletal muscle wasting is a prefer-
ential loss of type II muscle ﬁbers (Lexell and Taylor, 1991; Lexell,
1995; Kadi et al., 2004; Verdijk et al., 2007), resulting in a pro-
gressive decline in muscle mass, strength and function (Evans,
1995b; Deschenes, 2004). On average, 0.5–1.0% of muscle mass
is lost per year from 40 years of age, with the loss of muscle
mass rapidly increasing after 65 years of age (Greenlund and
Nair, 2003). Age-related muscle wasting reduces functional inde-
pendence (Cooper, 1997) and increases the risk of falls, chronic
metabolic disease (obesity, type 2 diabetes) (Park et al., 2006) and
ultimately, mortality (Mahoney et al., 1994; Newman et al., 2006).
A better understanding of the molecular mechanisms involved
in the decline of muscle mass as we age is therefore required
to aid the development of effective countermeasures to prevent,
attenuate and/or reverse this process.
In healthy individuals, muscle mass is maintained via the
ﬁnely regulated balance existing between muscle protein synthe-
sis (MPS) and muscle protein breakdown (MPB). An increase
in muscle mass is largely due to an increase in the size of
pre-existing muscle ﬁbers via net accretion of muscle sarcoplas-
mic and myoﬁbrillar proteins (Goldberg, 1969; Roman et al.,
1993; Staron et al., 1994; Mccall et al., 1996). In contrast, the
ubiquitin proteasome pathway (UPP) is one of the major mecha-
nisms responsible for human MPB (Passmore and Barford, 2004;
Sandri, 2013). The muscle-speciﬁc E3-ubiquitin ligases, muscle
ring ﬁnger-1 (MURF1) and atrogin-1 [muscle atrophy F-box
(MAFbx), FBXO32] (Bodine et al., 2001; Gomes et al., 2001)
are transcriptionally regulated by Forkhead box O (FOXO) fam-
ily members, FOXO1 and FOXO3 (Brunet et al., 1999; Sandri
et al., 2004; Stitt et al., 2004). Known substrate targets of MURF1
include pyruvate kinase M2 (PKM2) (Hirner et al., 2008) and
myosin heavy chain (MHC) (Clarke et al., 2007; Fielitz et al.,
2007; Cohen et al., 2009), whereas known substrate targets
of atrogin-1 include elongation initiation factor 3 subunit 5
(EIF3F) (Lagirand-Cantaloube et al., 2008), MYOD (Tintignac
et al., 2005) and myogenin (MYOG) (Jogo et al., 2009). These
substrate targets are proteins involved in biological processes
essential to muscle health and function, such as MPS (EIF3F),
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(Lagirand-Cantaloube et al., 2008), development and regenera-
tion (MYOD and MYOG) (Tintignac et al., 2005; Jogo et al.,
2009), metabolism (PKM2) (Hirner et al., 2008) as well as struc-
ture and contraction (MHC) (Clarke et al., 2007; Fielitz et al.,
2007; Cohen et al., 2009).
Resistance exercise (RE) training increases muscle mass,
strength and function (Roman et al., 1993; Staron et al., 1994;
Hortobagyi et al., 1996; Mccall et al., 1996; Wernbom et al., 2007)
and is often used as an intervention to improve muscle functional
capacity (Evans, 1995a). The principal response after a single-
bout of RE is a rapid (within 2–4 h) transient increase in MPS,
particularly in myoﬁbrillar MPS (Phillips et al., 1997). However,
MPB also increases following RE, albeit to a lesser extent and of
a shorter-lived duration than MPS (Biolo et al., 1995; Phillips
et al., 1997). While the aetiology of aged-related muscle atrophy
is multifactorial, a disruption in the regulation of skeletal mus-
cle protein turnover seems to play a major role (Boirie, 2009).
Despite early reports of a large decrease in the basal rate of MPS
(Welle et al., 1993, 1995; Balagopal et al., 1997; Hasten et al., 2000)
and a large increase in the basal rate of MPB (Trappe et al., 2004)
in older compared to younger individuals, recent studies demon-
strate little or no signiﬁcant difference in basal MPS and MPB
between older vs. younger individuals (Volpi et al., 1999, 2000,
2001; Hasten et al., 2000; Paddon-Jones et al., 2004; Cuthbertson
et al., 2005; Katsanos et al., 2005, 2006; Rasmussen et al., 2006;
Kumar et al., 2009). RE-induced stimulation of MPS occurs in
both younger and older individuals (Yarasheski et al., 1993; Welle
et al., 1994; Volpi et al., 1999; Hasten et al., 2000; Shefﬁeld-Moore
et al., 2004), but with an attenuated magnitude in older individ-
uals (Kumar et al., 2009); a phenomenon referred to as anabolic
resistance. However, the regulation of MPB in older vs. younger
individuals in response to RE and how this may contribute to
anabolic resistance is not well deﬁned. In particular, the gene and
protein expression pattern of the members of the UPP pathway
at rest and following RE in older and younger individuals has
received little attention to date. Such investigations will provide a
better understanding of the activation and regulation of the UPP
pathway in older vs. younger individuals. A greater activation of
the proteolytic markers in older subjects may indicate an increase
in MPB; a phenomenon that might therefore contribute to the
attenuated MPS response characteristic of anabolic resistance.
Conﬂicting results have been observed in the age-related
mRNA regulation of MURF1 and atrogin-1 (FBXO32), sugges-
tive of gender, muscle type and species inﬂuences (rodent vs.
human muscle). Compared to younger rodent muscle, studies
have shown that baseline MURF1 and atrogin-1 mRNA levels in
aged rodents increase in the tibialis anterior (Clavel et al., 2006),
decrease in the gastrocnemius muscle (Edstrom et al., 2006) or
do not differ in the extensor digitorum longus and soleus muscle
(Gaugler et al., 2011). In humans, some studies ﬁnd an increase in
MURF1 baseline mRNA expression in older muscle compared to
younger muscle (Raue et al., 2007; Dalbo et al., 2011; Merritt et al.,
2013), while other groups report no differences (Welle et al., 2003;
Whitman et al., 2005; Léger et al., 2008; Greig et al., 2011; Fry
et al., 2013) Albeit one study showing a subtle elevation in base-
line atrogin-1 mRNA expression with ageing (Merritt et al., 2013),
age-related differences in basal atrogin-1 mRNA expression do
not occur (Welle et al., 2003; Whitman et al., 2005; Raue et al.,
2007; Léger et al., 2008; Dalbo et al., 2011; Greig et al., 2011; Fry
et al., 2013; Sandri et al., 2013). In response to single-bout RE
in human muscle, MURF1 mRNA increases in both younger and
older subjects 3–6 h post-RE (Raue et al., 2007; Fry et al., 2013).
Atrogin-1 mRNA is either unchanged between older vs. younger
individuals (Fry et al., 2013), or increases 4 h post-single-bout
RE in older individuals only (Raue et al., 2007). Although the
effect of RE on MURF1 and atrogin-1 expression has been well
described (for review see Russell, 2010), whether the protein lev-
els of muscle-speciﬁc E3-ubiquitin ligases as well as their substrate
targets are differentially altered in younger vs. older individuals in
human skeletal muscle in response to RE is yet to be investigated.
Therefore, the aim of the current study was to report the
gene and protein expression patterns of MURF1, atrogin-1 and
FBXO40, a gene encoding another muscle speciﬁc F-box protein
(Ye et al., 2007), the substrate targets PKM2, myogenin, MYOD,
MHC and EIF3F as well as MURF1 and atrogin-1 transcriptional
regulators FOXO1 and FOXO3 in older vs. younger individuals at
basal and in response to a single-bout of RE following overnight
fasting.
MATERIALS AND METHODS
SUBJECTS
Ten younger (18–30) and 10 older (60–75) healthy males par-
ticipated in the study. The study was approved by the Deakin
University Human Research Committee (#2011-043) in accor-
dance to the Declaration of Helsinki (2013)1. All participants gave
their informed consent and agreed to engage in muscle biop-
sies and physiological testing. The subjects were physically active
but had not participated in a RE training programme within 6
months prior to the study. Exclusion criteria included any type
of protein supplementation and anabolic steroids. Physiological
characteristics of the subjects are summarized in Table 2.
DUAL-ENERGY X-RAY ABSORPTIOMETRY SCAN (DXA)
Total body and regional (arms and legs) body composition [lean
mass (LM), fat mass (FM) and % body fat] and lumbar spine (L1-
L4) and proximal femur (femoral neck and total hip) areal bone
density (aBMD) were assessed via DXA (Lunar Prodigy, GE Lunar
Corp., Madison WI), using software version 12.30.008.
PRELIMINARY TESTING
At least 2 weeks prior to the single-bout exercise session, the
subjects were familiarized with the equipment (Nautilus Leg
Extension, Fitness Generation, Rowville, Australia) and correct
lifting technique. Their one-repetition-maximum (1RM) was
determined using a 5 RM test for leg extension exercise. Estimated
1 RM was then calculated using the Brzycki equation:
1RM = weight lifted (kg) /1.0278 − [reps to fatigue × 0.0278]
(Nascimento et al., 2007).
1http://www.wma.net/en/30publications/10policies/b3/
Frontiers in Physiology | Striated Muscle Physiology January 2014 | Volume 5 | Article 30 | 2
Stefanetti et al. Atrogene signaling with exercise and ageing
MUSCLE BIOPSIES
Skeletal muscle samples were obtained under local anesthesia (1%
Xylocaine) from the belly of the vastus lateralis muscle using a
percutaneous needle biopsy technique (Bergstrom, 1962) modi-
ﬁed to include suction (Evans et al., 1982). Following an incision
through the skin, muscle biopsies were taken using a Bergstrom
needle. The muscle samples were immediately frozen in liquid
nitrogen and used for RNA and protein extraction.
SINGLE-BOUT EXERCISE PROTOCOL
Subjects had been instructed to abstain from strenuous exercise,
caffeine and alcohol consumption for 24 h prior to the trial. One
night before the trial, the subjects were instructed to consume a
provided standardized meal containing 20% fat, 14% protein and
66% carbohydrate. The subjects arrived after an overnight fast
and rested in the supine position for 2 h prior to the sampling of
the 1st muscle biopsy. Immediately following the muscle biopsy,
subjects completed a 3-min light cycling warm-up followed by
a leg extension exercise session. The single-bout exercise proto-
col consisted of three sets of 14 repetitions at 60% of maximal
voluntary contraction (60% 1RM) with 2-min recovery between
sets. Immediately following this, subjects completed another 3-
min light cycling exercise, and were thereafter instructed to rest in
the supine position again. Two hours post-exercise, another mus-
cle biopsy was taken from the opposite leg to avoid any local effect
of the pre-exercise biopsy.
PROTEIN EXTRACTION AND WESTERN BLOTTING
Total protein from whole tissue lysates was extracted using
RIPA buffer (Millipore, North Ryde, Australia) with 1μL/mL
protease inhibitor cocktail (Sigma, Castle Hill, Australia)
and 10μL/mL Halt Phosphatase Inhibitor Single-Use Cocktail
(Thermo Scientiﬁc, Rockford, USA). Total protein content
was determined using the BCA Protein Assay Kit (Pierce
Biotechnology, Rockford, USA) according to the manufacturer’s
instructions. Proteins were separated by SDS-polyacrylamide
gel (PAGE) in a buffer containing 12mM Tris-HCl (pH 8.8),
200mM glycine and 0.1% SDS. Proteins were transferred onto
an Immobilon-FL PDVF membrane (Millipore, Billerica, MA)
in a Bjerrum buffer containing 50mM Tris, 17mM glycine
and 10% methanol. Membranes were blocked with 5% BSA
in PBS for 1 h at room temperature and were thereafter
incubated at 4◦C overnight with the following primary anti-
bodies diluted in 5% BSA in PBS: MURF1 (MP3401, ECM
Biosciences, Versailles, KY) at 1:1000; FBXO40 (H00051725-
B01P, Abnova, Taipei City, Taiwan) at 1:200; FOXO1 (C29H4,
Cell Signaling Technology, Danvers, MA) at 1:500; and FOXO3
(ab17026, Abcam, Cambridge, MA, USA) at 1:500; EIF3F (Jomar
Bioscience, Adelaide, Australia) at 1:500; MYOD (M-318: sc-760,
Santa Cruz Biotechnology) at 1:200; myogenin (MAB3876, Merck
Millipore, Billerica, MA) at 1:300; PKM2 (3198, Cell Signaling
Technology, Danvers, MA) at 1:1000; and MHC/ sarcomeric
myosin (MF 20, Developmental Studies Hybridoma Bank, Iowa
City, IA) at 1:1000. Alternatively, membranes were blocked with
5% BSA in TBST for 1 h at room temperature and were thereafter
incubated at 4◦C overnight with the following primary antibod-
ies: phospho-FOXO1 (Ser256, 9461, Cell Signaling Technology,
Danvers, MA) at 1:500; and phospho-FOXO3 (Ser253, 9466,
Cell Signaling Technology, Danvers, MA) at 1:400. FOXO1
and FOXO3 can be activated through phosphorylation by Akt
at Ser256 and Ser253, respectively, resulting in their nuclear
export and inhibition of transcription factor activity. Following
overnight primary antibody incubation, membranes were washed
with either PBS or TBST (4 × 5min) and were subsequently
incubated for 1 h with the following infrared-ﬂuorescent conju-
gated secondary antibodies, diluted at 1:5000 in PBS or TBST
containing 50% Odyssey® Blocking Buffer (LI-COR Biosciences,
Lincoln, USA) and 0.01% SDS: IRDye 800CW goat anti-rabbit
IgG (LI-COR Biosciences, Lincoln, USA) for MURF1, FOXO1,
phospho-FOXO1, phospho-FOXO3, EIF3F, MYOD and PKM2;
IRDye 800CW donkey anti-goat IgG (LI-COR Biosciences,
Lincoln, USA) for FOXO3; and Alexa Fluor® 680 rabbit anti-
mouse IgG (Invitrogen, Carlsbad, CA) for FBXO40, myogenin,
MHC and GAPDH. After washing, the proteins were exposed
on an Odyssey® Infrared Imaging System (LI-COR Biosciences,
Lincoln, USA) and individual protein band optical densities were
determined using the Odyssey® Image Studio Lite Version 3.3.4.
All blots were normalized against the GAPDH protein (G8795;
Sigma-Aldrich, Sydney, Australia) (see Figure A1B). Extended
western blot pictures for the proteins myogenin, MYOD and
FOXO3 are represented in Figure A2.
RNA EXTRACTION AND REVERSE TRANSCRIPTION
RNA was extracted from ∼15mg of skeletal muscle samples using
Tri-Reagent® Solution (Ambion Inc., Austin, TX, USA) accord-
ing to the manufacturer’s protocol. The RNA concentration was
assessed using the Nanodrop 1000 Spectrophotometer (Thermo
Fisher Scientiﬁc, MA, USA). The ratio between A260/A280 was
1.75–1.95 for all samples. First-strand cDNA was generated from
1μg RNA in 20μl reaction buffer using the High Capacity RT-
kit (Applied Biosystems, Carlsbad, CA, USA), 1 × RT buffer and
random primers, 8mM dNTP and 2.5U μl−1 MultiScribeTM RT
enzyme. The RT protocol consisted of 10min at 25◦C, 120min at
37◦C, 5min at 85◦C then cooled to 4◦C. The cDNA was stored at
−20◦C until further analysis.
REAL-TIME PCR
Real-time PCR (RT-PCR) was carried out using a Stratagene
MX3000 thermal cycler to measure mRNA levels. mRNA lev-
els for atrogin-1, MURF1, FX040, FOXO1 and FOXO3 were
measured using 1 × SYBR® Green PCR MasterMix (Applied
Biosystems, Carlsbad, CA, USA) and 5 ng of cDNA. To compen-
sate for variations in input RNA amounts and efﬁciency of the
reverse transcription, data were normalized to cyclophilin (see
Figure A1A). All primers were used at a ﬁnal concentration of
300 nM and probes at 100 nM. Primer details are provided in
Table 1. The PCR conditions were 1 cycle of 10min at 95◦C; 40
cycles of 30 s at 95◦C; 60 s at 60◦C. For cyclophilin, a melting
curve was included at the end of the PCR cycles. RT-PCR anal-
yses were conducted in triplicate. Ct values were obtained from
the MxPro QPCR software (Agilent Technologies, Santa Clara,
CA, USA). Mean Ct values and their standard error of the mean
(s.e.m.) were calculated for each of the samples. Ct values were
logarithmically transformed and mean log transformed Ct values
(referred to as arbitrary unit values) were then considered for
further analysis.
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Table 1 | PCR human primer sequences.
Gene GenBank accession number Sequences
MURF1 NM_032588.3 Forward CCTGAGAGCCATTGACTTTGG
Reverse CTTCCCTTCTGTGGACTCTTCCT
Probe (Texas Red)-AGGAAGAATTCATTGAAGAAGAAGATCAGG(BHQ-2)
FBXO32 (Atrogin-1) NM_058229.3 Forward GCAGCTGAACAACATTCAGATCAC
Reverse CAGCCTCTGCATGATGTTCAGT
Probe (FAM)-CTTCAAAGGCACCTTCACTGACCT G(BHQ-1)
FBXO40 NM_016298.3 Forward AGTCCACAGAGAGATCTG
Reverse TGTGCTCTACAATGTTGAA
Probe (HEX)-AGTTCAGCAGCCTCTTCTCCA(BHQ)
FOXO1 NM_002015 Forward AAGAGCGTGCCCTACTTCAA
Reverse CTGTTGTTGTCCATGGATGC
FOXO3 NM_001455 Forward CTTCAAGGATAAGGGCGACA
Reverse TCTTGCCAGTTCCCTCATT
PPIA (cyclophilin A) NM_021130 Forward CATCTGCACTGCCAAGACTGA
Reverse TTCATGCCTTCTTTCACTTTGC
MuRF1, muscle ring ﬁnger-1; FBXO32, F-box only protein 32/Atrogin-1, muscle atrophy F-box; FBXO40, F-box protein 40; FOXO1, forkhead transcription factor-1;
FOXO3, forkhead transcription factor-3; PPIA, peptidylprolyl isomerase A, cyclophilin A.
STATISTICAL METHODS
All data are reported as mean ± s.e.m. Unless speciﬁed differently,
a Two-Way analysis of variance (ANOVA) for age and exercise was
used to compare group means. Diagnostic plots of residuals and
ﬁtted values were checked to ensure homogeneity of variance (a
key assumption for ANOVA). Consequently, all data were log10-
transformed and analyses were conducted on these transformed
scales. The least signiﬁcant difference (LSD) test was used to com-
pare pairs of means. The signiﬁcance levels for both the F-tests in
the ANOVA and the LSD tests were set at p < 0.05.
RESULTS
SUBJECTS’ DEMOGRAPHICS
Table 2 summarizes the subjects’ physiological characteristics. No
signiﬁcant difference in body mass, tissue composition and maxi-
mal voluntary contraction (1 RM) could be observed between the
two subjects groups.
GENE EXPRESSION WITH EXERCISE AND AGEING
In both younger and older subjects MURF1, atrogin-1 (FBXO32)
and FBXO40 mRNA levels were signiﬁcantly increased 1.5-fold
and 1.3-fold (p < 0.05), 3.8-fold and 2-fold (p < 0.01) and
1.5-fold and 1.2-fold (p < 0.01), respectively, 2 h following RE
(Figure 1). In addition, FBXO40 mRNA levels were decreased by
25% in older subjects when compared to younger subjects (p <
0.01). Exercise and ageing had no effect on FOXO1 and FOXO3
mRNA levels (data not shown). No age × exercise interaction was
observed for any of the genes measured.
PROTEIN EXPRESSION WITH EXERCISE AND AGEING
A single-bout of RE did not inﬂuence the expression of any
of the proteins measured. In relation to the effect of age on
protein expression, FBXO40 protein levels were 1.5-fold higher
Table 2 | Subjects’ demographics.
Younger Older P-value
Age [years] 24.2 ± 0.9 66.6 ± 1.1 <0.05
Height [cm] 180.0 ± 2.0 174.60 ± 1.8 0.06
Body mass [kg] 73.8 ± 3.6 83.4 ± 7.1 0.25
Fat [kg] 13.6 ± 2.7 19.5 ± 3.9 0.23
Lean [kg] 57.9 ± 1.9 60.2 ± 3.3 0.55
BMC [kg] 3.3 ± 0.2 3.2 ± 0.2 0.67
BMI 23.3 ± 0.9 27.7 ± 1.9 0.10
Lean/total body mass 0.8 ± 0.02 0.7 ± 0.02 0.09
1 RM [kg] 98.2 ± 7.0 80.9 ± 7.2 0.1
Values are mean ± s.e.m. BMC, bone mass content; BMI, body mass
index; 1RM, 1 repetition maximum. Statistical signiﬁcance was determined by
unpaired Student’s t-tests.
in younger subjects than in older subjects (p < 0.01). We also
observed a trend (p = 0.051) for the effect of age on PKM2 pro-
tein levels, which were 1.6-fold higher in older subjects when
compared to younger subjects. Figure 2 depicts changes in pro-
tein expression as well as representative western blot pictures for
each protein measured.
DISCUSSION
Age-related muscle atrophy is linked to disrupted protein
turnover in MPS and MPB as well as reduced regenerative capac-
ity (Brack and Rando, 2007). When compared to younger sub-
jects, older subjects display an impaired phosphorylation of the
members of the MPS pathways at rest (Léger et al., 2008) and
impaired MPS following RE (Kumar et al., 2009), a phenomenon
referred to as anabolic resistance. However, how the UPP-related
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genes and proteins involved in MPB are regulated in older subjects
in response to RE and their potential contribution to anabolic
resistance is currently unknown.
Differences in the baseline expression levels of the skeletal
muscle MURF1 and atrogin-1 in younger vs. older individuals
is a contentious topic. This is due, at least partially, to the dis-
crepancies existing between the studied population cohorts in
terms of sex, age, physiological characteristics and level of ﬁtness.
For example, it is commonly acknowledged that the older sub-
jects recruited on a voluntary basis for an exercise trial protocol
FIGURE 1 | MURF1, atrogin-1 (FBXO32) and FBXO40 mRNA expression
following a single-bout of resistance exercise in younger and older
people. Note that no changes were observed for the other genes
measured. ∗signiﬁcant exercise effect, p < 0.05, ∗∗signiﬁcant exercise
effect, p < 0.01, ##signiﬁcantly different from Young, p < 0.01. The
reported statistical signiﬁcance is based on analysis of the transformed data
but the reported means ± s.e.m. are on the original (untransformed) scale.
are not representative of the average elderly population and that
their average level of ﬁtness is expected to be higher; a param-
eter that needs to be considered when comparing our results
to others. In the present study, we failed to observe an upreg-
ulation of MURF1 mRNA or protein in older subjects when
compared to younger subjects; a result in line with previous
results from our group (Léger et al., 2008) and others (Welle
et al., 2003; Whitman et al., 2005; Greig et al., 2011). However,
it has been reported that at baseline, MURF1 mRNA levels were
increased in older men displaying a similar average age and
level of ﬁtness as our subjects (Dalbo et al., 2011), as well as
in much older women (>80 years) (Raue et al., 2007) when
compared to younger individuals. Consistent with previous ﬁnd-
ings in humans, no age-related difference was found in the basal
level of atrogin-1 (FBXO32) mRNA (Welle et al., 2003; Whitman
et al., 2005; Raue et al., 2007; Léger et al., 2008; Dalbo et al.,
2011; Greig et al., 2011; Fry et al., 2013; Sandri et al., 2013).
Similarly, no age-dependent differences were observed at baseline
for FOXO1 and FOXO3 mRNA and protein or in the phosphory-
lation levels of FOXO1 and FOXO3 protein, the transcriptional
regulators of MURF1 and atrogin-1. Baseline FOXO3 mRNA
levels were increased in much older women (>80 years) com-
pared to younger women (Raue et al., 2007). At baseline, older
subjects had a lower cytosolic FOXO3 phosphorylation and a
higher total nuclear FOXO3 level compared to younger subjects
(Williamson et al., 2010); potentially resulting in more transcrip-
tional activity. However, we previously observed a decrease in
nuclear FOXO1 and FOXO3 protein in sarcopenic human skele-
tal muscle (Léger et al., 2008). Although we did not measure
nuclear proteins in this study, no differences in FOXO1 and
FOXO3 phosphorylation levels were observed between younger
FIGURE 2 | (A) FBXO40 and PKM2 protein expression following a
single-bout of resistance exercise in younger and older people. Note that
no changes were observed for the other proteins measured. ##signiﬁcantly
different from Young, p < 0.01. The reported statistical signiﬁcance is
based on analysis of the transformed data but the reported means ±
s.e.m. are on the original (untransformed) scale. (B) Representative
western blot images of the MURF1, total and phospho-FOXO1, total and
phospho-FOXO3, myogenin (MYOG), MYOD, MHC, and EIF3F proteins
measured before and after exercise. GAPDH was measured as a control
for protein loading.
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and older subjects. This suggests that the sub-cellular localization
of the FOXO proteins might not be a direct indication of their
activity.
Although other protein degradation mechanisms such as the
autophagy-lysosome system are unbalanced during age-related
muscle atrophy, at least in rodent muscle (for review see Bonaldo
and Sandri, 2013), our observations are consistent with recent
work demonstrating that the basal MPB rate does not signiﬁ-
cantly differ with ageing (Volpi et al., 1999, 2000, 2001; Hasten
et al., 2000; Paddon-Jones et al., 2004; Cuthbertson et al., 2005;
Katsanos et al., 2005, 2006; Rasmussen et al., 2006; Kumar et al.,
2009). However, gene and protein expression analysis 2 h post-
exercise can not be reﬂective of the whole MPB process occurring
following RE. Further investigations that include a post-exercise
time course and direct measure of MPB obtained at similar time
points are therefore required. Basic limitations of most MBP mea-
sures, including the AV balance approach, such as invasiveness,
possible inclusion of non-muscle tissue or potential variations
due to non-steady state conditions such as an exercise inter-
vention should yet be taken into account. Interestingly, genetic
deletion of atrogin-1 in rodents during ageing results in signif-
icant muscle atrophy and a shortened lifespan, while a reduced
muscle force occurs in both MURF1 and atrogin-1 aged knock-
out mice (Sandri et al., 2013); suggesting that these UPP genes
are essential for normal protein turnover during ageing (Sandri
et al., 2013).
MURF1, atrogin-1 and FBXO40 mRNA levels were all
increased by exercise, with no differential effect of exercise
between the age groups. MURF1 and atrogin-1 are typically reg-
ulated in response to a single-bout of RE. MURF1 mRNA is
commonly upregulated 1-4 h post-RE (Louis et al., 2007; Mascher
et al., 2008; Glynn et al., 2010). In contrast, some studies observed
no changes in atrogin-1 mRNA at 1–2 h post-exercise (Hulmi
et al., 2009; Glynn et al., 2010) or a decreased atrogin-1 mRNA
2 h post-exercise (Reitelseder et al., 2013). Raue et al. reported an
age effect in the increase of atrogin-1 mRNA, but not MURF1
mRNA, 4 h following RE in older women (>80 y.o.) (Raue et al.,
2007). However, in line with our ﬁndings, another study com-
paring similarly aged women to the study by Raue observed no
changes in MURF1 and atrogin-1 mRNA after 2.5 h of RE (Greig
et al., 2011). Again, different population cohorts and exercise pro-
tocols may lead to different or temporally shifted gene expression
patterns.
None of the proteins measured in this study displayed changes
in response to a single-bout of RE in any of the age groups.
The effects of single-bout RE on the protein levels and activ-
ity of FOXO1 and FOXO3 have only been partly described and
phosphorylation of FOXO3 was unaltered at 1 h following RE
(Glynn et al., 2010). However, MURF1 protein has been reported
to slightly increase at 1 h following bilateral leg extension exer-
cise (10 × 10 repetitions at 70% 1RM) (Glynn et al., 2010) and
at 3 h after unilateral leg press RE (4 × 10 repetitions at 80%
followed by 4 × 15 at 65% 1RM) (Borgenvik et al., 2012) in
untrained younger subjects; a difference that might be explained
by the lower intensity and total volume of work completed in
our study. Consistent with this result, the expression levels of
the MURF1 substrate targets PKM2 and MHC did not vary with
exercise. While atrogin-1 mRNA was induced by exercise, this
increase was not paralleled by a decrease in its substrate target
proteins MYOD, myogenin and EIF3F. A lack of visible change in
protein expression at 2 h post-exercise does not reﬂect a lack of
functional outcome. With respect to the delay existing between
gene transcription and protein translation, changes in protein
levels might occur later than 2 h post-exercise, as reported with
certain types of exercise protocols (Borgenvik et al., 2012). MPB
measured after a single-bout of RE has been shown to be max-
imal at 3 h post-exercise (Phillips et al., 1997), suggesting that
an increase in the proteolytic activity of MURF1 and atrogin-1
might occur concomitantly. In addition, E3-ubiquitin-ligases are
reported to self-ubiquinate, so that protein levels may not always
mirror mRNA levels (Sandri, 2013).
We report a decrease in FBXO40 gene and protein levels in
the muscle of older subjects when compared to younger subjects.
Similar to atrogin-1, FBXO40 is a gene encoding a muscle spe-
ciﬁc F-box protein (Ye et al., 2007). F-box proteins associate with
other proteins to form Skp1–Cullin1–F-box (SCF) complexes that
regulate proteasome-mediated protein breakdown via their ubiq-
uitin ligase activity. In skeletal muscle, FBXO40 ubiquitinates
and degrades insulin receptor substrate 1 (IRS1); the latter being
an upstream positive regulator of the PI3K/Akt pathway activity
(Shi et al., 2011). Mice lacking FBXO40 demonstrate abnormal
skeletal muscle hypertrophy. However, in humans, FBXO40 gene
expression decreases in the muscle of Limb-girdle muscular dys-
trophy (LGMD) patients (Ye et al., 2007). Attenuated FBXO40
expression in the skeletal muscle of older subjects might there-
fore reﬂect a compensatory mechanism to limit the amount of
age-related muscle wasting. It would be of interest to determine
if a resistance training intervention, potentially combined with
amino acid supplementation, would be able to rescue, at least par-
tially, the levels of FBXO40 in old muscle. Although we observed
no age-related change in MURF1 protein levels, PKM2 protein
expression tended to be higher in the older subjects when com-
pared to younger subjects. PKM2 is a substrate target for MURF1
(Hirner et al., 2008) and a molecular switch toward a more gly-
colytic phenotype ﬁber type (Gao and Cooper, 2013). A possible
hypothesis is that elevated PKM2 protein levels might account for
the reduced oxidative metabolism associated with muscle wasting
in older people (Rogers et al., 1990; Nair, 2005; Short et al., 2005),
even if oxidative metabolism or ﬁber type composition have not
been assessed in this study; however, PKM2 regulation is probably
multi-factorial.
In conclusion, we demonstrate that the UPP-related genes
involved in MPB display comparable regulation in healthy
younger and older subjects following RE. However, the lack of
signiﬁcant difference in the physiological characteristics, body
composition and level of ﬁtness of our older subjects when com-
pared to younger subjects must be considered when interpreting
these ﬁndings. We did not observe a change in the baseline levels
of atrogin-1 and MURF1 mRNA and protein of younger vs. older
individuals, but identiﬁed an age-related decline in FBXO40,
another recently described muscle speciﬁc F-box protein. Our
observations support the hypothesis that the UPP plays a limited
role in the disruption of the protein synthesis/degradation bal-
ance that is characteristic of age-related muscle atrophy. However,
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future investigations are required to measure skeletal MPB fol-
lowing RE in the ageing population. Additionally, measurements
of proteasomal content and/or proteasomal activity as well as
investigation of the role of other protein degradation mecha-
nisms, such as the autophagy-lysosome system, will aid in gaining
a deeper understanding of the contribution of the ubiquitin-
proteasome system in anabolic resistance.
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APPENDIX
FIGURE A1 | (A) Cyclophilin mRNA expression (AU), (B) GAPDH protein expression (AU) and representative blot for GAPDH protein analysis. IC, internal
control; Y, young; O, old.
FIGURE A2 | Representative western blots for the proteins myogenin (A), MYOD (B), and FOXO3 (C).
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